globalresearch のすべての投稿

微小残存病変検査の世界市場予測（～2027）：技術別、用途別、エンドユーザー別、地域別

■ 英語タイトル：Minimal Residual Disease Testing Market by Technology (PCR, Flow Cytometry, NGS), Application (Leukemia, Lymphoma, Solid Tumors), End User(Hospitals, Specialty Clinics, Diagnostic Labs, Research and Academic Institutes) & Region - Global Forecast to 2027
	■ 発行会社/調査会社：MarketsandMarkets ■ 商品コード：MD8516-23 ■ 発行日：2022年12月15日最新版(2025年又は2026年)はお問い合わせください。 ■ 調査対象地域：グローバル ■ 産業分野：医療機器 ■ ページ数：175 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後24時間以内）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧）	USD4,950 ⇒換算￥772,200	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥1,037,400	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥1,271,400	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[微小残存病変検査の世界市場予測（～2027）：技術別、用途別、エンドユーザー別、地域別]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

MarketsandMarkets社は、世界の微小残存病変検査市場規模が2022年12億ドルから2027年23億ドルに達し、予測期間中に年平均14.0％で成長すると予測しています。本調査資料では、微小残存病変検査の世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、技術別（PCR、NGS、フローサイトメトリー、その他）分析、用途別（血液ガン、固形腫瘍、その他）分析、エンドユーザー別（病院＆専門クリニック、診断検査室、研究＆教育機関、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、企業情報などの内容を掲載しています。また、本レポートに掲載されている企業情報には、Labcorp Inc. (US)、F. Hoffmann-La Roche Ltd. (Switzerland)、Guardant Health (US)、Sysmex Corporation (Japan)、NeoGenomics Laboratories,Inc. (US)、Adaptive Biotechnologies Corporation (US)、ArcherDX,Inc. (US)、Asuragen Inc. (US)、Arup Laboratories Inc. (US)、Bio-Rad Laboratories,Inc. (US)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の微小残存病変検査市場規模：技術別
- PCR技術の市場規模
- NGS技術の市場規模
- フローサイトメトリー技術の市場規模
- その他技術の市場規模
・世界の微小残存病変検査市場規模：用途別
- 血液ガンにおける市場規模
- 固形腫瘍における市場規模
- その他用途における市場規模
・世界の微小残存病変検査市場規模：エンドユーザー別
- 病院＆専門クリニックにおける市場規模
- 診断検査室における市場規模
- 研究＆教育機関における市場規模
- その他エンドユーザーにおける市場規模
・世界の微小残存病変検査市場規模：地域別
- 北米の微小残存病変検査市場規模
- ヨーロッパの微小残存病変検査市場規模
- アジア太平洋の微小残存病変検査市場規模
- 中南米の微小残存病変検査市場規模
- 中東・アフリカの微小残存病変検査市場規模
・競争状況
・企業情報

“世界の微小残存病変検査市場は、2022年に推定12億米ドルとなり、予測期間中のCAGRは14.0%で拡大し、2027年には23億米ドルに達すると予測”
市場成長の原動力は、がんや血液悪性腫瘍の患者数の増加、政府によるがんに関する啓発活動の活発化、企業間の共同研究や提携の増加です。

“微小残存病変検査市場において、予測期間中、技術別ではPCR分野が最も高い成長率を占める”
微小残存病変検査市場は、フローサイトメトリー、ポリメラーゼ連鎖反応（PCR）、次世代シーケンサー（NGS）に区分されます。2021年、微小残存病変検査市場で最も高い成長率を占めたのはPCRセグメントです。デバイスの使いやすさ、アッセイキットの入手のしやすさ、感度の高さが、このセグメントの大きなシェアに貢献している主な要因です。

“最も高いCAGRを占めた血液悪性腫瘍のアプリケーション分野”
微小残存病変検査市場は、アプリケーションに基づき、血液悪性腫瘍、固形腫瘍、その他のアプリケーションに区分されます。2021年には、血液悪性腫瘍のアプリケーションセグメントが最大のシェアを占めました。同分野の成長要因は、白血病、リンパ腫、およびそれらのタイプの罹患率の増加、およびこれらの疾患の患者の継続的なモニタリングに関する認識です。

“アジア太平洋：微小残存病変検査市場の急成長地域”
世界の微小残存病変検査市場は、北米、欧州、アジア太平洋地域、その他の地域に区分されます。アジア太平洋地域は予測期間中に最も高いCAGRを記録すると予測されています。
アジア太平洋地域の微小残存病変検査市場は、予測期間中に最も高いCAGRで成長すると予測されています。その主な理由は、医療インフラの改善、多くの患者集団の存在、同地域における主要企業の注力度の上昇、疾病の検出に関する認識を高めるための政府の取り組み、継続的な医療費の上昇、インドと中国における病院と臨床診断ラボの数の増加、インド、中国、日本における診断手順の研究基盤の強化です。

本レポートのために実施した一次インタビューは以下のように分類されます：
– 企業タイプ別 Tier1：20％、Tier2：45％、Tier3：35％
– 役職別 Cレベル：30％、Dレベル：20％、その他：50％
– 地域別北米36％、欧州25％、アジア太平洋地域27％、中南米9％、中東・アフリカ3％

レポート掲載企業一覧
• Labcorp Inc. (US)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Guardant Health (US)
• Sysmex Corporation (Japan)
• NeoGenomics Laboratories, Inc. (US)
• Adaptive Biotechnologies Corporation (US)
• ArcherDX, Inc. (US)
• Asuragen Inc. (US)
• Arup Laboratories Inc. (US)
• Bio-Rad Laboratories, Inc. (US)
• Cergentis B.V. (Netherlands)
• Molecular MD (ICON plc) (Ireland)
• Invivoscribe, Inc. (US)
• Mission Bio, Inc. (US)
• Natera, Inc. (US)
• Opko Health, Inc. (US)
• Quest Diagnostics (US)
• Genetron Health (China)

調査範囲
この調査レポートは、世界の微小残存病変検査市場を詳細に掲載しています。技術、用途、エンドユーザーなどの異なるセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要市場プレイヤーの企業プロフィール、最近の動向、主要市場戦略とともに、詳細な競合分析も掲載しています。

レポート購入の主な利点
本レポートは、微小残存病変検査市場全体とそのサブセグメントにおける収益数の最も近い近似値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競合状況をよりよく理解し、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるための洞察を深めるのにも役立ちます。本レポートは、関係者が市場のを理解し、主要な市場促進要因、阻害要因、機会、および課題に関する情報を提供することを可能にします。

*** レポート目次（コンテンツ）***

1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.2.1 INCLUSIONS AND EXCLUSIONS 25
1.3 MARKETS COVERED 26
1.3.1 MINIMAL RESIDUAL DISEASE TESTING MARKET SEGMENTATION 26
1.3.2 YEARS CONSIDERED 26
1.4 CURRENCY CONSIDERED 27
1.5 LIMITATIONS 27
1.6 STAKEHOLDERS 27
1.7 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
2.2 RESEARCH APPROACH 29
FIGURE 1 MINIMAL RESIDUAL DISEASE TESTING MARKET: RESEARCH DESIGN 29
2.2.1 SECONDARY DATA 30
2.2.1.1 Key data from secondary sources 30
2.2.2 PRIMARY DATA 31
2.2.2.1 Primary sources 32
2.2.2.2 Key data from primary sources 32
2.2.2.3 Key industry insights 33
2.2.2.4 Breakdown of primary interviews 33
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 33
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34
2.3 MARKET SIZE ESTIMATION 34
2.3.1 BOTTOM-UP APPROACH 35
2.3.1.1 Approach 1: Company revenue estimation 35
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 35
2.3.1.2 Approach 2: Presentations of companies and primary interviews 35
2.3.1.3 Growth forecast 36
2.3.1.4 CAGR projections 36
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 36
2.3.2 TOP-DOWN APPROACH 36
FIGURE 6 MINIMAL RESIDUAL DISEASE TESTING MARKET: TOP-DOWN APPROACH 37
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 38
FIGURE 7 DATA TRIANGULATION METHODOLOGY 38
2.5 MARKET SHARE 39
2.6 STUDY ASSUMPTIONS 39
2.7 GROWTH RATE ASSUMPTIONS 39
2.8 RISK ASSESSMENT 40
2.8.1 RISK ASSESSMENT: MINIMAL RESIDUAL DISEASE TESTING MARKET 40
3 EXECUTIVE SUMMARY 41
FIGURE 8 MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION) 41
FIGURE 9 MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 42
FIGURE 10 MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 42
FIGURE 11 MINIMAL RESIDUAL DISEASE TESTING MARKET, BY REGION, 2022 VS. 2027 (USD MILLION) 43
4 PREMIUM INSIGHTS 44
4.1 MINIMAL RESIDUAL DISEASE TESTING MARKET OVERVIEW 44
FIGURE 12 RISING INCIDENCE OF CANCER TO DRIVE MARKET 44
4.2 MINIMAL RESIDUAL DISEASE TESTING MARKET SHARE, BY TECHNOLOGY, 2022 VS. 2027 44
FIGURE 13 POLYMERASE CHAIN REACTION SEGMENT TO DOMINATE MARKET IN 2027 44
4.3 MINIMAL RESIDUAL DISEASE TESTING MARKET SHARE, BY APPLICATION, 2022 VS. 2027 45
FIGURE 14 HEMATOLOGICAL MALIGNANCIES WILL CONTINUE TO DOMINATE MARKET IN 2027 45
4.4 MINIMAL RESIDUAL DISEASE TESTING MARKET SHARE, BY END USER, 2022 VS. 2027 45
FIGURE 15 HOSPITALS & SPECIALTY CLINICS LARGEST END USERS OF MINIMAL RESIDUAL DISEASE TESTING 45
4.5 MINIMAL RESIDUAL DISEASE TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 46
FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
FIGURE 17 MINIMAL RESIDUAL DISEASE TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47
5.2.1 DRIVERS 48
5.2.1.1 Rising incidence of hematological malignancies 48
TABLE 1 HEMATOLOGIC CANCER INCIDENCE, BY TYPE, 2020 48
TABLE 2 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 48
5.2.1.2 Increasing collaborations and partnerships between pharmaceutical companies and product manufacturers 49
5.2.1.3 Increasing cancer awareness initiatives by global health organizations 49
5.2.2 RESTRAINTS 50
5.2.2.1 Complex regulatory frameworks delaying approval of new molecular diagnostics tests 50
5.2.2.2 High cost of minimal residual disease testing kits 50
5.2.3 OPPORTUNITIES 51
5.2.3.1 Growth opportunities in minimal residual disease testing in emerging countries 51
TABLE 3 INCIDENCE OF HEMATOLOGIC CANCERS, BY COUNTRY, 2018 VS. 2030 51
5.2.4 CHALLENGES 52
5.2.4.1 Unclear reimbursement scenario and policies for patients 52
5.3 PRICING ANALYSIS 52
TABLE 4 AVERAGE SELLING PRICE OF MINIMAL RESIDUAL DISEASE TESTING PRODUCTS (2022) 52
5.4 PATENT ANALYSIS 53
FIGURE 18 PATENT ANALYSIS FOR MINIMAL RESIDUAL DISEASE TESTING MARKET 53
5.4.1 LIST OF KEY PATENTS IN MINIMAL RESIDUAL DISEASE TESTING MARKET 54
5.5 VALUE CHAIN ANALYSIS 54
FIGURE 19 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 55
5.6 SUPPLY CHAIN ANALYSIS 56
FIGURE 20 MINIMAL RESIDUAL DISEASE TESTING MARKET: SUPPLY CHAIN ANALYSIS 56
5.7 ECOSYSTEM/MARKET ANALYSIS 57
FIGURE 21 MINIMAL RESIDUAL DISEASE TESTING MARKET: ECOSYSTEM/MARKET ANALYSIS 57
TABLE 5 MINIMAL RESIDUAL DISEASE TESTING MARKET: ROLE IN ECOSYSTEM 57
5.8 PORTER’S FIVE FORCES ANALYSIS 58
TABLE 6 MINIMAL RESIDUAL DISEASE TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS 58
5.8.1 THREAT OF NEW ENTRANTS 58
5.8.2 THREAT OF SUBSTITUTES 58
5.8.3 BARGAINING POWER OF BUYERS 58
5.8.4 BARGAINING POWER OF SUPPLIERS 58
5.8.5 DEGREE OF COMPETITION 59
5.9 REGULATORY ANALYSIS 59
TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 59
TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 59
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
5.9.1 NORTH AMERICA 61
5.9.1.1 US 61
5.9.1.2 Canada 61
5.9.2 EUROPE 61
5.9.3 ASIA PACIFIC 61
5.9.3.1 China 61
TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES 62
5.9.3.2 Japan 63
TABLE 13 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 63
5.9.4 LATIN AMERICA 64
5.9.4.1 Brazil 64
5.9.4.2 Mexico 64
5.9.5 MIDDLE EAST 64
5.9.6 AFRICA 64
5.10 TRADE ANALYSIS 65
5.10.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS/KITS 65
TABLE 14 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS/KITS, BY COUNTRY, 2017–2021 (USD MILLION) 65
TABLE 15 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS/KITS, BY COUNTRY, 2017–2021 (USD MILLION) 65
5.11 TECHNOLOGY ANALYSIS 66
5.12 KEY CONFERENCES AND EVENTS IN 2022–2023 66
TABLE 16 MINIMAL RESIDUAL DISEASE TESTING MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 66
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67
5.13.1 REVENUE SHIFT AND REVENUE POCKETS FOR MINIMAL RESIDUAL DISEASE TESTING PRODUCT MANUFACTURERS 67
FIGURE 22 REVENUE SHIFT IN MINIMAL RESIDUAL DISEASE TESTING MARKET 68
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 68
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 68
FIGURE 23 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP THREE APPLICATIONS 68
TABLE 17 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF MINIMAL RESIDUAL DISEASE TESTING PRODUCTS 69
5.14.2 BUYING CRITERIA 69
FIGURE 24 KEY BUYING CRITERIA FOR MINIMAL RESIDUAL DISEASE TESTING PRODUCTS 69
TABLE 18 KEY BUYING CRITERIA FOR MINIMAL RESIDUAL DISEASE TESTING PRODUCTS 69
5.15 CASE STUDY ANALYSIS 70
6 MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY 71
6.1 INTRODUCTION 72
TABLE 19 MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 72
6.2 POLYMERASE CHAIN REACTION 72
6.2.1 COST BENEFITS OF PCR TECHNOLOGY TO DRIVE ADOPTION 72
TABLE 20 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION) 73
6.3 NEXT-GENERATION SEQUENCING 73
6.3.1 HIGH SENSITIVITY AND ECONOMICAL BENEFITS TO BOOST MARKET 73
TABLE 21 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR NGS, BY REGION, 2020–2027 (USD MILLION) 74
6.4 FLOW CYTOMETRY 74
6.4.1 GROWING INCIDENCE AND PREVALENCE OF CANCER TO SUPPORT GROWTH 74
TABLE 22 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR FLOW CYTOMETRY, BY REGION, 2020–2027 (USD MILLION) 75
6.5 OTHER TECHNOLOGIES 75
TABLE 23 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2020–2027 (USD MILLION) 76
7 MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION 77
7.1 INTRODUCTION 78
TABLE 24 MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 78
7.2 HEMATOLOGICAL MALIGNANCIES 78
TABLE 25 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR HEMATOLOGICAL MALIGNANCIES, BY REGION, 2020–2027 (USD MILLION) 78
TABLE 26 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR HEMATOLOGICAL MALIGNANCIES, BY TYPE, 2020–2027 (USD MILLION) 79
7.2.1 LEUKEMIA 79
TABLE 27 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR LEUKEMIA, BY REGION, 2020–2027 (USD MILLION) 80
TABLE 28 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR LEUKEMIA, BY TYPE, 2020–2027 (USD MILLION) 80
7.2.1.1 Myeloid leukemia 80
7.2.1.1.1 High prevalence of AML in adults to support growth 80
TABLE 29 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR MYELOID LEUKEMIA, BY REGION, 2020–2027 (USD MILLION) 81
7.2.1.2 Lymphocytic leukemia 81
7.2.1.2.1 High incidence of ALL in children to drive market 81
TABLE 30 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR LYMPHOCYTIC LEUKEMIA, BY REGION, 2020–2027 (USD MILLION) 82
7.2.1.3 Other leukemias 82
TABLE 31 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR OTHER LEUKEMIAS, BY REGION, 2020–2027 (USD MILLION) 82
7.2.2 LYMPHOMA 83
TABLE 32 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR LYMPHOMA, BY REGION, 2020–2027 (USD MILLION) 83
TABLE 33 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR LYMPHOMA, BY TYPE, 2020–2027 (USD MILLION) 84
7.2.2.1 Non-Hodgkin lymphoma 84
7.2.2.1.1 Growing consumption of medications that suppress immune system to drive growth 84
TABLE 34 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR NON-HODGKIN LYMPHOMA, BY REGION, 2020–2027 (USD MILLION) 84
7.2.2.2 Hodgkin lymphoma 85
7.2.2.2.1 Growing incidence of Hodgkin lymphoma to propel MRD testing 85
TABLE 35 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR HODGKIN LYMPHOMA, BY REGION, 2020–2027 (USD MILLION) 85
7.3 SOLID TUMORS 85
7.3.1 ABILITY OF MRD TO ASSESS TREATMENT RESPONSE TO FUEL GROWTH 85
TABLE 36 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR SOLID TUMORS, BY REGION, 2020–2027 (USD MILLION) 86
7.4 OTHER APPLICATIONS 86
TABLE 37 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 86
8 MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER 87
8.1 INTRODUCTION 88
TABLE 38 MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 88
8.2 HOSPITALS & SPECIALTY CLINICS 88
8.2.1 INCREASING NUMBER OF PATIENTS VISITING HOSPITALS TO DRIVE GROWTH 88
TABLE 39 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR HOSPITALS & SPECIALTY CLINICS, BY REGION, 2020–2027 (USD MILLION) 89
8.3 DIAGNOSTIC LABORATORIES 89
8.3.1 ROBUST INFRASTRUCTURE AND SPECIALIZED TESTING CAPABILITIES TO SUPPORT GROWTH 89
TABLE 40 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 90
8.4 ACADEMIC & RESEARCH INSTITUTES 90
8.4.1 INCREASING RESEARCH ACTIVITIES TO BOOST MARKET 90
TABLE 41 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION) 90
8.5 OTHER END USERS 91
TABLE 42 MINIMAL RESIDUAL DISEASE TESTING MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION) 91
9 MINIMAL RESIDUAL DISEASE TESTING MARKET, BY REGION 92
9.1 INTRODUCTION 93
TABLE 43 MINIMAL RESIDUAL DISEASE TESTING MARKET, BY REGION, 2020–2027 (USD MILLION) 93
9.2 NORTH AMERICA 93
FIGURE 25 NORTH AMERICA: MINIMAL RESIDUAL DISEASE TESTING MARKET SNAPSHOT 94
TABLE 44 NORTH AMERICA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 94
TABLE 45 NORTH AMERICA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 95
TABLE 46 NORTH AMERICA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 95
TABLE 47 NORTH AMERICA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 95
9.2.1 US 96
9.2.1.1 Increasing prevalence of cancer to drive market 96
TABLE 48 US: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 96
TABLE 49 US: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 97
TABLE 50 US: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 97
9.2.2 CANADA 97
9.2.2.1 Availability of various cancer screening programs to support market growth 97
TABLE 51 CANADA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 98
TABLE 52 CANADA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 99
TABLE 53 CANADA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 99
9.3 EUROPE 99
TABLE 54 EUROPE: INCIDENCE OF LEUKEMIA, BY COUNTRY, 2020–2035 99
TABLE 55 EUROPE: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100
TABLE 56 EUROPE: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 100
TABLE 57 EUROPE: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 101
TABLE 58 EUROPE: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 101
9.3.1 GERMANY 101
9.3.1.1 Government support for research funding to support MRD testing market 101
TABLE 59 GERMANY: CANCER INCIDENCE, BY TYPE, 2020 102
TABLE 60 GERMANY: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 102
TABLE 61 GERMANY: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 103
TABLE 62 GERMANY: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 103
9.3.2 UK 103
9.3.2.1 Increasing number of diagnostic laboratories to propel market growth 103
TABLE 63 UK: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 104
TABLE 64 UK: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 104
TABLE 65 UK: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 105
9.3.3 FRANCE 105
9.3.3.1 Rising R&D expenditure in France to drive market 105
TABLE 66 FRANCE: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 105
TABLE 67 FRANCE: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 106
TABLE 68 FRANCE: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 106
9.3.4 ITALY 106
9.3.4.1 Favorable funding scenario to drive market 106
TABLE 69 ITALY: CANCER INCIDENCE, BY TYPE, 2020 106
TABLE 70 ITALY: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 107
TABLE 71 ITALY: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 107
TABLE 72 ITALY: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 108
9.3.5 SPAIN 108
9.3.5.1 Consolidation of laboratories in Spain to support market growth 108
TABLE 73 SPAIN: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 108
TABLE 74 SPAIN: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 109
TABLE 75 SPAIN: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 109
9.3.6 REST OF EUROPE 109
TABLE 76 REST OF EUROPE: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 110
TABLE 77 REST OF EUROPE: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 110
TABLE 78 REST OF EUROPE: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 110
9.4 ASIA PACIFIC 111
FIGURE 26 ASIA PACIFIC: MINIMAL RESIDUAL DISEASE TESTING MARKET SNAPSHOT 111
TABLE 79 ASIA PACIFIC: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 80 ASIA PACIFIC: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 112
TABLE 81 ASIA PACIFIC: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 112
TABLE 82 ASIA PACIFIC: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 113
9.4.1 CHINA 113
9.4.1.1 Growing public access to advanced healthcare facilities to drive market 113
TABLE 83 CHINA: HEMATOLOGY CANCER INCIDENCE, BY TYPE, 2020 113
TABLE 84 CHINA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 114
TABLE 85 CHINA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 114
TABLE 86 CHINA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 114
9.4.2 JAPAN 115
9.4.2.1 Universal healthcare reimbursement policy to support market growth 115
TABLE 87 JAPAN: HEMATOLOGY CANCER INCIDENCE, BY TYPE, 2020 115
TABLE 88 JAPAN: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 115
TABLE 89 JAPAN: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 116
TABLE 90 JAPAN: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 116
9.4.3 INDIA 116
9.4.3.1 Increasing private and public investments in healthcare system to drive market 116
TABLE 91 INDIA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 117
TABLE 92 INDIA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 117
TABLE 93 INDIA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 118
9.4.4 REST OF ASIA PACIFIC 118
TABLE 94 REST OF ASIA PACIFIC: GERIATRIC POPULATION, BY COUNTRY, 2019 118
TABLE 95 REST OF ASIA PACIFIC: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 119
TABLE 96 REST OF ASIA PACIFIC: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 119
TABLE 97 REST OF ASIA PACIFIC: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 119
9.5 LATIN AMERICA 120
9.5.1 INCREASING PRIVATE AND PUBLIC INVESTMENTS TO DRIVE MARKET 120
TABLE 98 LATIN AMERICA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 120
TABLE 99 LATIN AMERICA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 100 LATIN AMERICA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 121
9.6 MIDDLE EAST & AFRICA 121
9.6.1 INCREASING FUNDING IN RESEARCH TO DRIVE MARKET 121
TABLE 101 MIDDLE EAST & AFRICA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 122
TABLE 102 MIDDLE EAST & AFRICA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 122
TABLE 103 MIDDLE EAST & AFRICA: MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER, 2020–2027 (USD MILLION) 123
10 COMPETITIVE LANDSCAPE 124
10.1 OVERVIEW 124
10.2 STRATEGIES OF KEY PLAYERS/RIGHT TO WIN 124
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN MINIMAL RESIDUAL DISEASE TESTING MARKET 124
TABLE 104 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN MINIMAL RESIDUAL DISEASE TESTING MARKET 124
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 127
FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN MINIMAL RESIDUAL DISEASE TESTING MARKET 127
10.4 MARKET SHARE ANALYSIS 128
FIGURE 28 MINIMAL RESIDUAL DISEASE TESTING MARKET SHARE, BY KEY PLAYER (2021) 128
TABLE 105 MINIMAL RESIDUAL DISEASE TESTING MARKET: DEGREE OF COMPETITION 128
10.5 COMPANY EVALUATION QUADRANT 129
10.5.1 LIST OF EVALUATED VENDORS 129
10.5.2 STARS 129
10.5.3 EMERGING LEADERS 129
10.5.4 PERVASIVE PLAYERS 129
10.5.5 PARTICIPANTS 130
FIGURE 29 MINIMAL RESIDUAL DISEASE TESTING MARKET: COMPANY EVALUATION MATRIX FOR MAJOR PLAYERS, 2021 130
10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2021) 130
10.6.1 PROGRESSIVE COMPANIES 130
10.6.2 STARTING BLOCKS 131
10.6.3 RESPONSIVE COMPANIES 131
10.6.4 DYNAMIC COMPANIES 131
FIGURE 30 MINIMAL RESIDUAL DISEASE TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2021 131
10.7 COMPETITIVE BENCHMARKING 132
10.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS 132
FIGURE 31 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS 132
TABLE 106 MINIMAL RESIDUAL DISEASE TESTING MARKET: REGIONAL FOOTPRINT OF COMPANIES 132
TABLE 107 MINIMAL RESIDUAL DISEASE TESTING MARKET: PRODUCT & SERVICE FOOTPRINT OF COMPANIES 133
TABLE 108 MINIMAL RESIDUAL DISEASE TESTING MARKET: DETAILED LIST OF KEY STARTUPS/SMES 133
10.8 COMPETITIVE SCENARIO 134
10.8.1 PRODUCT LAUNCHES 134
TABLE 109 KEY PRODUCT LAUNCHES 134
10.8.2 DEALS 135
TABLE 110 KEY DEALS 135
11 COMPANY PROFILES 137
11.1 KEY PLAYERS 137
(Business overview, Products offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and competitive threats)*
11.1.1 ADAPTIVE BIOTECHNOLOGIES 137
TABLE 111 ADAPTIVE BIOTECHNOLOGIES: BUSINESS OVERVIEW 137
FIGURE 32 ADAPTIVE BIOTECHNOLOGIES: COMPANY SNAPSHOT (2021) 138
11.1.2 ARCHERDX (INVITAE CORPORATION) 140
TABLE 112 ARCHERDX (INVITAE CORPORATION): BUSINESS OVERVIEW 140
FIGURE 33 ARCHERDX (INVITAE CORPORATION): COMPANY SNAPSHOT (2021) 141
11.1.3 ASURAGEN, INC. 143
TABLE 113 ASURAGEN, INC.: BUSINESS OVERVIEW 143
11.1.4 BIO-RAD LABORATORIES, INC. 144
TABLE 114 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 144
FIGURE 34 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021) 145
11.1.5 F. HOFFMANN-LA ROCHE AG 147
TABLE 115 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW 147
FIGURE 35 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2021) 148
11.1.6 GUARDANT HEALTH, INC. 150
TABLE 116 GUARDANT HEALTH, INC.: BUSINESS OVERVIEW 150
FIGURE 36 GUARDANT HEALTH, INC.: COMPANY SNAPSHOT (2021) 151
11.1.7 MOLECULARMD (SUBSIDIARY OF ICON PLC) 154
TABLE 117 MOLECULAR MD (SUBSIDIARY OF ICON PLC): BUSINESS OVERVIEW 154
FIGURE 37 MOLECULAR MD (ICON PLC): COMPANY SNAPSHOT (2021) 154
11.1.8 INVIVOSCRIBE, INC. 156
TABLE 118 INVIVOSCRIBE, INC.: BUSINESS OVERVIEW 156
11.1.9 LABORATORY CORPORATION OF AMERICA HOLDINGS 158
TABLE 119 LABORATORY CORPORATION OF AMERICA HOLDINGS: BUSINESS OVERVIEW 158
FIGURE 38 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2021) 159
11.1.10 NATERA, INC. 161
TABLE 120 NATERA, INC.: BUSINESS OVERVIEW 161
FIGURE 39 NATERA, INC.: COMPANY SNAPSHOT (2021) 162
11.1.11 SYSMEX CORPORATION 163
TABLE 121 SYSMEX CORPORATION: BUSINESS OVERVIEW 163
FIGURE 40 SYSMEX CORPORATION: COMPANY SNAPSHOT (2021) 163
11.2 OTHER PLAYERS 165
11.2.1 NEOGENOMICS LABORATORIES 165
11.2.2 OPKO HEALTH, INC. 167
11.2.3 GENETRON HEALTH 168
11.2.4 QUEST DIAGNOSTICS, INC. 169
11.2.5 ARUP LABORATORIES INC. 170
11.2.6 MISSION BIO, INC. 171
11.2.7 CERGENTIS B.V. 172
*Details on Business overview, Products offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX 173
12.1 DISCUSSION GUIDE 173
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 176
12.3 CUSTOMIZATION OPTIONS 178
12.4 RELATED REPORTS 178
12.5 AUTHOR DETAILS 179

※参考情報

微小残存病変検査（MRD検査）は、がん治療後の患者における微小残存病変を検出するための重要な技術です。MRDとは、完全な寛解状態にあると見なされる患者においてもなお身体に残存する微小ながん細胞のことを指します。これらの微小残存病変は、通常の画像診断や血液検査では検出できないほど少量であるため、MRD検査はがんの再発リスクを評価するための有効な手段となります。
MRD検査には、いくつかの異なる方法があります。その中でも、最も広く利用されているのは、フローサイトメトリーとPCR（ポリメラーゼ連鎖反応）です。フローサイトメトリーは、細胞の表面マーカーを分析することで、特定のがん細胞を識別します。この方法は、特に白血病やリンパ腫の患者において有効です。一方、PCRは、がん細胞に特有な遺伝子を検出するために使用されます。この技術は、特に骨髄中の微小残存病変の検出に敏感であるため、血液癌だけでなく固形腫瘍にも適用できる可能性があります。

MRD検査の用途は多岐にわたります。まず、治療の効果を評価するための指標として用いられます。治療後にMRDが陰性である場合、患者の再発リスクが低いとされ、引き続き観察が行われます。一方、MRDが陽性であれば、再発のリスクが高まるため、早期の介入や追加治療が検討されます。また、治療戦略を変更する際の重要な情報源ともなります。例えば、特定の抗がん剤が効果を示さなかった場合、MRD検査を通じて別の治療法への切り替えがスムーズに進むことがあります。

現在、MRD検査はさまざまな血液がんや一部の固形腫瘍において標準的な検査方法として認識されています。特に、急性リンパ性白血病（ALL）や慢性リンパ性白血病（CLL）などでは、その有用性が高く評価されています。近年では、治療のたびにMRDをモニタリングすることで、個々の患者に合わせた精密医療が進められています。

MRDに関連する技術も進化を続けています。例えば、次世代シーケンシング（NGS）は、がん細胞の遺伝子レベルでの詳細な解析を可能にしています。この技術により、MRDを非常に高い感度で検出することが可能となり、より早期の再発の予測や治療の効果の評価が期待されています。また、血液中の循環腫瘍DNA（ctDNA）の測定は、非侵襲的にMRDを評価する新たな手法として注目されています。この方法は、患者に対する負担を軽減しながらも、高い感度での残存病変の評価を可能にします。

MRD検査が普及することで、がん治療における個別化医療が実現しつつあります。患者ごとの特性や病状に応じた適切な治療法を選択する際、MRDの情報は不可欠なものであり、治療効果を最大限に引き出すための重要な要素となっています。今後も、MRD検査の技術が進化し、さまざまながんに対する新たな治療戦略が確立されることが期待されます。これにより、患者の生存率の向上や生活の質の維持に貢献できるでしょう。MRDの理解が深まることで、がん治療の未来がより明るくなることを願っています。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

カテゴリ： IT/電子, MarketsandMarkets, 世界

電池製造機の世界市場予測（～2027）：製品種類別、電池種類別、用途別、地域別

■ 英語タイトル：Battery Production Machine Market by Machine Type (Mixing, Coating & Drying, Calendaring, Slitting, Electrode Stacking, Assembly & Handling, Formation & Testing Machines), Battery Type (NMC, NCA, LFP), Application and Region - Global Forecast to 2027
	■ 発行会社/調査会社：MarketsandMarkets ■ 商品コード：SE8515-23 ■ 発行日：2022年12月15日最新版(2025年又は2026年)はお問い合わせください。 ■ 調査対象地域：グローバル ■ 産業分野：半導体 ■ ページ数：210 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後24時間以内）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧）	USD4,950 ⇒換算￥772,200	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥1,037,400	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥1,271,400	見積依頼/購入/質問フォーム

★グローバルリサーチ資料[電池製造機の世界市場予測（～2027）：製品種類別、電池種類別、用途別、地域別]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

MarketsandMarkets社は、世界の電池製造機市場規模が2022年73億ドルから2027年194億ドルに達し、予測期間中に年平均21.5％で成長すると予測しています。本調査資料では、電池製造機の世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品種類別（混合機、コーティング＆乾燥機、カレンダー機、スリッター、電極積層機）分析、電池種類別（NMC、NCA、LFP）分析、用途別（自動車、再生可能エネルギー、工業）分析、地域別（北米、ヨーロッパ、アジア太平洋、その他地域）分析、競争状況、企業情報、隣接/関連市場などの内容を掲載しています。また、本レポートに掲載されている企業情報には、Wuxi Lead Intelligent Equipment Co.Ltd. (China)、Shenzhen Yinghe Technology Co.Ltd. (China)、Hitachi、Ltd. (Japan)、Schuler Group (Germany)、Durr Group (Germany)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の電池製造機市場規模：製品種類別
- 混合機の市場規模
- コーティング＆乾燥機の市場規模
- カレンダー機の市場規模
- スリッター機の市場規模
- 電極積層機機の市場規模
・世界の電池製造機市場規模：電池種類別
- NMCの市場規模
- NCAの市場規模
- LFPの市場規模
・世界の電池製造機市場規模：用途別
- 自動車における市場規模
- 再生可能エネルギーにおける市場規模
- 工業における市場規模
・世界の電池製造機市場規模：地域別
- 北米の電池製造機市場規模
- ヨーロッパの電池製造機市場規模
- アジア太平洋の電池製造機市場規模
- その他地域の電池製造機市場規模
・競争状況
・企業情報
・隣接/関連市場

“世界の電池製造機市場規模は、2022年の73億米ドルから2027年には194億米ドルまで、年平均成長率21.5%で成長すると推定”
近年、リチウムイオン電池の需要は、自動車、再生可能エネルギー、産業用途で目覚ましいペースで増加しています。軽量商用車、乗用小型車、バス、トラックなどの電気自動車の需要拡大に伴い、世界の自動車分野でもリチウムイオン電池の需要が急増しています。リチウムイオン電池メーカーは、EV用電池の効率を高めるためにさまざまな技術を採用しています。また、特にエネルギー貯蔵や産業用途向けに、電池をより効率的で安全かつ長持ちさせるための研究開発にも多額の投資が行われています。中国、欧州、米国、日本、インドが最大のEV市場になると予想されています。EV市場におけるリチウムイオン電池の需要動向の上昇に伴い、電池製造機の需要は急増すると予測されます。

“2027年、電池製造機市場で形成・試験機が最大シェアを占める”
セルの形成と試験は、組み立てが完了してから実施されます。セルの組み立てが完了した後、少なくとも1回、慎重に時間を決めた充放電サイクルにセルを通すことで、作動材料を活性化し、使用可能な状態に変換する必要があります。充電プロセスは低電圧から始まり、通常の定電流・定電圧ではなく、徐々に上昇していきます。この徐々に電圧を上昇させるプロセスを形成プロセスと呼びます。このプロセスでは、異なるリチウムイオン電池化学物質用の負極にSEI（固体電解質界面）を形成します。この不動態化層は、通常の使用において充電プロセスを制御するために非常に重要です。また、バッテリーセルやバッテリーバックの最終出荷前に、バッテリーの品質検査が行われます。これはバッテリーの事故や不具合を避けるための重要なテストです。したがって、組み立て工程の後、電池は、形成および試験工程によって品質検査されます。

“予測期間中、欧州市場が最も高いCAGRで成長する見込み”
欧州は自動車メーカーの存在感が大きく、e-モビリティのトレンドの高まりに伴い、この地域では電気自動車用電池の膨大な需要が生まれています。さらに、化石燃料から再生可能エネルギー発電へのシフトが進んでおり、家電、電気自動車、エネルギー貯蔵などあらゆる分野で、リチウムイオン電池などの持続可能な電池の需要が増加しています。この需要に対応するため、欧州電池アライアンスは “Battery 2030+”のような取り組みを行っています。これは、この地域における新しい電池技術の研究、開発、発明を推進する大規模な研究イニシアチブです。このイニシアチブは、電池の研究開発を加速するための欧州委員会による2億6500万米ドルの支援の一環です。

本レポートで紹介する主なプレーヤーは以下の通りです：Wuxi Lead Intelligent Equipment Co., Ltd. (China), Shenzhen Yinghe Technology Co., Ltd. (China), Hitachi, Ltd. (Japan), Schuler Group (Germany), Durr Group (Germany) など

調査範囲
本レポートでは、機械タイプ、電池タイプ、用途、地域に基づくセグメント化により、電池製造機市場を詳細に調査しています。機械タイプには、混合、コーティングと乾燥、カレンダー、スリット、電極積層、組み立てとハンドリング、形成とテストなどの製造工程で使用される様々な機械が含まれます。電池の種類には、ニッケル・コバルト・アルミニウム（NCA）、ニッケル・マンガン・コバルト（NMC）、リン酸鉄リチウム（LFP）などがあります。さらに、本レポートでは、電池製造機の自動車、再生可能エネルギー、産業用アプリケーションをカバーしています。また、市場は北米、アジア太平洋、欧州、RoWの4地域に区分されています。

レポート購入の主な利点
本レポートは、本市場における市場リーダー/新規参入企業にとって、以下の点で役立ちます：
本レポートは、バッテリー製造機市場を包括的にセグメント化し、全体市場規模および機械タイプ、バッテリータイプ、用途、地域を含むサブセグメントに最も近い近似値を提供します。
本レポートは、利害関係者が市場動向を理解するのに役立ち、バッテリー製造機市場に関連する主要な促進要因、阻害要因、課題、機会に関する情報を提供します。
本レポートは、利害関係者が競合他社をよりよく理解し、ビジネスにおける地位を高めるためのより多くの洞察を得るのに役立ちます。
競争環境のセクションには、競合他社のエコシステム、主要市場企業が実施した製品発表や買収などの成長戦略が含まれます。

*** レポート目次（コンテンツ）***

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS AND EXCLUSIONS 30
1.3 STUDY SCOPE 31
1.3.1 MARKETS COVERED 31
FIGURE 1 BATTERY PRODUCTION MACHINE MARKET: SEGMENTATION 31
1.3.2 REGIONAL SCOPE 31
1.3.3 YEARS CONSIDERED 32
1.4 CURRENCY CONSIDERED 32
1.5 LIMITATIONS 32
1.6 STAKEHOLDERS 33
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA 34
FIGURE 2 BATTERY PRODUCTION MACHINE MARKET: RESEARCH DESIGN 34
2.1.1 SECONDARY AND PRIMARY RESEARCH 35
FIGURE 3 BATTERY PRODUCTION MACHINE MARKET: RESEARCH APPROACH 36
2.1.2 SECONDARY DATA 37
2.1.2.1 List of major secondary sources 37
2.1.2.2 Key data from secondary sources 38
2.1.3 PRIMARY DATA 38
2.1.3.1 Primary interviews with experts 39
2.1.3.2 Key data from primary sources 39
2.1.3.3 Key industry insights 40
2.1.3.4 Breakdown of primaries 40
2.2 MARKET SIZE ESTIMATION 41
2.2.1 BOTTOM-UP APPROACH 41
2.2.1.1 Approach to derive market size using bottom-up analysis 41
FIGURE 4 BATTERY PRODUCTION MACHINE MARKET: BOTTOM-UP APPROACH 42
2.2.2 TOP-DOWN APPROACH 42
2.2.2.1 Approach to derive market size using top-down analysis 42
FIGURE 5 BATTERY PRODUCTION MACHINE MARKET: TOP-DOWN APPROACH 43
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY FOR BATTERY PRODUCTION MACHINE MARKET USING SUPPLY-SIDE ANALYSIS 43
2.3 DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION 44
2.4 RESEARCH ASSUMPTIONS 45
2.5 RISK ASSESSMENT 46
3 EXECUTIVE SUMMARY 47
FIGURE 8 BATTERY PRODUCTION MACHINE MARKET, 2018–2027 (USD MILLION) 47
FIGURE 9 COATING AND DRYING MACHINES SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 48
FIGURE 10 NICKEL MANGANESE COBALT (NMC) SEGMENT TO HOLD LARGEST MARKET SHARE DURING FORECAST PERIOD 49
FIGURE 11 AUTOMOTIVE SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 49
FIGURE 12 EUROPE TO EXHIBIT HIGHEST CAGR IN BATTERY PRODUCTION MACHINE MARKET DURING FORECAST PERIOD 50
4 PREMIUM INSIGHTS 51
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS OPERATING IN BATTERY PRODUCTION MACHINE MARKET 51
FIGURE 13 RISING DEMAND FOR LITHIUM-ION BATTERIES IN AUTOMOTIVE SECTOR 51
4.2 BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE 51
FIGURE 14 FORMATION AND TESTING MACHINES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 51
4.3 BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE 52
FIGURE 15 NMC SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 52
4.4 BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION 52
FIGURE 16 AUTOMOTIVE SEGMENT TO HOLD LARGEST SHARE OF BATTERY PRODUCTION MACHINE MARKET IN 2027 52
4.5 NORTH AMERICAN BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION AND COUNTRY 53
FIGURE 17 AUTOMOTIVE SEGMENT AND US TO HOLD LARGEST SHARES OF NORTH AMERICAN BATTERY PRODUCTION MACHINE MARKET IN 2027 53
4.6 BATTERY PRODUCTION MACHINE MARKET, BY COUNTRY 53
FIGURE 18 GERMANY TO EXHIBIT HIGHEST CAGR IN BATTERY PRODUCTION MACHINE MARKET FROM 2022 TO 2027 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
FIGURE 19 BATTERY PRODUCTION MACHINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
5.2.1 DRIVERS 55
5.2.1.1 Expanding electric vehicle (EV) industry 55
FIGURE 20 GLOBAL ELECTRIC VEHICLE (EV) STOCK, BY COUNTRY/REGION, 2010–2020 (MILLION UNITS) 55
FIGURE 21 EV SALES AND SHARE IN CHINA, 2016–2021 (THOUSAND UNITS) 56
FIGURE 22 EV SALES AND SHARE IN US, 2016–2021 (THOUSAND UNITS) 56
FIGURE 23 EV SALES AND SHARE IN EUROPE, 2016–2021 (THOUSAND UNITS) 57
5.2.1.2 Increasing number of lithium-ion gigafactories 57

TABLE 1 UPCOMING BATTERY FACTORIES WORLDWIDE 58
5.2.1.3 Presence of favorable government policies and regulations 58
TABLE 2 GLOBAL EV-RELATED POLICY OUTLOOK 59
FIGURE 24 BATTERY PRODUCTION MACHINE MARKET: IMPACT ANALYSIS OF DRIVERS 59
5.2.2 RESTRAINTS 60
5.2.2.1 Requirement for high initial investments and setup costs 60
FIGURE 25 BATTERY PRODUCTION MACHINE MARKET: IMPACT ANALYSIS OF RESTRAINTS 60
5.2.3 OPPORTUNITIES 60
5.2.3.1 Emerging energy storage applications 60
FIGURE 26 ANNUAL GRID-SCALE BATTERY STORAGE ADDITIONS, BY COUNTRY/REGION, 2016–2021 (GW) 61
5.2.3.2 Rising demand for lithium-ion batteries in various industries 61
FIGURE 27 BATTERY PRODUCTION MACHINE MARKET: IMPACT ANALYSIS OF OPPORTUNITIES 62
5.2.4 CHALLENGES 62
5.2.4.1 Continuous development of new battery technologies 62
FIGURE 28 BATTERY PRODUCTION MACHINE MARKET: IMPACT ANALYSIS OF CHALLENGES 62
5.3 EV SECTOR: KEY STRATEGIC ALLIANCES 63
TABLE 3 STRATEGIC PARTNERSHIPS BETWEEN KEY BATTERY MANUFACTURERS AND AUTOMAKERS 63
5.4 LITHIUM-ION BATTERY PRODUCTION: FUTURE PLANS AND OUTLOOK 64
TABLE 4 GLOBAL GIGAFACTORIES OUTLOOK TILL 2030, BY KEY COMPANY 64
TABLE 5 UPCOMING GIGAFACTORIRES IN US 66
5.5 VALUE CHAIN ANALYSIS 66
FIGURE 29 BATTERY PRODUCTION MACHINE MARKET: VALUE CHAIN ANALYSIS 67
5.6 ECOSYSTEM ANALYSIS 69
FIGURE 30 BATTERY PRODUCTION MACHINE MARKET: ECOSYSTEM ANALYSIS 69
TABLE 6 BATTERY PRODUCTION MACHINE MARKET: ECOSYSTEM ANALYSIS 69
5.7 PRICING ANALYSIS 70
5.7.1 BATTERY PRODUCTION PLANT: COST DISTRIBUTION 71
FIGURE 31 BATTERY PRODUCTION PLANT: COST DISTRIBUTION 71
5.7.2 AVERAGE SELLING PRICE OF ELECTRODE STACKING MACHINES OFFERED BY KEY PLAYERS 71
FIGURE 32 AVERAGE SELLING PRICE OF ELECTRODE STACKING MACHINES OFFERED BY KEY PLAYERS 71
TABLE 7 AVERAGE SELLING PRICE OF ELECTRODE STACKING MACHINES OFFERED BY KEY PLAYERS (USD) 72
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 72
FIGURE 33 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS OPERATING IN BATTERY PRODUCTION MACHINE MARKET 72
5.9 TECHNOLOGY ANALYSIS 73
5.9.1 AUTOMATION AND DIGITAL TRANSFORMATION IN BATTERY MANUFACTURING 73
5.9.2 EMERGING LITHIUM-ION BATTERY TECHNOLOGIES 73
5.10 PORTER’S FIVE FORCES ANALYSIS 74
TABLE 8 BATTERY PRODUCTION MACHINE MARKET: PORTER’S FIVE FORCES ANALYSIS 74
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 75
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 75
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 75
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%) 75
5.11.2 BUYING CRITERIA 76
FIGURE 35 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 76
TABLE 10 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 76
5.12 CASE STUDY ANALYSES 77
TABLE 11 BRITISHVOLT USES BUHLER’S LOW-CARBON BATTERY MIXING TECHNOLOGY 77
TABLE 12 CELLFORCE SELECTED DURR GROUP’S COATING ELECTRODE TECHNOLOGY TO BOOST PRODUCTION CAPACITY 77
TABLE 13 INOBAT INSTALLED BATTERY PRODUCTION TURNKEY SOLUTIONS TO MANUFACTURE PREMIUM ELECTRIC BATTERIES 77
5.13 TRADE ANALYSIS 78
FIGURE 36 IMPORT OF LITHIUM CELLS AND BATTERIES, BY COUNTRY, 2017–2021 (USD MILLION) 78
FIGURE 37 EXPORT OF LITHIUM CELLS AND BATTERIES, BY COUNTRY, 2017–2021 (USD MILLION) 78
5.14 PATENT ANALYSIS 79
FIGURE 38 TOP 10 COMPANIES WITH HIGHEST NUMBER OF PATENT APPLICATIONS IN LAST 10 YEARS 79
TABLE 14 TOP 20 PATENT OWNERS IN US IN LAST 10 YEARS 79
FIGURE 39 NUMBER OF PATENTS GRANTED PER YEAR, 2012–2021 80
TABLE 15 BATTERY PRODUCTION MACHINE MARKET: LIST OF PATENTS, 2020–2022 80
5.15 KEY CONFERENCES AND EVENTS, 2022–2023 82
TABLE 16 BATTERY PRODUCTION MACHINE MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 82
5.16 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
TABLE 17 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
TABLE 18 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 19 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 20 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
5.16.1 REGULATORY LANDSCAPE 85
TABLE 21 STANDARDS RELATED TO LITHIUM-ION BATTERIES 85

6 BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE 87
6.1 INTRODUCTION 88
FIGURE 40 BATTERY MANUFACTURING PROCESS: THREE KEY STAGES 88
FIGURE 41 BATTERY MANUFACTURING PROCESS: FLOW CHART 88
FIGURE 42 FORMATION AND TESTING MACHINES SEGMENT TO HOLD LARGEST SHARE OF BATTERY PRODUCTION MACHINE MARKET DURING FORECAST PERIOD 89
TABLE 22 BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE, 2018–2021 (USD MILLION) 89
TABLE 23 BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE, 2022–2027 (USD MILLION) 90
FIGURE 43 ELECTRODE MANUFACTURING PROCESS: KEY BASIC STAGES 90
6.2 MIXING MACHINES 90
6.2.1 GROWING NEED TO ACCURATELY BLEND RAW MATERIALS 90
FIGURE 44 MIXING MACHINE 91
FIGURE 45 BUHLER’S CONTINUOUS MIXING PROCESS FOR ELECTRODE SLURRIES 91
TABLE 24 MIXING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2018–2021 (USD MILLION) 92
TABLE 25 MIXING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2022–2027 (USD MILLION) 92
TABLE 26 MIXING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2018–2021 (USD MILLION) 92
TABLE 27 MIXING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2022–2027 (USD MILLION) 93
6.3 COATING AND DRYING MACHINES 93
6.3.1 HIGH DEMAND FOR UNIFORMITY AND CONSISTENCY IN MANUFACTURING PROCESSES 93
FIGURE 46 COATING MACHINE 93
FIGURE 47 HITACHI’S COATAR-DRYER MACHINE 94
FIGURE 48 DURR’S SIMULTANEOUS TWO-SIDED ELECTRODE COATING PROCESS 94
TABLE 28 COATING AND DRYING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2018–2021 (USD MILLION) 95
TABLE 29 COATING AND DRYING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2022–2027 (USD MILLION) 95
TABLE 30 COATING AND DRYING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2018–2021 (USD MILLION) 95
TABLE 31 COATING AND DRYING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2022–2027 (USD MILLION) 96
6.4 CALENDARING MACHINES 96
6.4.1 INCREASING DEMAND FOR HIGH ENERGY DENSITY IN BATTERIES 96
FIGURE 49 CALENDARING MACHINE 96
FIGURE 50 CALENDARING MACHINE 97
TABLE 32 CALENDARING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2018–2021 (USD MILLION) 97
TABLE 33 CALENDARING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2022–2027 (USD MILLION) 97
TABLE 34 CALENDARING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2018–2021 (USD MILLION) 98
TABLE 35 CALENDARING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2022–2027 (USD MILLION) 98
6.5 SLITTING MACHINES 99
6.5.1 GROWING USE OF SLITTING MACHINES TO ACHIEVE DESIRED BATTERY MEASUREMENTS 99
FIGURE 51 BATTERY ELECTRODE SLITTING MACHINE 99
TABLE 36 SLITTING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2018–2021 (USD MILLION) 99
TABLE 37 SLITTING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2022–2027 (USD MILLION) 100
TABLE 38 SLITTING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2018–2021 (USD MILLION) 100
TABLE 39 SLITTING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2022–2027 (USD MILLION) 100
6.6 ELECTRODE STACKING MACHINES 101
6.6.1 GROWING NEED TO ACHIEVE HIGH MANUFACTURING SPEED 101
FIGURE 52 ELECTRODE STACKING MACHINE 101
FIGURE 53 ELECTRODE STACKING MACHINE 102
TABLE 40 ELECTRODE STACKING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2018–2021 (USD MILLION) 102
TABLE 41 ELECTRODE STACKING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2022–2027 (USD MILLION) 102
TABLE 42 ELECTRODE STACKING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2018–2021 (USD MILLION) 103
TABLE 43 ELECTRODE STACKING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2022–2027 (USD MILLION) 103
6.7 ASSEMBLING AND HANDLING MACHINES 103
6.7.1 HIGH EFFICIENCY OF AUTOMATIC ASSEMBLY LINES 103
FIGURE 54 ASSEMBLY MACHINE 104
TABLE 44 ASSEMBLING AND HANDLING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2018–2021 (USD MILLION) 104
TABLE 45 ASSEMBLING AND HANDLING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2022–2027 (USD MILLION) 104
TABLE 46 ASSEMBLING AND HANDLING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2018–2021 (USD MILLION) 105
TABLE 47 ASSEMBLING AND HANDLING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2022–2027 (USD MILLION) 105
6.8 FORMATION AND TESTING MACHINES 105
6.8.1 GROWING USE OF TESTING MACHINES TO INCREASE BATTERY SAFETY 105
FIGURE 55 FORMATION AND TESTING SYSTEM 106
FIGURE 56 FORMATION MACHINE 106
FIGURE 57 TESTING MACHINE 107
TABLE 48 FORMATION AND TESTING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2018–2021 (USD MILLION) 107
TABLE 49 FORMATION AND TESTING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2022–2027 (USD MILLION) 107
TABLE 50 FORMATION AND TESTING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2018–2021 (USD MILLION) 108
TABLE 51 FORMATION AND TESTING MACHINES: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2022–2027 (USD MILLION) 108
7 BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE 109
7.1 INTRODUCTION 110
FIGURE 58 BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE 110
FIGURE 59 DEVELOPMENT ROADMAP OF LITHIUM-ION BATTERY MATERIALS IN EV SECTOR 110
TABLE 52 BATTERY PERFORMANCE COMPARISON: NCA VS. NMC VS. LFP 111
TABLE 53 COMPARISON OF KEY ATTRIBUTES IN EV BATTERY CHEMISTRIES 111
FIGURE 60 NMC SEGMENT TO HOLD LARGEST SHARE OF BATTERY PRODUCTION MACHINE MARKET DURING FORECAST PERIOD 112
TABLE 54 BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2018–2021 (USD MILLION) 112
TABLE 55 BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2022–2027 (USD MILLION) 112
7.2 NICKEL COBALT ALUMINUM (NCA) 113
7.2.1 RISING DEMAND FOR NCA BATTERIES IN HIGH ENERGY DENSITY APPLICATIONS 113
TABLE 56 NCA BATTERY: KEY CHARACTERISTICS 113
TABLE 57 NCA: BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE, 2018–2021 (USD MILLION) 113
TABLE 58 NCA: BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE, 2022–2027 (USD MILLION) 114
TABLE 59 NCA: BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 114
TABLE 60 NCA: BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 114
TABLE 61 NCA: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2018–2021 (USD MILLION) 115
TABLE 62 NCA: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2022–2027 (USD MILLION) 115
7.3 NICKEL MANGANESE COBALT (NMC) 115
7.3.1 INCREASING DEMAND FOR NMC BATTERIES IN ENTRY-LEVEL ELECTRIC VEHICLES (EVS) 115
TABLE 63 NMC BATTERY: KEY CHARACTERISTICS 116
TABLE 64 NMC: BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE, 2018–2021 (USD MILLION) 116
TABLE 65 NMC: BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE, 2022–2027 (USD MILLION) 117
TABLE 66 NMC: BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 117
TABLE 67 NMC: BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 117
TABLE 68 NMC: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2018–2021 (USD MILLION) 118
TABLE 69 NMC: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2022–2027 (USD MILLION) 118
7.4 LITHIUM IRON PHOSPHATE (LFP) 118
7.4.1 GROWING USE OF LFP BATTERIES IN HIGH-POWER DEVICES AND EQUIPMENT 118
TABLE 70 LFP BATTERY: KEY CHARACTERISTICS 119
TABLE 71 LFP: BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE, 2018–2021 (USD MILLION) 119
TABLE 72 LFP: BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE, 2022–2027 (USD MILLION) 120
TABLE 73 LFP: BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 120
TABLE 74 LFP: BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 120
TABLE 75 LFP: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2018–2021 (USD MILLION) 121
TABLE 76 LFP: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2022–2027 (USD MILLION) 121
8 BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION 122
8.1 INTRODUCTION 123
FIGURE 61 BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION 123
FIGURE 62 AUTOMOTIVE SEGMENT TO HOLD LARGEST SHARE OF BATTERY PRODUCTION MACHINE MARKET DURING FORECAST PERIOD 123
TABLE 77 BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 124
TABLE 78 BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 124
8.2 AUTOMOTIVE 124
8.2.1 GROWING GLOBAL DEMAND FOR ELECTRIC VEHICLES (EVS) 124
FIGURE 63 GLOBAL EV OUTLOOK, 2020–2030 (MILLION UNITS) 125
TABLE 79 AUTOMOTIVE: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2018–2021 (USD MILLION) 125
TABLE 80 AUTOMOTIVE: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2022–2027 (USD MILLION) 126
TABLE 81 AUTOMOTIVE: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2018–2021 (USD MILLION) 126
TABLE 82 AUTOMOTIVE: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2022–2027 (USD MILLION) 126
8.3 RENEWABLE ENERGY 127
8.3.1 HIGH ADOPTION OF RENEWABLE ENERGY SOURCES 127
TABLE 83 TOP 10 COUNTRIES, BY TOTAL INSTALLED PV CAPACITY, 2021 127
TABLE 84 RENEWABLE ENERGY: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2018–2021 (USD MILLION) 128
TABLE 85 RENEWABLE ENERGY: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2022–2027 (USD MILLION) 128
TABLE 86 RENEWABLE ENERGY: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2018–2021 (USD MILLION) 129
TABLE 87 RENEWABLE ENERGY: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2022–2027 (USD MILLION) 129
8.4 INDUSTRIAL 129
8.4.1 HIGH SAFETY AND LONG OPERATIONAL LIFE OF LITHIUM-ION BATTERIES 129
TABLE 88 INDUSTRIAL: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2018–2021 (USD MILLION) 130
TABLE 89 INDUSTRIAL: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2022–2027 (USD MILLION) 130
TABLE 90 INDUSTRIAL: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2018–2021 (USD MILLION) 131
TABLE 91 INDUSTRIAL: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2022–2027 (USD MILLION) 131
9 BATTERY PRODUCTION MACHINE MARKET, BY REGION 132
9.1 INTRODUCTION 133
FIGURE 64 BATTERY PRODUCTION MACHINE MARKET, BY REGION 133
FIGURE 65 GERMANY TO EXHIBIT HIGHEST CAGR IN BATTERY PRODUCTION MACHINE MARKET DURING FORECAST PERIOD 133
TABLE 92 BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2018–2021 (USD MILLION) 134
TABLE 93 BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2022–2027 (USD MILLION) 134
9.2 NORTH AMERICA 134
FIGURE 66 NORTH AMERICA: SNAPSHOT OF BATTERY PRODUCTION MACHINE MARKET 135
FIGURE 67 US TO ACCOUNT FOR LARGER SHARE OF NORTH AMERICAN BATTERY PRODUCTION MACHINE MARKET DURING FORECAST PERIOD 135
TABLE 94 NORTH AMERICA: BATTERY PRODUCTION MACHINE MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 136
TABLE 95 NORTH AMERICA: BATTERY PRODUCTION MACHINE MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 136
TABLE 96 NORTH AMERICA: BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE, 2018–2021 (USD MILLION) 136
TABLE 97 NORTH AMERICA: BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE, 2022–2027 (USD MILLION) 137
TABLE 98 NORTH AMERICA: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2018–2021 (USD MILLION) 137
TABLE 99 NORTH AMERICA: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2022–2027 (USD MILLION) 137
TABLE 100 NORTH AMERICA: BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 138
TABLE 101 NORTH AMERICA: BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 138
9.2.1 US 138
9.2.1.1 Increased investments in EV manufacturing 138
9.2.2 CANADA 139
9.2.2.1 Easy access to raw materials used to manufacture batteries 139
9.3 EUROPE 139
FIGURE 68 EUROPE: SNAPSHOT OF BATTERY PRODUCTION MACHINE MARKET 140
FIGURE 69 GERMANY TO REGISTER HIGHEST CAGR IN EUROPEAN BATTERY PRODUCTION MACHINE MARKET DURING FORECAST PERIOD 141
TABLE 102 EUROPE: BATTERY PRODUCTION MACHINE MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 141
TABLE 103 EUROPE: BATTERY PRODUCTION MACHINE MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 141
TABLE 104 EUROPE: BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE, 2018–2021 (USD MILLION) 142
TABLE 105 EUROPE: BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE, 2022–2027 (USD MILLION) 142
TABLE 106 EUROPE: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2018–2021 (USD MILLION) 142
TABLE 107 EUROPE: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2022–2027 (USD MILLION) 143
TABLE 108 EUROPE: BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 143
TABLE 109 EUROPE: BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 143
9.3.1 GERMANY 143
9.3.1.1 Large presence of key automakers 143
9.3.2 HUNGARY 144
9.3.2.1 Government-led initiatives to boost growth of battery industry 144
9.3.3 POLAND 144
9.3.3.1 Rising investments by battery manufacturers 144
9.3.4 REST OF EUROPE 145
TABLE 110 REST OF EUROPE: UPCOMING BATTERY FACTORIES 145
9.4 ASIA PACIFIC 146
FIGURE 70 ASIA PACIFIC: SNAPSHOT OF BATTERY PRODUCTION MACHINE MARKET 146
FIGURE 71 CHINA TO HOLD LARGEST SHARE OF ASIA PACIFIC BATTERY PRODUCTION MACHINE MARKET DURING FORECAST PERIOD 147
TABLE 111 ASIA PACIFIC: BATTERY PRODUCTION MACHINE MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 147
TABLE 112 ASIA PACIFIC: BATTERY PRODUCTION MACHINE MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 147
TABLE 113 ASIA PACIFIC: BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE, 2018–2021 (USD MILLION) 148
TABLE 114 ASIA PACIFIC: BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE, 2022–2027 (USD MILLION) 148
TABLE 115 ASIA PACIFIC: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2018–2021 (USD MILLION) 148
TABLE 116 ASIA PACIFIC: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2022–2027 (USD MILLION) 149
TABLE 117 ASIA PACIFIC: BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 149
TABLE 118 ASIA PACIFIC: BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 149
9.4.1 CHINA 149
9.4.1.1 Increasing number of battery gigafactories 149
9.4.2 JAPAN 150
9.4.2.1 Increasing investments in electric vehicle (EV) manufacturing 150
9.4.3 SOUTH KOREA 150
9.4.3.1 Availability of government-led subsidies for electric vehicle (EV) battery manufacturers and users 150
9.4.4 REST OF ASIA PACIFIC 151
9.5 ROW 151
FIGURE 72 SOUTH AMERICA TO REGISTER HIGHER CAGR IN ROW BATTERY PRODUCTION MACHINE MARKET DURING FORECAST PERIOD 152
TABLE 119 ROW: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2018–2021 (USD MILLION) 152
TABLE 120 ROW: BATTERY PRODUCTION MACHINE MARKET, BY REGION, 2022–2027 (USD MILLION) 152
TABLE 121 ROW: BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE, 2018–2021 (USD MILLION) 153
TABLE 122 ROW: BATTERY PRODUCTION MACHINE MARKET, BY MACHINE TYPE, 2022–2027 (USD MILLION) 153
TABLE 123 ROW: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2018–2021 (USD MILLION) 153
TABLE 124 ROW: BATTERY PRODUCTION MACHINE MARKET, BY BATTERY TYPE, 2022–2027 (USD MILLION) 154
TABLE 125 ROW: BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 154
TABLE 126 ROW: BATTERY PRODUCTION MACHINE MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 154
9.5.1 MIDDLE EAST & AFRICA 154
9.5.1.1 Large presence of lithium reserves 154
9.5.2 SOUTH AMERICA 155
9.5.2.1 Growing demand for lithium-ion batteries in developing countries 155
10 COMPETITIVE LANDSCAPE 156
10.1 INTRODUCTION 156
10.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN 156
TABLE 127 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BATTERY PRODUCTION MACHINE MARKET 156
10.3 TOP 5 COMPANY REVENUE ANALYSIS 159
FIGURE 73 BATTERY PRODUCTION MACHINE MARKET: REVENUE ANALYSIS OF TOP 5 PLAYERS, 2017–2021 159
10.4 MARKET SHARE ANALYSIS, 2021 159
TABLE 128 BATTERY PRODUCTION MACHINE MARKET: MARKET SHARE ANALYSIS (2021) 160

10.5 COMPANY EVALUATION QUADRANT, 2021 161
10.5.1 STARS 161
10.5.2 EMERGING LEADERS 161
10.5.3 PERVASIVE PLAYERS 161
10.5.4 PARTICIPANTS 161
FIGURE 74 BATTERY PRODUCTION MACHINE MARKET: COMPANY EVALUATION QUADRANT, 2021 162
10.6 SMALL AND MEDIUM-SIZED ENTERPRISES (SMES) EVALUATION QUADRANT, 2021 162
10.6.1 PROGRESSIVE COMPANIES 162
10.6.2 RESPONSIVE COMPANIES 163
10.6.3 DYNAMIC COMPANIES 163
10.6.4 STARTING BLOCKS 163
FIGURE 75 BATTERY PRODUCTION MACHINE MARKET: SME EVALUATION QUADRANT, 2021 163
10.7 BATTERY PRODUCTION MACHINE MARKET: COMPANY FOOTPRINT 164
TABLE 129 COMPANY FOOTPRINT 164
TABLE 130 APPLICATION: COMPANY FOOTPRINT 165
TABLE 131 REGION: COMPANY FOOTPRINT 166
10.8 COMPETITIVE BENCHMARKING 167
TABLE 132 BATTERY PRODUCTION MACHINE MARKET: DETAILED LIST OF KEY SMES/STARTUPS 167
TABLE 133 BATTERY PRODUCTION MACHINE MARKET: COMPETITIVE BENCHMARKING OF KEY SMES/STARTUPS 167
10.9 COMPETITIVE SCENARIOS AND TRENDS 168
10.9.1 BATTERY PRODUCTION MACHINE MARKET: PRODUCT LAUNCHES 168
10.9.2 BATTERY PRODUCTION MACHINE MARKET: DEALS 168
11 COMPANY PROFILES 171
(Business overview, Products offered, Recent Developments, MNM view)*
11.1 KEY PLAYERS 171
11.1.1 HITACHI, LTD. 171
TABLE 134 HITACHI, LTD.: COMPANY OVERVIEW 171
FIGURE 76 HITACHI, LTD.: COMPANY SNAPSHOT 172
TABLE 135 HITACHI, LTD.: PRODUCT OFFERINGS 172
TABLE 136 HITACHI, LTD.: PRODUCT LAUNCHES 173
TABLE 137 HITACHI, LTD.: DEALS 173
11.1.2 DURR GROUP 175
TABLE 138 DURR GROUP: COMPANY OVERVIEW 175
FIGURE 77 DURR GROUP: COMPANY SNAPSHOT 176
TABLE 139 DURR GROUP: PRODUCT OFFERINGS 176
TABLE 140 DURR GROUP: DEALS 177

11.1.3 WUXI LEAD INTELLIGENT EQUIPMENT CO., LTD. 178
TABLE 141 WUXI LEAD INTELLIGENT EQUIPMENT CO., LTD.: COMPANY OVERVIEW 178
TABLE 142 WUXI LEAD INTELLIGENT EQUIPMENT CO., LTD.: PRODUCT OFFERINGS 178
TABLE 143 WUXI LEAD INTELLIGENT EQUIPMENT CO., LTD.: DEALS 179
11.1.4 SCHULER GROUP 181
TABLE 144 SCHULER GROUP: COMPANY OVERVIEW 181
TABLE 145 SCHULER GROUP: PRODUCT OFFERINGS 181
TABLE 146 SCHULER GROUP: DEALS 182
11.1.5 SHENZHEN YINGHE TECHNOLOGY CO., LTD. 183
TABLE 147 SHENZHEN YINGHE TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 183
TABLE 148 SHENZHEN YINGHE TECHNOLOGY CO., LTD.: PRODUCT OFFERINGS 183
TABLE 149 SHENZHEN YINGHE TECHNOLOGY CO., LTD.: PRODUCT LAUNCHES 184
TABLE 150 SHENZHEN YINGHE TECHNOLOGY CO., LTD.: DEALS 184
11.1.6 BUHLER AG 186
TABLE 151 BUHLER AG: COMPANY OVERVIEW 186
FIGURE 78 BUHLER AG: COMPANY SNAPSHOT 187
TABLE 152 BUHLER AG: PRODUCT OFFERINGS 187
11.1.7 GUANGDONG LYRIC ROBOT CO., LTD. 188
TABLE 153 GUANGDONG LYRIC ROBOT CO., LTD.: COMPANY OVERVIEW 188
TABLE 154 GUANGDONG LYRIC ROBOT CO., LTD.: PRODUCT OFFERINGS 188
11.1.8 MANZ AG 189
TABLE 155 MANZ AG: COMPANY OVERVIEW 189
FIGURE 79 MANZ AG: COMPANY SNAPSHOT 190
TABLE 156 MANZ AG: PRODUCT OFFERINGS 190
TABLE 157 MANZ AG: PRODUCT LAUNCHES 191
TABLE 158 MANZ AG: DEALS 191
11.1.9 NORDSON 192
TABLE 159 NORDSON: COMPANY OVERVIEW 192
FIGURE 80 NORDSON: COMPANY SNAPSHOT 193
TABLE 160 NORDSON: PRODUCT OFFERINGS 193
11.1.10 ROSENDAHL NEXTROM GMBH 194
TABLE 161 ROSENDAHL NEXTROM GMBH: COMPANY OVERVIEW 194
TABLE 162 ROSENDAHL NEXTROM GMBH: PRODUCT OFFERINGS 194
11.2 OTHER PLAYERS 195
11.2.1 BRY-AIR (ASIA) PVT. LTD. 195
11.2.2 CHARLES ROSS & SON COMPANY 196
11.2.3 CKD CORPORATION 197
11.2.4 FOSHAN GOLDEN MILKY WAY INTELLIGENT EQUIPMENT CO., LTD. 198
11.2.5 HIRANO TECSEED CO., LTD. 199
11.2.6 KAMPF LSF 200
11.2.7 MONDRAGON ASSEMBLY 201
11.2.8 NAGANO AUTOMATION CO., LTD. 202
11.2.9 NINGDE KATOP AUTOMATION TECHNOLOGY CO., LTD. 203
11.2.10 SEMCO INFRATECH PVT. LTD. 204
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
12 ADJACENT AND RELATED MARKETS 205
12.1 INTRODUCTION 205
12.2 BATTERY ENERGY STORAGE SYSTEM MARKET, BY REGION 205
TABLE 163 BATTERY ENERGY STORAGE SYSTEM MARKET, BY REGION,
2018–2021 (USD MILLION) 205
TABLE 164 BATTERY ENERGY STORAGE SYSTEM MARKET, BY REGION,
2022–2027 (USD MILLION) 206
12.3 NORTH AMERICA 207
12.3.1 US 207
12.3.1.1 Increasing adoption of large-scale battery storage systems
in power grids 207
12.3.2 CANADA 208
12.3.2.1 Growing focus on advancements in battery energy storage technology 208
12.3.3 MEXICO 208
12.3.3.1 Rising demand for electricity 208
13 APPENDIX 210
13.1 INSIGHTS FROM INDUSTRY EXPERTS 210
13.2 DISCUSSION GUIDE 211
13.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 214
13.4 CUSTOMIZATION OPTIONS 216
13.5 RELATED REPORTS 216
13.6 AUTHOR DETAILS 217

※参考情報

電池製造機は、さまざまな種類の電池を作るために使用される機械であり、電池産業において非常に重要な役割を果たしています。これらの機械は、電池の各構成要素を製造、加工、組み立てるための高度な技術を使用しています。電池は、携帯電話やノートパソコン、電動自動車、再生可能エネルギーシステムなど、日常生活や産業に欠かせないエネルギー源として広く利用されています。そのため、電池製造機の需要は年々増加しています。
電池製造機には、さまざまな種類があります。主なものとしては、リチウムイオン電池製造機、ニッケル水素電池製造機、鉛酸電池製造機などがあります。リチウムイオン電池製造機は、特に電動自動車やモバイルデバイスに対する需要が高まっているため、最も注目されています。この機械は、正極材、負極材、電解液を組み合わせて電池セルを製造するための装置です。ニッケル水素電池製造機は、家電製品やハイブリッド車に使用される電池を製造するために特化しています。鉛酸電池製造機は、主に自動車の始動用バッテリーや大型電力貯蔵システムに使用されます。

それぞれの製造機には、さまざまな工程が含まれます。まず、素材の準備から始まり、活物質の混合、塗布、乾燥、切断、組立などの複雑な工程があります。これらのプロセスは、精密な操作が求められるため、自動化技術やロボティクスの導入が進んでいます。また、検査や品質管理のための機器も重要であり、製造過程での異常を迅速に発見し、対応する能力が不可欠です。

電池製造機の用途は多岐にわたります。例えば、電動車両の普及に伴い、リチウムイオン電池の大量生産が迫られています。また、再生可能エネルギーの普及により、蓄電池への需要も増加しています。これに対処するために、電池製造機は効率的かつ高品質な電池を生産するために進化を続けています。加えて、家庭用蓄電池や商業用蓄電池システムの市場も成長し、バッテリー製造機の適応が求められています。

関連技術としては、材料科学やナノテクノロジーの進展が電池製造に大きな影響を与えています。新しい材料の開発により、電池の性能向上やコスト削減が実現されています。また、自動化技術により製造効率が向上し、作業者の負担軽減にも寄与しています。さらに、リサイクル技術も重要です。電池が廃棄される際、環境への影響を最小限に抑えるための再利用技術も研究されています。

最近の革新としては、フレキシブルバッテリーや固体電池の開発が進んでおり、新しい製造プロセスの導入が求められています。固体電池は、リチウムイオン電池よりも高いエネルギー密度を持つと期待されており、安全性も改善される可能性があります。これにより、新しい電池製造機の設計や開発が進んでいます。

結論として、電池製造機は現代のエネルギー社会において不可欠な機械であり、電池の需要が増大する中でその重要性はさらに高まっています。さまざまな技術の進歩により、今後も新たな製造方法や製品が登場することが期待されており、持続可能なエネルギーの実現に向けた大きな役割を果たすでしょう。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

カテゴリ： IT/電子, MarketsandMarkets, 世界

5G NTNの世界市場予測（～2027）：コンポーネント別、産業別、用途別、地域別

■ 英語タイトル：5G NTN Market by Component (Hardware, Solutions, Services), End-Use Industry (Maritime, Aerospace and Defense, Government, Mining), Application (EMBB, URLLC, and MMTC), & Region (North America, Europe, APAC, MEA, Latin America) - Global Forecast to 2027
	■ 発行会社/調査会社：MarketsandMarkets ■ 商品コード：TC8514-23 ■ 発行日：2022年12月15日最新版(2025年又は2026年)はお問い合わせください。 ■ 調査対象地域：グローバル ■ 産業分野：通信＆IT ■ ページ数：206 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後24時間以内）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧）	USD4,950 ⇒換算￥772,200	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥1,037,400	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥1,271,400	見積依頼/購入/質問フォーム

★グローバルリサーチ資料[5G NTNの世界市場予測（～2027）：コンポーネント別、産業別、用途別、地域別]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

MarketsandMarkets社は、世界の5G NTN市場規模が2022年32億ドルから2027年161億ドルに達し、予測期間中に年平均38.2％で成長すると予測しています。本調査資料では、5G NTNの世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要・産業動向、コンポーネント別（ハードウェア、ソリューション、サービス）分析、プラットフォーム別（UASプラットフォーム、低軌道衛星、中軌道衛星、静止軌道衛星）分析、用途別（EMBB、URLLC、MMTC）分析、産業別（海運、航空宇宙＆防衛、政府、鉱業）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東/アフリカ、中南米）分析、競争状況、企業情報、隣接/関連市場などの内容を掲載しています。また、本レポートに掲載されている企業情報には、Qualcomm Technologies,Inc (US)、Gilat Satellite Networks (Israel)、SoftBank Group Corporation (Japan)、Thales Group (France)、Thales Alena Space (France)、Rohde & Schwarz GmbH & Co KG (Germany)、Keysight Technologies,Inc (US)、MediaTek Inc. (Taiwan)、Anritsu Corporation (Japan)、SES S.A. (Luxembourg)、EchoStar Corporation (EchoStar) (US)、SpaceX (US)、AST & Science、LLC (US)、ZTE Corporation (China)、OneWeb (UK)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要・産業動向
・世界の5G NTN市場規模：コンポーネント別
- ハードウェアの市場規模
- ソリューションの市場規模
- サービスの市場規模
・世界の5G NTN市場規模：プラットフォーム別
- UASプラットフォームの市場規模
- 低軌道衛星の市場規模
- 中軌道衛星の市場規模
- 静止軌道衛星の市場規模
・世界の5G NTN市場規模：用途別
- EMBBにおける市場規模
- URLLCにおける市場規模
- MMTCにおける市場規模
・世界の5G NTN市場規模：産業別
- 海運における市場規模
- 航空宇宙＆防衛における市場規模
- 政府における市場規模
- 鉱業における市場規模
・世界の5G NTN市場規模：地域別
- 北米の5G NTN市場規模
- ヨーロッパの5G NTN市場規模
- アジア太平洋の5G NTN市場規模
- 中東・アフリカの5G NTN市場規模
- 中南米の5G NTN市場規模
・競争状況
・企業情報
・隣接/関連市場

“5G NTN市場は2022年の32億米ドルから2027年には161億米ドルに成長し、予測期間中の年平均成長率は38.2%と予測”
鉱業会社は、最新の自動化技術を導入して業務を改善しています。例えば、スウェーデンの鉱山事業者であるBolidenは、Ericssonと提携して自律型金鉱山を建設し、Ericssonは採掘現場に5Gネットワークを設置しました。また、ビデオやデータファイル転送などのアプリケーションで、高いデータレートで船舶をサポートする必要性が高まっていることも、5G NTNソリューションの需要を促進しています。

“プラットフォーム別では、LEO衛星が予測期間中に高いCAGRを記録”
LEOは、ネットワークカバレッジを強化し、接続格差を埋める十分な機会を提供する5G NTNシステムを開発するための好ましいソリューションとして浮上しています。サウジアラビアやアブダビなどの中東・アフリカ諸国は、2030年のビジョンに向けてLEO技術の能力を活用しています。
各国の政府も、地上ネットワークとLEO衛星を統合して5G NTNシステムを構築することで、ネットワークのカバレッジ拡大を支援しています。2019年7月、カナダ政府とTelesatは、TelesatのLEO衛星コンステレーションでカナダ全土の接続格差を縮小するため、6億米ドルの契約に調印しました。2022年8月、MediaTekと Rohde & Schwarzは共同で、LEO衛星を利用したノードBネットワーク（gNB）試験を実施し、より信頼性が高く高速な接続を提供する5G NTNの機能を実証しました。同社は、5G NTN接続で初めてスマートフォンに電力を供給し、新たな5Gのマイルストーンを達成しました。

“アプリケーション別では、予測期間中にeMBBが最大の市場シェアを占める”
5G NTNは、中程度の遅延で広帯域を提供し、時速約500Kmの高移動性をサポートし、1万倍のトラフィックを処理するeMBBの展開に焦点を当てました。リリース-18では、eMBBに関連するユースケースとして、モビリティの向上、MIMO、ネットワークの省電力化などが挙げられています。様々な大手企業がエンハンスト・モバイル・ブロードバンドを採用し、LTEサービスと同様の5Gネットワーク接続を提供しています。5G NTNにより、eMBBサービスは、航空機や船舶などの移動プラットフォーム上で、農村部や過疎地域で優れたブロードバンド接続を提供します。

“アジア太平洋地域が予測期間中に最も高いCAGRを記録”
アジア太平洋地域における5G NTN市場の成長は、人口が多く、インフラや技術が発展していることが大きな原動力となっています。また、災害やその他の緊急事態における公共の安全を向上させる必要性も、この地域における5G NTNソリューションの採用の主な促進要因となっています。この地域では、スマートシティプロジェクトなどのスマートインフラが急増しており、監視システム、スキャンおよびスクリーニングシステム、重要な通信ネットワークなどの公共の安全とセキュリティ技術に対する需要が高まっています。航空宇宙、海洋、防衛など、さまざまな産業が、さまざまな場所でのネットワークカバレッジを強化するために、統合5Gネットワークと衛星ベースのソリューションを採用しています。海洋産業では、高度な通信ネットワークを活用して、遠隔地の海上で働く従業員との通信を確立するために、海事衛星技術が採用されています。

主な内訳
5G NTN市場で事業を展開する様々な主要組織の最高経営責任者（CEO）、イノベーション・技術責任者、システムインテグレータ、経営幹部に対して詳細なインタビューを実施しました。
 企業タイプ別：ティアI: 25%、ティアII: 35%、ティアIII: 40％
 役職別 C-Level Executives： 60%, マネージャー: 40％
 地域別北米：30％、欧州：35％、アジア太平洋：25％、中東・アフリカ：5％、中南米：5％

本レポートでは、5G NTNのハードウェア、ソリューション、サービスを提供する主要プレイヤーを調査しました。5G NTN市場の主要ベンダのプロフィールを掲載しています。5G NTN市場の主要ベンダーには、Qualcomm Technologies, Inc (US), Gilat Satellite Networks (Israel), SoftBank Group Corporation (Japan), Thales Group (France), Thales Alena Space (France), Rohde & Schwarz GmbH & Co KG (Germany), Keysight Technologies, Inc (US), MediaTek Inc. (Taiwan), Anritsu Corporation (Japan), SES S.A. (Luxembourg), EchoStar Corporation (EchoStar) (US), SpaceX (US), AST & Science, LLC (US), ZTE Corporation (China), OneWeb (UK), GateHouse SatCom A/S (Denmark), Omnispace, LLC (US), Nelco Limited (US), Inmarsat Global Limited (UK), Skylo Technologies (US), Globalstar, Inc (US), Spirent Communications (Spirent) (UK), Telefonaktiebolaget LM Ericsson (Sweden), Nokia Corporation (Finland), Intelsat US LLC (US), and Telefonica S.A. (Spain), Viasat Inc, (US), Telesat (Canada)です。

調査範囲
この調査レポートは、5G NTN市場をセグメント横断的にカバーしています。コンポーネント別、プラットフォーム別、アプリケーション別、最終用途産業別、場所別、地域別など、さまざまなセグメントにわたって市場規模と成長性を推定することを目的としています。本レポートには、市場の主要企業の詳細な競合分析、企業プロフィール、製品および事業の提供に関する主な見解、最近の動向、主要な市場戦略などを掲載しています。

レポート購入の主な利点
本レポートは、5G NTN市場全体とそのサブセグメントにおける売上高の概算情報を、市場のリーダー/新規参入者に提供します。本レポートは、5G NTN市場のリーダー/新規参入者に、5G NTN市場全体とサブセグメント別の売上高の概算に関する情報を提供します。また、市場動向を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

*** レポート目次（コンテンツ）***

1 INTRODUCTION 20
1.1 STUDY OBJECTIVES 20
1.2 MARKET DEFINITION 20
1.3 STUDY SCOPE 21
1.3.1 MARKETS COVERED 21
FIGURE 1 5G NTN MARKET SEGMENTATION 21
1.3.2 GEOGRAPHIC SCOPE 21
FIGURE 2 5G NTN MARKET: GEOGRAPHIC SCOPE 21
1.3.3 INCLUSIONS AND EXCLUSIONS 22
1.3.4 YEARS CONSIDERED 22
1.4 CURRENCY 22
TABLE 1 USD EXCHANGE RATES, 2019–2021 23
1.5 LIMITATIONS 23
1.6 STAKEHOLDERS 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH DATA 24
FIGURE 3 5G NTN MARKET: RESEARCH DESIGN 24
2.1.1 SECONDARY DATA 25
2.1.1.1 Secondary sources 25
2.1.2 PRIMARY DATA 26
2.1.2.1 Primary interviews with experts 26
2.1.2.2 List of key primary interview participants 26
2.1.2.3 Breakdown of primaries 26
2.1.2.4 Primary sources 27
2.1.2.5 Key industry insights 27
2.2 MARKET SIZE ESTIMATION 28
2.2.1 BOTTOM-UP APPROACH 28
FIGURE 4 BOTTOM-UP APPROACH 28
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY, BOTTOM-UP (SUPPLY-SIDE): COLLECTIVE REVENUE FROM ALL SOLUTIONS/SERVICES IN 5G NTN MARKET 29
2.2.2 TOP-DOWN APPROACH 29
FIGURE 6 TOP-DOWN APPROACH 30
2.2.3 5G NTN MARKET ESTIMATION: DEMAND-SIDE ANALYSIS 30
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: DEMAND-SIDE ANALYSIS 30
2.2.4 5G NTN MARKET ESTIMATION: SUPPLY-SIDE ANALYSIS 31
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: SUPPLY-SIDE ANALYSIS 31
2.2.5 GROWTH FORECAST ASSUMPTIONS 31
TABLE 2 MARKET GROWTH ASSUMPTIONS 31
2.3 DATA TRIANGULATION 32
FIGURE 9 DATA TRIANGULATION 32
2.4 RESEARCH ASSUMPTIONS 33
2.4.1 FACTOR ASSESSMENT 33
TABLE 3 FACTOR ASSESSMENT: 5G NTN MARKET 33
3 EXECUTIVE SUMMARY 34
FIGURE 10 5G NTN MARKET SIZE, 2022–2027 (USD MILLION) 35
FIGURE 11 5G NTN MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION) 35
FIGURE 12 5G NTN MARKET, BY PLATFORM, 2022 VS. 2027 (USD MILLION) 36
FIGURE 13 5G NTN MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 36
FIGURE 14 5G NTN MARKET, BY END-USE INDUSTRY, 2022 VS. 2027 (USD MILLION) 37
FIGURE 15 5G NTN MARKET, BY LOCATION, 2022 VS. 2027 (USD MILLION) 37
FIGURE 16 5G NTN MARKET, BY REGION, 2022 VS. 2027 (USD MILLION) 38
4 PREMIUM INSIGHTS 39
4.1 5G NTN MARKET OVERVIEW 39
FIGURE 17 INCREASING USE OF ECOMMERCE AND COMMERCE PLATFORMS TO DRIVE MARKET GROWTH 39
4.2 NORTH AMERICA: 5G NTN MARKET, BY LOCATION AND APPLICATION 40
FIGURE 18 RURAL AND EMBB SEGMENTS TO ACCOUNT FOR LARGEST MARKET SIZES IN NORTH AMERICA IN 2022 40
4.3 ASIA PACIFIC: 5G NTN MARKET, BY LOCATION AND APPLICATION 41
FIGURE 19 RURAL AND EMBB SEGMENTS TO ACCOUNT FOR LARGEST MARKET SIZES IN ASIA PACIFIC IN 2022 41
4.4 EUROPE: 5G NTN MARKET, BY LOCATION AND APPLICATION 42
FIGURE 20 RURAL AND EMBB SEGMENTS TO ACCOUNT FOR LARGEST MARKET SIZES IN EUROPE IN 2022 42
4.5 GEOGRAPHICAL SNAPSHOT OF 5G NTN MARKET 43
FIGURE 21 ASIA PACIFIC TO ACHIEVE HIGHEST GROWTH RATE DURING FORECAST PERIOD 43
5 MARKET OVERVIEW AND INDUSTRY TRENDS 44
5.1 INTRODUCTION 44
5.2 MARKET DYNAMICS 44
FIGURE 22 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: 5G NTN MARKET 44
5.2.1 DRIVERS 45
5.2.1.1 Need to address extreme coverage extension 45
5.2.1.2 3GPP evolution toward NTN interworking and integration 45
5.2.2 RESTRAINTS 46
5.2.2.1 Meeting demand on ground stations 46
5.2.3 OPPORTUNITIES 46
5.2.3.1 Need for NTN in evolution toward 5G and 6G 46
5.2.3.2 5G NB-IoT NTN contributing to global high speed 46
5.2.4 CHALLENGES 47
5.2.4.1 Propagation delay and low latency due to large distance between satellites and terrestrial UE 47
5.2.4.2 Doppler frequency shift owing to mobility issues 47
5.3 SUPPLY CHAIN ANALYSIS 48
FIGURE 23 5G NTN MARKET: SUPPLY CHAIN 48
5.4 ECOSYSTEM 49
TABLE 4 5G NTN MARKET: ECOSYSTEM 49
5.5 TECHNOLOGY ANALYSIS 50
5.5.1 INTRODUCTION 50
5.5.2 INTERNET OF THINGS 50
5.6 CASE STUDY ANALYSIS 50
5.6.1 CASE STUDY 1: ERICSSON, QUALCOMM, AND THALES PROVIDED GLOBAL COVERAGE THROUGH 5G SMARTPHONES 51
5.6.2 CASE STUDY 2: SMART AND OMNISPACE TEAMED UP TO EXPLORE SPACE-BASED 5G TECHNOLOGIES 52
5.6.3 CASE STUDY 3: T-MOBILE AND SPACEX COLLABORATED TO PROVIDE TEXT COVERAGE AND OFFER NO DEAD ZONES 52
5.6.4 CASE STUDY 4: ZTE CORPORATION AND CHINA MOBILE SHOWCASED FIRST 5G NTN FIELD TRIAL 53
5.6.5 CASE STUDY 5: APPLE PARTNERED WITH GLOBALSTAR TO DELIVER EMERGENCY SOS SERVICES THROUGH SATELLITE COMMUNICATIONS 54
5.7 PATENT ANALYSIS 54
5.7.1 METHODOLOGY 54
5.7.2 DOCUMENT TYPES OF PATENTS 54
TABLE 5 PATENTS FILED, 2019–2022 54
5.7.3 INNOVATION AND PATENT APPLICATIONS 55
FIGURE 24 TOTAL NUMBER OF PATENTS GRANTED ANNUALLY, 2019–2022 55
5.7.3.1 Top applicants 55
FIGURE 25 TOP TEN COMPANIES WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2019–2022 55
TABLE 6 US: TOP TEN PATENT OWNERS IN 5G NTN MARKET, 2019–2022 56
TABLE 7 LIST OF FEW PATENTS IN 5G NTN MARKET, 2020–2022 56
5.8 PORTER’S FIVE FORCES ANALYSIS 57
TABLE 8 5G NTN MARKET: PORTER’S FIVE FORCES MODEL 57
5.8.1 THREAT OF NEW ENTRANTS 57
5.8.2 THREAT OF SUBSTITUTES 57
5.8.3 BARGAINING POWER OF BUYERS 58
5.8.4 BARGAINING POWER OF SUPPLIERS 58
5.8.5 DEGREE OF COMPETITION 58
5.9 REGULATORY LANDSCAPE 58
5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 58
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 58
TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 59
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 59
TABLE 12 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
TABLE 13 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
5.9.1.1 North America 60
5.9.1.1.1 US 60
5.9.1.1.2 Canada 60
5.9.1.2 Europe 61
5.9.1.3 Asia Pacific 61
5.9.1.3.1 China 61
5.9.1.3.2 Australia 61
5.9.1.3.3 Japan 61
5.9.1.4 Middle East & Africa 61
5.9.1.4.1 Saudi Arabia 61
5.10 TRENDS AND DISRUPTIONS IN 5G NTN MARKET 62
FIGURE 26 TRENDS AND DISRUPTIONS IN 5G NTN MARKET 62
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 62
5.11.1 INFLUENCE OF KEY STAKEHOLDERS IN BUYING PROCESS 62
FIGURE 27 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS 62
TABLE 14 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS 63
5.11.2 BUYING CRITERIA 63
FIGURE 28 KEY BUYING CRITERIA 63
TABLE 15 KEY BUYING CRITERIA 64
5.12 KEY CONFERENCES & EVENTS 64
TABLE 16 5G NTN MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2022–2023 64
6 5G NTN MARKET, BY COMPONENT 66
6.1 INTRODUCTION 67
6.1.1 COMPONENT: 5G NTN MARKET DRIVERS 67
FIGURE 29 SOLUTIONS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 67
TABLE 17 5G NTN MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 67
6.2 HARDWARE 68
6.2.1 SHIFT TOWARD 5G NTN HARDWARE INSTALLATION TO ENHANCE NETWORK COVERAGE 68
TABLE 18 HARDWARE: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 68
6.3 SOLUTIONS 68
6.3.1 COMPANIES TO OFFER SOLUTIONS TO TEST CAPABILITY OF 5G NTN SYSTEM BEFORE DEPLOYMENT 68
TABLE 19 SOLUTIONS: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 69
6.4 SERVICES 69
6.4.1 RISING DEMAND FOR SERVICES TO PROVIDE UNINTERRUPTED CONNECTIVITY IN UNDERSERVED AREAS 69
TABLE 20 SERVICES: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 69
7 5G NTN MARKET, BY PLATFORM 70
7.1 INTRODUCTION 71
7.1.1 PLATFORM: 5G NTN MARKET DRIVERS 71
FIGURE 30 LEO SATELLITE SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 71
TABLE 21 5G NTN MARKET, BY PLATFORM, 2022–2027 (USD MILLION) 72
7.2 UAS PLATFORM 72
7.2.1 SUPPORTING AIRBORNE COMMUNICATION AT ALTITUDES FROM 8 TO 50 KM TO DRIVE DEMAND FOR UAS PLATFORM 72
TABLE 22 UAS PLATFORM: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 72
7.3 LEO SATELLITE 73
7.3.1 LEO PROVIDES CONNECTIVITY COVERAGE AT ALTITUDES RANGING FROM 300 TO 1,500 KM 73
TABLE 23 LEO SATELLITE: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 73
7.4 MEO SATELLITE 73
7.4.1 MEO SATELLITE TO HELP REDUCE RF POWER REQUIREMENTS AND COMMUNICATION DELAY 73
TABLE 24 MEO SATELLITE: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 74
7.5 GEO SATELLITE 74
7.5.1 LEADING COMPANIES TO SUPPORT GEO PLATFORM FOR 5G NTN TECHNOLOGY 74
TABLE 25 GEO SATELLITE: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 74
8 5G NTN MARKET, BY APPLICATION 75
8.1 INTRODUCTION 76
FIGURE 31 MMTC SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 76
TABLE 26 5G NTN MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 76
8.1.1 APPLICATION: 5G NTN MARKET DRIVERS 76
8.2 EMBB 77
8.2.1 NEED TO OFFER HIGH-SPEED BROADBAND CONNECTIVITY IN DENSELY POPULATED AREAS TO DRIVE DEMAND 77
TABLE 27 EMBB: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 77
8.3 MMTC 77
8.3.1 MMTC DEVELOPED FOR SCALABLE AND EFFICIENT CONNECTIVITY OF MANY DEVICES 77
TABLE 28 MMTC: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 78
8.4 URLLC 78
8.4.1 URLLC TO PROVIDE DATA TRANSMISSION WITH HIGH RELIABILITY IN 5G NTN SYSTEM 78
TABLE 29 URLLC: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 78
9 5G NTN MARKET, BY END-USE INDUSTRY 79
9.1 INTRODUCTION 80
9.1.1 END-USE INDUSTRY: 5G NTN MARKET DRIVERS 80
FIGURE 32 AEROSPACE AND DEFENSE SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 80
TABLE 30 5G NTN MARKET, BY END-USE INDUSTRY, 2022–2027 (USD MILLION) 81
9.2 MARITIME 81
9.2.1 ENHANCED 5G NETWORK COVERAGE TO SUPPORT TRACKING AND MONITORING IN MARITIME 81
TABLE 31 MARITIME: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 81
9.3 AEROSPACE AND DEFENSE 82
9.3.1 OFFERS SAME LEVEL OF CONNECTIVITY FOR AIRCRAFT PASSENGERS AS ON GROUND 82
TABLE 32 AEROSPACE AND DEFENSE: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 82
9.4 GOVERNMENT 82
9.4.1 5G NTN SOLUTIONS IMPROVE SAFETY AND SECURITY OF GOVERNMENT NETWORK 82
TABLE 33 GOVERNMENT: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 83
9.5 MINING 83
9.5.1 SEAMLESS NTN-BASED 5G CONNECTIVITY IN MINES.TO ENSURE SAFETY OF WORKERS 83
TABLE 34 MINING: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 83
9.6 OTHER END-USE INDUSTRIES 84
TABLE 35 OTHER END-USE INDUSTRIES: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 84
10 5G NTN MARKET, BY LOCATION 85
10.1 INTRODUCTION 86
10.1.1 LOCATION: 5G NTN MARKET DRIVERS 86
FIGURE 33 REMOTE SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 86
TABLE 36 5G NTN MARKET, BY LOCATION, 2022–2027 (USD MILLION) 86
10.2 URBAN 87
10.2.1 DEMAND FOR HIGH-SPEED INTERNET IN SMART INFRASTRUCTURE TO DRIVE URBAN MARKET 87
TABLE 37 URBAN: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 87
10.3 RURAL 87
10.3.1 BETTER CONNECTIVITY TO BRIDGE DIGITAL DIVIDED IN RURAL AREAS 87
TABLE 38 RURAL: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 88
10.4 REMOTE 88
10.4.1 BETTER COVERAGE TO SUPPORT MOVEMENT OF URBAN WORKERS TO REMOTE AREAS 88
TABLE 39 REMOTE: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 88
10.5 ISOLATED 89
10.5.1 CAPABILITY TO PROVIDE 5G COVERAGE IN UNSERVED AND ISOLATED AREAS TO AUGMENT MARKET 89
TABLE 40 ISOLATED: 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 89
11 5G NTN MARKET, BY REGION 90
11.1 INTRODUCTION 91
FIGURE 34 5G NTN MARKET: REGIONAL SNAPSHOT, 2022 91
FIGURE 35 5G NTN MARKET, BY REGION, 2022 VS. 2027 (USD MILLION) 92
TABLE 41 5G NTN MARKET, BY REGION, 2022–2027 (USD MILLION) 92
11.2 NORTH AMERICA 92
11.2.1 PESTLE ANALYSIS: NORTH AMERICA 93
FIGURE 36 NORTH AMERICA MARKET SNAPSHOT 94
TABLE 42 NORTH AMERICA: 5G NTN MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 94
TABLE 43 NORTH AMERICA: 5G NTN MARKET, BY PLATFORM, 2022–2027 (USD MILLION) 95
TABLE 44 NORTH AMERICA: 5G NTN MARKET, BY END-USE INDUSTRY, 2022–2027 (USD MILLION) 95
TABLE 45 NORTH AMERICA: 5G NTN MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 95
TABLE 46 NORTH AMERICA: 5G NTN MARKET, BY LOCATION, 2022–2027 (USD MILLION) 96
TABLE 47 NORTH AMERICA: 5G NTN MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 96
11.2.2 US 96
11.2.2.1 Remarkable growth of smart connected devices to boost market growth 96
11.2.3 CANADA 97
11.2.3.1 Improvement in network connectivity in rural areas to drive market 97
TABLE 48 CANADA: 5G NTN MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 97
TABLE 49 CANADA: 5G NTN MARKET, BY PLATFORM, 2022–2027 (USD MILLION) 97
TABLE 50 CANADA: 5G NTN MARKET, BY END-USE INDUSTRY, 2022–2027 (USD MILLION) 98
TABLE 51 CANADA: 5G NTN MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 98
TABLE 52 CANADA: 5G NTN MARKET, BY LOCATION, 2022–2027 (USD MILLION) 98
11.3 EUROPE 99
11.3.1 PESTLE ANALYSIS: EUROPE 99
TABLE 53 EUROPE: 5G NTN MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 100
TABLE 54 EUROPE: 5G NTN MARKET, BY PLATFORM, 2022–2027 (USD MILLION) 100
TABLE 55 EUROPE: 5G NTN MARKET, BY END-USE INDUSTRY, 2022–2027 (USD MILLION) 101
TABLE 56 EUROPE: 5G NTN MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 101
TABLE 57 EUROPE: 5G NTN MARKET, BY LOCATION, 2022–2027 (USD MILLION) 101
TABLE 58 EUROPE: 5G NTN MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 102
11.3.2 UK 102
11.3.2.1 5G deployment to help reduce carbon emission 102
TABLE 59 UK: 5G NTN MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 102
TABLE 60 UK: 5G NTN MARKET, BY PLATFORM, 2022–2027 (USD MILLION) 103
TABLE 61 UK: 5G NTN MARKET, BY END-USE INDUSTRY, 2022–2027 (USD MILLION) 103
TABLE 62 UK: 5G NTN MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 103
TABLE 63 UK: 5G NTN MARKET, BY LOCATION, 2022–2027 (USD MILLION) 104
11.3.3 GERMANY 104
11.3.3.1 74 licenses released by German regulator released to develop 5G network 104
11.3.4 FRANCE 104
11.3.4.1 Rising need to expand 5G coverage to boost market growth 104
11.3.5 REST OF EUROPE 104
11.4 ASIA PACIFIC 105
11.4.1 PESTLE ANALYSIS: ASIA PACIFIC 105
TABLE 64 ASIA PACIFIC: 5G NTN MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 106
TABLE 65 ASIA PACIFIC: 5G NTN MARKET, BY PLATFORM, 2022–2027 (USD MILLION) 107
TABLE 66 ASIA PACIFIC: 5G NTN MARKET, BY END-USE INDUSTRY, 2022–2027 (USD MILLION) 107
TABLE 67 ASIA PACIFIC: 5G NTN MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 107
TABLE 68 ASIA PACIFIC: 5G NTN MARKET, BY LOCATION, 2022–2027 (USD MILLION) 108
TABLE 69 ASIA PACIFIC: 5G NTN MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 108
11.4.2 CHINA 108
11.4.2.1 Successful field trial of 5G NTN to demonstrate communication services 108
11.4.3 INDIA 109
11.4.3.1 Increasing focus on smart infrastructure development to lead to adoption of 5G NTN 109
TABLE 70 INDIA: 5G NTN MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 109
TABLE 71 INDIA: 5G NTN MARKET, BY PLATFORM, 2022–2027 (USD MILLION) 109
TABLE 72 INDIA: 5G NTN MARKET, BY END-USE INDUSTRY, 2022–2027 (USD MILLION) 110
TABLE 73 INDIA: 5G NTN MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 110
TABLE 74 INDIA: 5G NTN MARKET, BY LOCATION, 2022–2027 (USD MILLION) 110
11.4.4 SOUTH KOREA 111
11.4.4.1 Increasing demand for 5G and 6G wireless technology to drive market 111
11.4.5 REST OF ASIA PACIFIC 111
11.5 MIDDLE EAST & AFRICA 111
11.5.1 PESTLE ANALYSIS: MIDDLE EAST & AFRICA 112
TABLE 75 MIDDLE EAST & AFRICA: 5G NTN MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 113
TABLE 76 MIDDLE EAST & AFRICA: 5G NTN MARKET, BY PLATFORM, 2022–2027 (USD MILLION) 113
TABLE 77 MIDDLE EAST & AFRICA: 5G NTN MARKET, BY END-USE INDUSTRY, 2022–2027 (USD MILLION) 113
TABLE 78 MIDDLE EAST & AFRICA: 5G NTN MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 114
TABLE 79 MIDDLE EAST & AFRICA: 5G NTN MARKET, BY LOCATION, 2022–2027 (USD MILLION) 114
TABLE 80 MIDDLE EAST & AFRICA: 5G NTN MARKET, BY SUBREGION, 2022–2027 (USD MILLION) 114
11.5.2 MIDDLE EAST 114
11.5.2.1 Government initiatives to enhance 5G network coverage to grow demand for solutions 114
TABLE 81 MIDDLE EAST: 5G NTN MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 115
TABLE 82 MIDDLE EAST: 5G NTN MARKET, BY PLATFORM, 2022–2027 (USD MILLION) 115
TABLE 83 MIDDLE EAST: 5G NTN MARKET, BY END-USE INDUSTRY, 2022–2027 (USD MILLION) 115
TABLE 84 MIDDLE EAST: 5G NTN MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 116
TABLE 85 MIDDLE EAST: 5G NTN MARKET, BY LOCATION, 2022–2027 (USD MILLION) 116
11.5.2.2 Saudi Arabia 116
11.5.2.2.1 CITC to accelerate deployment of 5G in Saudi Arabia 116
11.5.3 AFRICA 116
11.5.3.1 Large players to invest in African countries to expand their footprint 116
11.6 LATIN AMERICA 117
11.6.1 PESTLE ANALYSIS: LATIN AMERICA 117
TABLE 86 LATIN AMERICA: 5G NTN MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 118
TABLE 87 LATIN AMERICA: 5G NTN MARKET, BY PLATFORM, 2022–2027 (USD MILLION) 118
TABLE 88 LATIN AMERICA: 5G NTN MARKET, BY END-USE INDUSTRY, 2022–2027 (USD MILLION) 119
TABLE 89 LATIN AMERICA: 5G NTN MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 119
TABLE 90 LATIN AMERICA: 5G NTN MARKET, BY LOCATION, 2022–2027 (USD MILLION) 119
TABLE 91 LATIN AMERICA: 5G NTN MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 120
11.6.2 BRAZIL 120
11.6.2.1 Increased investment in digital infrastructure to drive demand for 5G NTN solutions 120
TABLE 92 BRAZIL: 5G NTN MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 120
TABLE 93 BRAZIL: 5G NTN MARKET, BY PLATFORM, 2022–2027 (USD MILLION) 120
TABLE 94 BRAZIL: 5G NTN MARKET, BY END-USE INDUSTRY, 2022–2027 (USD MILLION) 121
TABLE 95 BRAZIL: 5G NTN MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 121
TABLE 96 BRAZIL: 5G NTN MARKET, BY LOCATION, 2022–2027 (USD MILLION) 121
11.6.3 MEXICO 122
11.6.3.1 Hughes Network System selected by various companies to enhance network connectivity 122
11.6.4 REST OF LATIN AMERICA 122
12 COMPETITIVE LANDSCAPE 123
12.1 OVERVIEW 123
12.2 STRATEGIES ADOPTED BY KEY PLAYERS 123
TABLE 97 OVERVIEW OF STRATEGIES BY KEY PLAYERS IN 5G NTN MARKET 123
12.3 MARKET SHARE ANALYSIS OF TOP PLAYERS 124
FIGURE 37 5G NTN MARKET: KEY VENDORS 124
12.4 COMPETITIVE BENCHMARKING 124
TABLE 98 PRODUCT FOOTPRINT WEIGHTAGE 124
TABLE 99 5G NTN MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS 125
TABLE 100 5G NTN MARKET: DETAILED LIST OF KEY STARTUP/SMES 126
TABLE 101 5G NTN MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES 126
TABLE 102 5G NTN MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES, BY REGION 127
TABLE 103 5G NTN MARKET: COMPETITIVE BENCHMARKING OF MAJOR PLAYERS, BY REGION 127
12.5 MARKET RANKING OF KEY PLAYERS IN 5G NTN MARKET 128
TABLE 104 MARKET RANKING OF KEY PLAYERS, 2022 128
12.6 COMPANY EVALUATION QUADRANT 129
12.6.1 STARS 129
12.6.2 EMERGING LEADERS 129
12.6.3 PERVASIVE PLAYERS 129
12.6.4 PARTICIPANTS 129
FIGURE 38 5G NTN MARKET (GLOBAL): COMPANY EVALUATION MATRIX, 2022 130
12.7 STARTUP/SME EVALUATION QUADRANT 130
12.7.1 PROGRESSIVE COMPANIES 130
12.7.2 RESPONSIVE COMPANIES 131
12.7.3 DYNAMIC COMPANIES 131
12.7.4 STARTING BLOCKS 131
FIGURE 39 5G NTN MARKET (STARTUPS/SMES): COMPANY EVALUATION MATRIX, 2022 132
12.8 COMPETITIVE SCENARIO 132
12.8.1 PRODUCT LAUNCHES 133
TABLE 105 PRODUCT LAUNCHES, FEBRUARY 2019–MAY 2022 133
12.8.2 DEALS 134
TABLE 106 DEALS, AUGUST 2020–AUGUST 2022 134

13 COMPANY PROFILES 137
13.1 MAJOR PLAYERS 137
(Business Overview, Solutions, Products & Services Offered, Recent Developments, MnM View)*
13.1.1 QUALCOMM 137
TABLE 107 QUALCOMM: BUSINESS OVERVIEW 137
FIGURE 40 QUALCOMM: COMPANY SNAPSHOT 138
TABLE 108 QUALCOMM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 138
TABLE 109 QUALCOMM: PRODUCT LAUNCHES 139
TABLE 110 QUALCOMM: DEALS 139
13.1.2 GILAT SATELLITE NETWORKS 141
TABLE 111 GILAT SATELLITE NETWORKS: BUSINESS OVERVIEW 141
FIGURE 41 GILAT SATELLITE NETWORKS: COMPANY SNAPSHOT 142
TABLE 112 GILAT SATELLITE NETWORKS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 142
TABLE 113 GILAT SATELLITE NETWORKS: DEALS 143
13.1.3 SOFTBANK 144
TABLE 114 SOFTBANK: BUSINESS OVERVIEW 144
FIGURE 42 SOFTBANK: COMPANY SNAPSHOT 145
TABLE 115 SOFTBANK: PRODUCTS/SOLUTIONS/SERVICES OFFERED 145
TABLE 116 SOFTBANK: PRODUCT LAUNCHES 146
TABLE 117 SOFTBANK: DEALS 146
13.1.4 THALES 147
TABLE 118 THALES: BUSINESS OVERVIEW 147
FIGURE 43 THALES: COMPANY SNAPSHOT 148
TABLE 119 THALES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 148
13.1.5 THALES ALENIA SPACE 150
TABLE 120 THALES ALENIA SPACE: BUSINESS OVERVIEW 150
TABLE 121 THALES ALENA SPACE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 150
TABLE 122 THALES ALENIA SPACE: PRODUCT LAUNCHES 151
TABLE 123 THALES ALENIA SPACE: DEALS 151
13.1.6 ROHDE & SCHWARZ 152
TABLE 124 ROHDE & SCHWARZ: BUSINESS OVERVIEW 152
TABLE 125 ROHDE & SCHWARZ: PRODUCTS/SOLUTIONS/SERVICES OFFERED 152
TABLE 126 ROHDE & SCHWARZ: DEALS 153
13.1.7 KEYSIGHT TECHNOLOGIES 154
TABLE 127 KEYSIGHT TECHNOLOGIES: BUSINESS OVERVIEW 154
FIGURE 44 KEYSIGHT TECHNOLOGIES: COMPANY SNAPSHOT 155
TABLE 128 KEYSIGHT TECHNOLOGIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 155
TABLE 129 KEYSIGHT TECHNOLOGIES: PRODUCT LAUNCHES 156
13.1.8 MEDIATEK 157
TABLE 130 MEDIATEK: BUSINESS OVERVIEW 157
FIGURE 45 MEDIATEK: COMPANY SNAPSHOT 158
TABLE 131 MEDIATEK: PRODUCTS/SOLUTIONS/SERVICES OFFERED 158
TABLE 132 MEDIATEK: DEALS 159
13.1.9 ANRITSU 160
TABLE 133 ANRITSU: BUSINESS OVERVIEW 160
FIGURE 46 ANRITSU: COMPANY SNAPSHOT 161
TABLE 134 ANRITSU: PRODUCTS/SOLUTIONS/SERVICES OFFERED 161
TABLE 135 ANRITSU: PRODUCT LAUNCHES 162
TABLE 136 ANRITSU: DEALS 163
13.1.10 SES 164
TABLE 137 SES: BUSINESS OVERVIEW 164
FIGURE 47 SES: COMPANY SNAPSHOT 165
TABLE 138 SES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 165
13.1.11 ECHOSTAR 166
TABLE 139 ECHOSTAR: BUSINESS OVERVIEW 166
FIGURE 48 ECHOSTAR: COMPANY SNAPSHOT 167
TABLE 140 ECHOSTAR: PRODUCTS/SOLUTIONS/SERVICES OFFERED 167
TABLE 141 ECHOSTAR: PRODUCT LAUNCHES 168
TABLE 142 ECHOSTAR: DEALS 168
13.2 OTHER KEY PLAYERS 169
13.2.1 SPACEX 169
13.2.2 AST SPACEMOBILE 170
13.2.3 ZTE 171
13.2.4 ONEWEB 172
13.2.5 GATEHOUSE 173
13.2.6 OMNISPACE 174
13.2.7 NELCO 175
13.2.8 INMARSAT 176
13.2.9 SKYLO 177
13.2.10 GLOBALSTAR 178
13.2.11 SPIRENT 179
13.2.12 ERICSSON 180
13.2.13 NOKIA 181
13.2.14 INTELSAT 182
13.2.15 TELEFONICA 183
13.2.16 VIASAT 184
13.2.17 TELESAT 185
*Details on Business Overview, Solutions, Products & Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
14 ADJACENT/RELATED MARKETS 186
14.1 MARITIME SATELLITE COMMUNICATION 186
14.1.1 MARKET OVERVIEW 186
14.1.2 MARITIME SATELLITE COMMUNICATION MARKET, BY COMPONENT 186
TABLE 143 MARITIME SATELLITE COMMUNICATION MARKET, BY COMPONENT, 2016–2018 (USD MILLION) 186
TABLE 144 MARITIME SATELLITE COMMUNICATION MARKET, BY COMPONENT, 2019–2025 (USD MILLION) 187
TABLE 145 SOLUTIONS: MARITIME SATELLITE COMMUNICATION MARKET, BY REGION, 2016–2018 (USD MILLION) 187
TABLE 146 SOLUTIONS: MARITIME SATELLITE COMMUNICATION MARKET, BY REGION, 2019–2025 (USD MILLION) 187
TABLE 147 SERVICES: MARITIME SATELLITE COMMUNICATION MARKET, BY REGION, 2016–2018 (USD MILLION) 188
TABLE 148 SERVICES: MARITIME SATELLITE COMMUNICATION MARKET, BY REGION, 2019–2025 (USD MILLION) 188
14.1.3 MARITIME SATELLITE COMMUNICATION MARKET, BY SOLUTION 188
TABLE 149 MARITIME SATELLITE COMMUNICATION MARKET, BY SOLUTION, 2016–2018 (USD MILLION) 188
TABLE 150 MARITIME SATELLITE COMMUNICATION MARKET, BY SOLUTION, 2019–2025 (USD MILLION) 189
TABLE 151 VERY SMALL APERTURE TERMINAL: MARITIME SATELLITE COMMUNICATION SOLUTIONS MARKET, BY REGION, 2016–2018 (USD MILLION) 189
TABLE 152 VERY SMALL APERTURE TERMINAL: MARITIME SATELLITE COMMUNICATION SOLUTIONS MARKET, BY REGION, 2019–2025 (USD MILLION) 189
14.1.4 MARITIME SATELLITE COMMUNICATION MARKET, BY SERVICE 190
TABLE 153 MARITIME SATELLITE COMMUNICATION MARKET, BY SERVICE, 2016–2018 (USD MILLION) 190
TABLE 154 MARITIME SATELLITE COMMUNICATION MARKET, BY SERVICE, 2019–2025 (USD MILLION) 190
14.1.5 MARITIME SATELLITE COMMUNICATION MARKET, BY END USER 190
TABLE 155 MARITIME SATELLITE COMMUNICATION MARKET, BY END USER, 2016–2018 (USD MILLION) 191
TABLE 156 MARITIME SATELLITE COMMUNICATION MARKET, BY END USER, 2019–2025 (USD MILLION) 191
14.2 NANOSATELLITE AND MICROSATELLITE MARKET 191
14.2.1 MARKET DEFINITION 191
14.2.2 NANOSATELLITE AND MICROSATELLITE MARKET, BY COMPONENT 192
TABLE 157 NANOSATELLITE AND MICROSATELLITE MARKET, BY COMPONENT, 2017–2021 (USD MILLION) 192
TABLE 158 NANOSATELLITE AND MICROSATELLITE MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 193
14.2.3 NANOSATELLITE AND MICROSATELLITE MARKET, BY TYPE 193
TABLE 159 NANOSATELLITE AND MICROSATELLITE MARKET, BY TYPE, 2017–2021 (USD MILLION) 193
TABLE 160 NANOSATELLITE AND MICROSATELLITE MARKET, BY TYPE, 2022–2027 (USD MILLION) 193
14.2.4 NANOSATELLITE AND MICROSATELLITE MARKET, BY ORGANIZATION SIZE 194
TABLE 161 NANOSATELLITE AND MICROSATELLITE MARKET, BY ORGANIZATION SIZE, 2017–2021 (USD MILLION) 194
TABLE 162 NANOSATELLITE AND MICROSATELLITE MARKET, BY ORGANIZATION SIZE, 2022–2027 (USD MILLION) 194
14.2.5 NANOSATELLITE AND MICROSATELLITE MARKET, BY APPLICATION 194
TABLE 163 NANOSATELLITE AND MICROSATELLITE MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 195
TABLE 164 NANOSATELLITE AND MICROSATELLITE MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 195
14.2.6 NANOSATELLITE AND MICROSATELLITE MARKET, BY ORBIT 195
TABLE 165 NANOSATELLITE AND MICROSATELLITE MARKET, BY VERTICAL, 2017–2021 (USD MILLION) 196
TABLE 166 NANOSATELLITE AND MICROSATELLITE MARKET, BY VERTICAL, 2022–2027 (USD MILLION) 196
14.2.7 NANOSATELLITE AND MICROSATELLITE MARKET, BY FREQUENCY 196
TABLE 167 NANOSATELLITE AND MICROSATELLITE MARKET, BY FREQUENCY, 2017–2021 (USD MILLION) 197
TABLE 168 NANOSATELLITE AND MICROSATELLITE MARKET, BY FREQUENCY, 2022–2027 (USD MILLION) 197
15 APPENDIX 198
15.1 DISCUSSION GUIDE 198
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 201
15.3 CUSTOMIZATION OPTIONS 203
15.4 RELATED REPORTS 203
15.5 AUTHOR DETAILS 204

※参考情報

5G NTN（5G Non-Terrestrial Network）とは、5G通信ネットワークにおいて地上に依存しない非地上ネットワークのことを指します。NTNは、衛星やドローンなどの空中に配置された通信設備を利用することで、地上の通信インフラが及ばない地域においても高速で低遅延の通信を実現することを目的としています。5G NTNは、広範囲にわたる接続性を提供し、特に通信が難しい環境や地域における通信手段の選択肢を増やします。
5G NTNの構成要素には、主に衛星通信、ハイアロフトプラットフォーム（HAP）、そして地上の通信ネットワークがあります。衛星通信は、Geostationary Orbit（GEO）やLow Earth Orbit（LEO）などの異なる軌道に配置された衛星を使って、地上と宇宙間のデータ通信を行います。GEO衛星は地球上の特定の位置に静止しているため、広範囲をカバーすることができます。一方、LEO衛星は地球に近い軌道を周回しており、より低遅延の通信を実現できます。HAPは、高高度に位置する無人航空機や気球を使用し、さらなる通信の可能性を提供します。

5G NTNの用途は多岐にわたります。まず、遠隔地や難アクセス地域の通信が挙げられます。これにより、農業や災害救助、海洋作業など、地上のインフラが整っていない場所でのデータ通信が可能になります。また、航空機や船舶での通信にも利用され、航空トラフィック管理や海洋監視の向上が期待されています。さらに、IoT（Internet of Things）デバイスの接続にも応用され、多様なセンサーやデバイスによるデータ収集や監視システムが発展することでしょう。

関連技術としては、衛星通信技術以外にも、無線通信技術やエッジコンピューティング、AI（人工知能）が挙げられます。無線通信技術は、5G NTNの通信方式として重要な役割を果たしています。また、エッジコンピューティングは、データ処理をネットワークのエッジで行うことで、通信遅延を最小限に抑え、リアルタイムでの応答速度を向上させます。AIは、通信ネットワークの最適化やトラフィック管理、データ分析などに利用され、全体の性能向上に寄与します。

5G NTNにはいくつかの利点があります。まず、通信のカバレッジが向上し、リモートエリアでの接続が強化されます。これにより、リアルタイムでのデータ収集や監視が可能となり、ビジネスや社会インフラの運用効率が向上します。また、災害時や緊急時の通信手段としても重要であり、地上インフラが損傷した場合でも通信を維持することができます。さらに、5G NTNは非地上通信の特性を活かし、多様なサービスを提供することができます。

一方で、5G NTNにはいくつかの課題も存在します。通信の遅延や帯域幅の制限が、特に衛星通信においてはクリティカルな要因となります。また、コストや技術的な障壁、そして規制に関する課題も考慮する必要があります。さらに、サイバーセキュリティに対する高い意識も求められます。このような課題を克服することで、5G NTNは今後ますます重要な通信手段としての地位を確立していくでしょう。

総じて、5G NTNは、未来の通信技術の発展において重要な役割を果たすと考えられています。地上の通信インフラを超えて、新たな可能性を拓く技術として、遠隔医療、スマートシティ、農業の効率化など、様々な分野での活用が期待されています。これにより、より多くの人々が恩恵を受け、社会全体のデジタル化が進むことでしょう。5G NTNは、今後の通信ネットワークの進化において、欠かせない存在となると予測されています。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

カテゴリ： MarketsandMarkets, 世界, 医療/バイオ

医薬品原薬（API）の世界市場予測（～2027）：種類別、メーカー別、合成別、製品別、薬物別、用途別

■ 英語タイトル：Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormones, Cytokines), Drug (OTC,Rx) Application (Diabetes, Oncology, CVD) - Global Forecast to 2027
	■ 発行会社/調査会社：MarketsandMarkets ■ 商品コード：PH1262-23 ■ 発行日：2022年12月15日最新版(2025年又は2026年)はお問い合わせください。 ■ 調査対象地域：グローバル ■ 産業分野：医薬品 ■ ページ数：361 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後24時間以内）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧）	USD4,950 ⇒換算￥772,200	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥1,037,400	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥1,271,400	見積依頼/購入/質問フォーム

★グローバルリサーチ資料[医薬品原薬（API）の世界市場予測（～2027）：種類別、メーカー別、合成別、製品別、薬物別、用途別]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

MarketsandMarkets社は、世界の医薬品原薬（API）市場規模が2022年1459億ドルから2027年2164億ドルに達し、予測期間中に年平均8.2％で成長すると予測しています。本調査資料では、医薬品原薬（API）の世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別（革新的、ジェネリック）分析、効力別（従来型、高活性医薬品成分）分析、合成別（合成、バイオテクノロジー）分析、薬物別（市販薬、処方薬）分析、地域別（北米、ヨーロッパ、アジア太平洋、その他地域）分析、競争状況、企業情報などの内容を掲載しています。また、本レポートに掲載されている企業情報には、Pfizer,Inc. (US)、Novartis AG (Switzerland)、Sanofi (France)、Boehringer Ingelheim (Germany)、Bristol-Myers Squibb (US)、Teva Pharmaceutical Industries Ltd. (Israel)、Eli Lilly and Company (US)、GlaxoSmithKline plc (UK)、Merck & Co.,Inc. (US)、F. Hoffmann-La Roche Ltd. (Switzerland)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の医薬品原薬（API）市場規模：種類別
- 革新的APIの市場規模
- ジェネリックAPIの市場規模
・世界の医薬品原薬（API）市場規模：効力別
- 従来型医薬品成分の市場規模
- 高活性医薬品成分の市場規模
・世界の医薬品原薬（API）市場規模：合成別
- 合成APIの市場規模
- バイオテクノロジーAPIの市場規模
・世界の医薬品原薬（API）市場規模：薬物別
- 市販薬の市場規模
- 処方薬の市場規模
・世界の医薬品原薬（API）市場規模：地域別
- 北米の医薬品原薬（API）市場規模
- ヨーロッパの医薬品原薬（API）市場規模
- アジア太平洋の医薬品原薬（API）市場規模
- その他地域の医薬品原薬（API）市場規模
・競争状況
・企業情報

“世界の医薬品原薬（API）市場は、予測期間中の年平均成長率8.2%で、2022年までに1,459億米ドルに達し、2027年には2,164億米ドルに達すると推定”
バイオ医薬品の取り込みの増加、ジェネリック医薬品の重要性の高まり、精密医療への注目の高まりなどの要因が、世界の医薬品原薬（API）市場の成長を促進する主な要因となっています。

“バイオ医薬品原薬（API）セグメントは予測期間中に最も高いCAGRで成長する見込み”
合成の種類に基づいて、API市場は合成APIとバイオテクノロジーAPIに分類されます。2021年には、合成APIセグメントが最大のシェアを占めました。しかし、バイオAPI分野は予測期間中、より高い成長率が見込まれています。作用の特異性によるバイオ医薬品への需要の高まりやバイオテクノロジーの進歩などの要因が、市場の成長を促進しています。

“モノクローナル抗体分野が世界のバイオ医薬品原薬（API）市場で最大のシェアを占める見込み”
製品別に見ると、バイオ医薬品原薬（API）市場は、モノクローナル抗体、ホルモン・成長因子、サイトカイン、融合タンパク質、治療用酵素、組み換えワクチン、血液因子に区分されます。2021年には、モノクローナル抗体分野がバイオ医薬品原薬（API）市場で最大のシェアを占めると推定されます。

“予測期間中、北米が市場を占める”
2021年、北米が市場を占め、次いで欧州が占めました。この地域のAPI市場全体の成長を促進する主な要因には、主要な製薬・バイオ医薬品製造施設の存在、ジェネリック医薬品に対する政府の関心の高まり、生物製剤や特殊医薬品の需要の高まり、APIの製造工程における技術進歩などがあります。この市場セグメントは、経済・医療危機対策やブランド薬の低価格・ジェネリック医薬品の導入が相まって、緩やかな成長が見込まれています。

主要参入企業のプロフィール内訳
– 企業タイプ別ティア1：37%、ティア2：22%、ティア3：41％
– 役職別 Cレベル：25%、取締役：20%、その他：55％
– 地域別北米：40%、ヨーロッパ：27%、アジア太平洋地域：20%、その他の地域：13％

レポート掲載企業一覧
• Pfizer, Inc. (US),
• Novartis AG (Switzerland),
• Sanofi (France),
• Boehringer Ingelheim (Germany),
• Bristol-Myers Squibb (US),
• Teva Pharmaceutical Industries Ltd. (Israel),
• Eli Lilly and Company (US),
• GlaxoSmithKline plc (UK),
• Merck & Co., Inc. (US),
• AbbVie Inc. (US),
• F. Hoffmann-La Roche Ltd. (Switzerland),
• AstraZeneca (UK),
• Cipla, Inc. (India),
• Mylan N.V. (US),
• Dr. Reddy’s Laboratories Ltd. (India),
• Sun Pharmaceutical Industries Ltd. (India),
• API Pharma Tech (India),
• BDR Pharmaceuticals Internationals Pvt. Ltd. (India),
• Sreepathi Pharmaceuticals Limited (India),
• Shilpa Medicare Limited (India),
• Evonik Industries AG (Germany),
• Aurobindo Pharma Limited (India).

調査範囲
本レポートは世界のAPI市場の全体像を提供します。タイプ、力価、合成のタイプ、医薬品のタイプ、治療用途、地域など、さまざまなセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。さらに、主要市場プレイヤーの企業プロフィール、最近の動向、主要市場戦略とともに、詳細な競合分析も掲載しています。

レポート購入の主な利点
本レポートは、API市場全体とそのサブセグメントにおける収益数の最も近い概算値を提供することで、市場リーダー/新規参入者を支援します。また、本レポートは、利害関係者が競争状況をより良く理解し、自社のビジネスをより良く位置づけ、適切な市場参入戦略を立てるためのより多くの洞察を得るのに役立ちます。また、利害関係者が市場の動向を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供することも可能になります。

*** レポート目次（コンテンツ）***

1 INTRODUCTION 48
1.1 STUDY OBJECTIVES 48
1.2 MARKET DEFINITION 48
1.2.1 INCLUSIONS AND EXCLUSIONS 48
1.3 MARKET SCOPE 49
1.3.1 MARKETS COVERED 49
FIGURE 1 MARKET SEGMENTATION 49
1.3.2 GEOGRAPHIC SCOPE 49
1.3.3 YEARS CONSIDERED 50
1.4 CURRENCY 50
1.5 LIMITATIONS 50
1.6 STAKEHOLDERS 50
1.7 SUMMARY OF CHANGES 51
2 RESEARCH METHODOLOGY 52
2.1 RESEARCH DATA 52
FIGURE 2 RESEARCH DESIGN 52
2.1.1 SECONDARY DATA 53
2.1.1.1 Key data from secondary sources 53
2.1.2 PRIMARY DATA 54
2.1.2.1 Primary sources 54
2.1.2.2 Key data from primary sources 55
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS 55
2.2 MARKET SIZE ESTIMATION 56
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 56
FIGURE 5 MARKET SIZE ESTIMATION: DEMAND-SIDE ANALYSIS 56
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 58
FIGURE 6 DATA TRIANGULATION METHODOLOGY 58
2.4 MARKET SHARE ESTIMATION 59
2.5 ASSUMPTIONS 59
3 EXECUTIVE SUMMARY 60
FIGURE 7 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022 VS. 2027 (USD BILLION) 60
FIGURE 8 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY TYPE OF SYNTHESIS, 2021 61
FIGURE 9 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2022 VS. 2027 (USD BILLION) 61
FIGURE 10 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2022 VS. 2027 (USD BILLION) 62
FIGURE 11 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY THERAPEUTIC APPLICATION, 2021 62
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 63
4 PREMIUM INSIGHTS 65
4.1 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET OVERVIEW 65
FIGURE 13 INCREASING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET 65
4.2 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE AND COUNTRY (2021) 66
FIGURE 14 INNOVATIVE APIS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 66
4.3 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 67
FIGURE 15 ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN FORECAST PERIOD 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
5.2 MARKET DYNAMICS 68
FIGURE 16 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 68
5.2.1 DRIVERS 68
5.2.1.1 Pharmaceutical and biopharmaceutical capacity expansion 68
5.2.1.2 Growing importance of generics 69
TABLE 1 INDICATIVE LIST OF DRUGS GOING GENERIC IN 2021 70
5.2.1.3 Increasing uptake of biopharmaceuticals 70
TABLE 2 US: INDICATIVE LIST OF BIOLOGICS THAT GAINED REGULATORY APPROVAL IN 2021 71
5.2.1.4 Technological advancements in API manufacturing 71
5.2.1.5 Focus on precision medicine 72
5.2.1.6 Increasing incidence of chronic diseases 73
5.2.2 RESTRAINTS 74
5.2.2.1 Complications during API manufacturing 74
5.2.2.2 Low profit margins and high manufacturing costs 74
5.2.3 OPPORTUNITIES 74
5.2.3.1 Emerging biosimilars market 74
TABLE 3 US: INDICATIVE LIST OF BIOSIMILARS THAT GAINED REGULATORY APPROVAL (2021–2022) 75
5.2.3.2 Highly potent active pharmaceutical ingredients 75
5.2.3.3 Emerging markets 75
5.2.3.4 Emerging technologies/processes 76
5.2.4 CHALLENGES 76
5.2.4.1 Increasing penetration of counterfeit drugs 76
5.3 VALUE CHAIN ANALYSIS 77
FIGURE 17 MAJOR VALUE ADDED DURING MANUFACTURING 77
5.4 SUPPLY CHAIN ANALYSIS 78
FIGURE 18 DIRECT DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES 78
5.5 ECOSYSTEM ANALYSIS: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 79
FIGURE 19 ECOSYSTEM ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 79
5.6 PATENT ANALYSIS 80
FIGURE 20 PATENT APPLICATIONS FOR ACTIVE PHARMACEUTICAL INGREDIENTS, JANUARY 2010–DECEMBER 2021 80
5.7 KEY CONFERENCES AND EVENTS 81
TABLE 4 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2022–2023 81
5.8 TARIFF AND REGULATORY LANDSCAPE 82
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
5.9 PORTER’S FIVE FORCES ANALYSIS 83
TABLE 8 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 83
5.9.1 THREAT OF NEW ENTRANTS 83
5.9.2 THREAT OF SUBSTITUTES 83
5.9.3 BARGAINING POWER OF SUPPLIERS 83
5.9.4 BARGAINING POWER OF BUYERS 83
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 83
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 84
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 84
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ACTIVE PHARMACEUTICAL INGREDIENTS 84
5.10.2 BUYING CRITERIA FOR ACTIVE PHARMACEUTICAL INGREDIENTS 84
FIGURE 22 KEY BUYING CRITERIA FOR END USERS 84
5.11 PRICING ANALYSIS 85
TABLE 9 IMPORTERS FOR ANTIBIOTICS (HS CODE – 2941) 85
TABLE 10 EXPORTERS FOR ANTIBIOTICS (HS CODE – 2941) 86
TABLE 11 IMPORTERS FOR NUCLEIC ACIDS AND THEIR SALTS, WHETHER OR NOT CHEMICALLY DEFINED; HETEROCYCLIC COMPOUNDS (EXCLUDING WITH OXYGEN ONLY OR WITH NITROGEN HETERO-ATOM[S] ONLY (HS CODE – 2934) 87
TABLE 12 EXPORTERS FOR NUCLEIC ACIDS AND THEIR SALTS, WHETHER OR NOT CHEMICALLY DEFINED; HETEROCYCLIC COMPOUNDS (EXCLUDING WITH OXYGEN ONLY OR WITH NITROGEN HETERO-ATOM[S] ONLY (HS CODE – 2934) 88
TABLE 13 IMPORTERS FOR HORMONES, PROSTAGLANDINS, THROMBOXANES, AND LEUKOTRIENES, NATURAL OR REPRODUCED BY SYNTHESIS; DERIVATIVES AND STRUCTURAL ANALOGUES THEREOF INCLUDE CHAIN-MODIFIED POLYPEPTIDES, USED PRIMARILY AS HORMONES (HS CODE – 2937) 89
TABLE 14 EXPORTERS FOR HORMONES, PROSTAGLANDINS, THROMBOXANES AND LEUKOTRIENES, NATURAL OR REPRODUCED BY SYNTHESIS; DERIVATIVES AND STRUCTURAL ANALOGUES THEREOF INCLUDE CHAIN-MODIFIED POLYPEPTIDES, USED PRIMARILY AS HORMONES (HS CODE – 2937) 90
5.12 TRADE ANALYSIS 91
TABLE 15 TOP 10 IMPORTERS FOR ANTIBIOTICS (HS CODE – 2941) 91
TABLE 16 TOP 10 EXPORTERS OF ANTIBIOTICS (HS CODE – 2941) 91
TABLE 17 TOP 10 IMPORTERS OF NUCLEIC ACIDS AND THEIR SALTS, WHETHER OR NOT CHEMICALLY DEFINED; HETEROCYCLIC COMPOUNDS (EXCLUDING WITH OXYGEN ONLY OR WITH NITROGEN HETERO-ATOM[S] ONLY (HS CODE – 2934) 92
TABLE 18 TOP 10 EXPORTERS OF NUCLEIC ACIDS AND THEIR SALTS, WHETHER OR NOT CHEMICALLY DEFINED; HETEROCYCLIC COMPOUNDS (EXCLUDING WITH OXYGEN ONLY OR WITH NITROGEN HETERO-ATOM[S] ONLY (HS CODE – 2934) 92
TABLE 19 TOP 10 IMPORTERS OF HORMONES, PROSTAGLANDINS, THROMBOXANES AND LEUKOTRIENES, NATURAL OR REPRODUCED BY SYNTHESIS; DERIVATIVES AND STRUCTURAL ANALOGUES THEREOF INCLUDE CHAIN-MODIFIED POLYPEPTIDES, USED PRIMARILY AS HORMONES (HS CODE – 2937) 93
TABLE 20 TOP 10 EXPORTERS OF HORMONES, PROSTAGLANDINS, THROMBOXANES AND LEUKOTRIENES, NATURAL OR REPRODUCED BY SYNTHESIS; DERIVATIVES AND STRUCTURAL ANALOGUES THEREOF INCLUDE CHAIN-MODIFIED POLYPEPTIDES, USED PRIMARILY AS HORMONES (HS CODE – 2937) 93
6 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE 94
6.1 INTRODUCTION 95
TABLE 21 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION) 95
6.2 ACTIVE PHARMACEUTICAL INGREDIENTS, BY TYPE (CAPTIVE AND MERCHANT) 95
TABLE 22 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE (CAPTIVE AND MERCHANT), 2020–2027 (USD BILLION) 95
TABLE 23 CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION) 96
6.3 INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS 96
6.3.1 GROWING NUMBER OF NEW MOLECULAR ENTITIES GAINING REGULATORY APPROVALS TO DRIVE MARKET 96
TABLE 24 INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION) 97
TABLE 25 NORTH AMERICA: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 97
TABLE 26 EUROPE: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 98
TABLE 27 ASIA PACIFIC: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 98
TABLE 28 REST OF THE WORLD: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 99
6.4 GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS 99
6.4.1 GOVERNMENT INITIATIVES SUPPORTING ADOPTION OF GENERIC DRUGS TO BOOST MARKET GROWTH 99
TABLE 29 GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION) 99
TABLE 30 NORTH AMERICA: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 100
TABLE 31 EUROPE: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 100
TABLE 32 ASIA PACIFIC: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 101
TABLE 33 REST OF THE WORLD: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 101
7 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY 102
7.1 INTRODUCTION 103
TABLE 34 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2020–2027 (USD BILLION) 103
7.2 TRADITIONAL ACTIVE PHARMACEUTICAL INGREDIENTS 103
7.2.1 APPLICATION IN VARIOUS THERAPEUTIC AREAS TO SUPPORT MARKET GROWTH 103
TABLE 35 TRADITIONAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION) 104
TABLE 36 NORTH AMERICA: TRADITIONAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 104
TABLE 37 EUROPE: TRADITIONAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 104
TABLE 38 ASIA PACIFIC: TRADITIONAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 105
TABLE 39 REST OF THE WORLD: TRADITIONAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 105
7.3 HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS 105
7.3.1 INCREASING APPLICATION ACROSS RANGE OF THERAPEUTIC AREAS TO DRIVE MARKET 105
TABLE 40 HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION) 106
TABLE 41 NORTH AMERICA: HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 106
TABLE 42 EUROPE: HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 107
TABLE 43 ASIA PACIFIC: HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 107
TABLE 44 REST OF THE WORLD: HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 108
8 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS 109
8.1 INTRODUCTION 110
TABLE 45 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION) 110

8.2 ACTIVE PHARMACEUTICAL INGREDIENTS, BY TYPE OF SYNTHESIS
(CAPTIVE AND MERCHANT) 110
TABLE 46 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS (CAPTIVE AND MERCHANT), 2020–2027 (USD BILLION) 110
TABLE 47 CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2020–2027 (USD BILLION) 111
8.3 SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS 111
TABLE 48 SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION) 112
TABLE 49 NORTH AMERICA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 112
TABLE 50 EUROPE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 113
TABLE 51 ASIA PACIFIC: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 113
TABLE 52 REST OF THE WORLD: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 114
8.3.1 SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE 114
TABLE 53 SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION) 114
8.3.1.1 Innovative synthetic APIs 115
8.3.1.1.1 High value of innovative APIs to drive market 115
TABLE 54 INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION) 115
TABLE 55 NORTH AMERICA: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 115
TABLE 56 EUROPE: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 116
TABLE 57 ASIA PACIFIC: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 116
TABLE 58 REST OF THE WORLD: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 117
8.3.1.2 Generic synthetic APIs 117
8.3.1.2.1 Initiatives to promote penetration of generics to support market growth 117
TABLE 59 GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION) 118
TABLE 60 NORTH AMERICA: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 118
TABLE 61 EUROPE: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 119
TABLE 62 ASIA PACIFIC: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 119
TABLE 63 REST OF THE WORLD: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 120
8.4 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS 120
TABLE 64 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION) 121
TABLE 65 NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 121
TABLE 66 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 122
TABLE 67 ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 122
TABLE 68 REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 123
8.4.1 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE 123
TABLE 69 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2027 (USD BILLION) 123
8.4.1.1 Innovative biotech APIs 123
8.4.1.1.1 Growing demand for innovative biopharmaceuticals to drive market 123
TABLE 70 INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION) 124
TABLE 71 NORTH AMERICA: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 124
TABLE 72 EUROPE: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 125
TABLE 73 ASIA PACIFIC: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 125
TABLE 74 REST OF THE WORLD: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 126
8.4.1.2 Generic biotech APIs 126
8.4.1.2.1 Increasing demand for biosimilar drugs due to cost-effectiveness to drive market 126
TABLE 75 GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2027 (USD BILLION) 127
TABLE 76 NORTH AMERICA: GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 127
TABLE 77 EUROPE: GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 128
TABLE 78 ASIA PACIFIC: GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 128
TABLE 79 REST OF THE WORLD: GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 129
8.4.2 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT 129
TABLE 80 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2020–2027 (USD BILLION) 129
8.4.2.1 Monoclonal antibodies 130
8.4.2.1.1 Growing applications of antibody-drug conjugates in treatment of cancer to drive growth 130
TABLE 81 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2020–2027 (USD BILLION) 130
TABLE 82 NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2020–2027 (USD BILLION) 131
TABLE 83 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2020–2027 (USD BILLION) 131
TABLE 84 ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2020–2027 (USD BILLION) 132
TABLE 85 REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2020–2027 (USD BILLION) 132
8.4.2.2 Hormones and growth factors 132
8.4.2.2.1 Growing incidence of hormonal disorders to drive market 132
TABLE 86 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES AND GROWTH FACTORS, BY REGION, 2020–2027 (USD BILLION) 133
TABLE 87 NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY COUNTRY, 2020–2027 (USD BILLION) 133
TABLE 88 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY COUNTRY, 2020–2027 (USD BILLION) 134
TABLE 89 ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY COUNTRY, 2020–2027 (USD BILLION) 134
TABLE 90 REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY COUNTRY, 2020–2027 (USD BILLION) 135
8.4.2.3 Cytokines 135
8.4.2.3.1 Interferons and interleukins boost immune system 135
TABLE 91 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY REGION, 2020–2027 (USD BILLION) 135
TABLE 92 NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 2020–2027 (USD BILLION) 136
TABLE 93 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 2020–2027 (USD BILLION) 136
TABLE 94 ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 2020–2027 (USD BILLION) 137
TABLE 95 REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 2020–2027 (USD BILLION) 137
8.4.2.4 Fusion proteins 137
8.4.2.4.1 Growing applications of fusion proteins in biopharmaceuticals to drive market 137
TABLE 96 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY REGION, 2020–2027 (USD BILLION) 138
TABLE 97 NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 2020–2027 (USD BILLION) 138
TABLE 98 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 2020–2027 (USD BILLION) 139
TABLE 99 ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 2020–2027 (USD BILLION) 139
TABLE 100 REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 2020–2027 (USD BILLION) 140
8.4.2.5 Recombinant vaccines 140
8.4.2.5.1 Growing prevalence of infectious diseases to boost vaccine development 140
TABLE 101 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY REGION, 2020–2027 (USD BILLION) 140
TABLE 102 NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 2020–2027 (USD BILLION) 141
TABLE 103 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 2020–2027 (USD BILLION) 141
TABLE 104 ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 2020–2027 (USD BILLION) 142
TABLE 105 REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 2020–2027 (USD BILLION) 142
8.4.2.6 Therapeutic enzymes 142
8.4.2.6.1 Growing significance of enzymes in therapies for cancer and pain management to drive market 142
TABLE 106 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY REGION, 2020–2027 (USD BILLION) 143
TABLE 107 NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 2020–2027 (USD BILLION) 143
TABLE 108 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 2020–2027 (USD BILLION) 144
TABLE 109 ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 2020–2027 (USD BILLION) 144
TABLE 110 REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, 2020–2027 (USD BILLION) 145
8.4.2.7 Blood factors 145
8.4.2.7.1 Growing incidence of hemophilia to drive market 145
TABLE 111 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY REGION, 2020–2027 (USD BILLION) 145
TABLE 112 NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY COUNTRY, 2020–2027 (USD BILLION) 146
TABLE 113 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY COUNTRY, 2020–2027 (USD BILLION) 146
TABLE 114 ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY COUNTRY, 2020–2027 (USD BILLION) 147
TABLE 115 REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, 2020–2027 (USD BILLION) 147
8.4.3 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM 148
TABLE 116 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2020–2027 (USD BILLION) 148
8.4.3.1 Mammalian expression systems 148
8.4.3.1.1 Ability to carry post-translational modifications to drive adoption 148
TABLE 117 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD BILLION) 149
TABLE 118 NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 149
TABLE 119 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 150
TABLE 120 ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 150
TABLE 121 REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 151
8.4.3.2 Microbial expression systems 151
8.4.3.2.1 High expression levels of proteins at low costs to drive market 151
TABLE 122 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD BILLION) 151
TABLE 123 NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 152
TABLE 124 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 152
TABLE 125 ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 153
TABLE 126 REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 153
8.4.3.3 Yeast expression systems 153
8.4.3.3.1 Efficient protein secretion, simple purification, and endotoxin-free products to boost demand 153
TABLE 127 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD BILLION) 154
TABLE 128 NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 154
TABLE 129 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 155
TABLE 130 ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 155
TABLE 131 REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 156
8.4.3.4 Insect expression systems 156
8.4.3.4.1 Efficient post-translational modifications to boost adoption 156
TABLE 132 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD BILLION) 156
TABLE 133 NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 157
TABLE 134 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 157
TABLE 135 ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 158
TABLE 136 REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 158
8.4.3.5 Other expression systems 158
TABLE 137 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD BILLION) 159
TABLE 138 NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 159
TABLE 139 EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 160
TABLE 140 ASIA PACIFIC: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 160
TABLE 141 REST OF THE WORLD: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD BILLION) 161
9 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG 162
9.1 INTRODUCTION 163
TABLE 142 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2020–2027 (USD BILLION) 163
9.2 PRESCRIPTION DRUGS 163
9.2.1 GROWING DISEASE PREVALENCE TO SUPPORT MARKET GROWTH 163
TABLE 143 PRESCRIPTION DRUGS MARKET, BY REGION, 2020–2027 (USD BILLION) 164
TABLE 144 NORTH AMERICA: PRESCRIPTION DRUGS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 164
TABLE 145 EUROPE: PRESCRIPTION DRUGS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 165
TABLE 146 ASIA PACIFIC: PRESCRIPTION DRUGS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 165
TABLE 147 REST OF THE WORLD: PRESCRIPTION DRUGS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 166
9.3 OVER-THE-COUNTER DRUGS 166
9.3.1 INCREASED SALES OF OTC DRUGS DUE TO INNOVATIONS, PROMOTION OF SELF-MEDICATION, AND INCREASED ACCESS 166
TABLE 148 OVER-THE-COUNTER DRUGS MARKET, BY REGION, 2020–2027 (USD BILLION) 167
TABLE 149 NORTH AMERICA: OVER-THE-COUNTER DRUGS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 167
TABLE 150 EUROPE: OVER-THE-COUNTER DRUGS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 168
TABLE 151 ASIA PACIFIC: OVER-THE-COUNTER DRUGS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 168
TABLE 152 REST OF THE WORLD: OVER-THE-COUNTER DRUGS MARKET, BY COUNTRY, 2020–2027 (USD BILLION) 169
10 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET,
BY THERAPEUTIC APPLICATION 170
10.1 INTRODUCTION 171
TABLE 153 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2020–2027 (USD BILLION) 171
10.2 COMMUNICABLE DISEASES 171
10.2.1 LARGEST AND FASTEST-GROWING MARKET SEGMENT 171
TABLE 154 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY REGION, 2020–2027 (USD BILLION) 172
TABLE 155 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 2020–2027 (USD BILLION) 172
TABLE 156 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 2020–2027 (USD BILLION) 173
TABLE 157 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 2020–2027 (USD BILLION) 173
TABLE 158 REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 2020–2027 (USD BILLION) 174
10.3 ONCOLOGY 174
10.3.1 INCREASING SPENDING ON CANCER MEDICATION TO SUPPORT MARKET GROWTH 174
TABLE 159 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY REGION, 2020–2027 (USD BILLION) 174
TABLE 160 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD BILLION) 175
TABLE 161 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD BILLION) 175
TABLE 162 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD BILLION) 176
TABLE 163 REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD BILLION) 176
10.4 DIABETES 177
10.4.1 HIGH PREVALENCE OF DIABETES TO DRIVE MARKET 177
TABLE 164 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY REGION, 2020–2027 (USD BILLION) 177
TABLE 165 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 2020–2027 (USD BILLION) 177
TABLE 166 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 2020–2027 (USD BILLION) 178
TABLE 167 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 2020–2027 (USD BILLION) 178
TABLE 168 REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 2020–2027 (USD BILLION) 179
10.5 CARDIOVASCULAR DISEASES 179
10.5.1 GROWING INCIDENCE OF CARDIOVASCULAR DISEASES OWING TO SEDENTARY LIFESTYLES 179
TABLE 169 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2020–2027 (USD BILLION) 179
TABLE 170 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2020–2027 (USD BILLION) 180
TABLE 171 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2020–2027 (USD BILLION) 180
TABLE 172 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2020–2027 (USD BILLION) 181
TABLE 173 REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2020–2027 (USD BILLION) 181
10.6 PAIN MANAGEMENT 182
10.6.1 INCREASING DEMAND FOR INNOVATIVE AND ADVANCED PAIN MEDICATIONS TO PROPEL MARKET 182
TABLE 174 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY REGION, 2020–2027 (USD BILLION) 182
TABLE 175 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2020–2027 (USD BILLION) 182
TABLE 176 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2020–2027 (USD BILLION) 183
TABLE 177 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2020–2027 (USD BILLION) 183
TABLE 178 REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2020–2027 (USD BILLION) 184
10.7 RESPIRATORY DISEASES 184
10.7.1 HIGH PREVALENCE OF RESPIRATORY DISEASES TO SUPPORT MARKET GROWTH 184
TABLE 179 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY REGION, 2020–2027 (USD BILLION) 184
TABLE 180 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2020–2027 (USD BILLION) 185
TABLE 181 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2020–2027 (USD BILLION) 185
TABLE 182 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2020–2027 (USD BILLION) 186
TABLE 183 REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2020–2027 (USD BILLION) 186
10.8 OTHER THERAPEUTIC APPLICATIONS 186
TABLE 184 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2020–2027 (USD BILLION) 187
TABLE 185 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD BILLION) 187
TABLE 186 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD BILLION) 188
TABLE 187 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD BILLION) 188
TABLE 188 REST OF THE WORLD: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD BILLION) 189

※参考情報

医薬品原薬、いわゆるAPI（Active Pharmaceutical Ingredient）は、医薬品の主成分であり、治療効果を持つ物質です。APIは、医薬品の治療目的に応じて特定の生理学的、または生化学的な作用を持ち、疾患の予防や治療に利用されます。医薬品は通常、APIとその他の添加物（賦形剤や保存剤など）から構成され、これらの添加物はAPIの効果を補完する役割を果たします。
APIは様々な種類があり、その分類は作用メカニズムや化学構造に基づいて行われます。たとえば、抗生物質、抗炎症薬、抗ウイルス薬、抗がん剤、ホルモン製剤など多岐にわたるカテゴリが存在します。また、自然由来のものや合成されたものも魅力的な分類として挙げられます。自然由来のAPIは、植物や動物から抽出されるものであり、例えばアスピリンはサリチル酸という植物成分から派生します。一方、合成APIは、化学合成によって人為的に作られるもので、例えばロサルタンのような高血圧治療薬が該当します。

APIの用途は非常に広範囲にわたり、特定の疾患の治療を目的とした医薬品に幅広く使われています。たとえば、高血圧や糖尿病などの生活習慣病、がんや感染症といった重大な疾患に至るまで、数多くの病気の治療にAPIは貢献しています。医薬品の開発において、APIの研究は重要なプロセスであり、その特性、効果、副作用について詳細に検討されます。

近年、医薬品原薬の開発には様々な技術が導入されています。例えば、コンピュータ支援ドラッグデザイン（CADD）や構造生物学の進展により、分子レベルでの相互作用を理解しやすくなりました。これにより、より効果的かつ安全なAPIの設計が可能となっています。また、製造工程においては、効率やコスト削減を図るため、プロセスの最適化や連続製造技術が注目されています。

さらに、APIの品質管理も非常に重要です。薬品の有効性や安全性を確保するために、規制当局はAPIの製造業者に対して厳格な基準を設けています。これには、原材料の選定から製造プロセス、最終製品の検査まで、多岐にわたる品質管理が含まれています。また、国際的な基準に基づくGMP（Good Manufacturing Practice）を遵守することが求められます。

近年の医薬品市場では、ジェネリック医薬品やバイオ医薬品の普及も重要なトピックです。ジェネリック医薬品は、特許が切れたAPIを基にして製造される医薬品です。これにより、医療コストの削減やアクセス向上が期待されています。一方、バイオ医薬品は遺伝子組み換え技術を用いて作られるAPIであり、高度な治療機能を持つものが多く、今後の医療における革新が期待されています。

このように、医薬品原薬（API）は、医薬品の核心を成す重要な成分であり、治療の効果や安全性を左右します。様々な種類や用途があり、技術の進歩によりその開発や製造が進化し続けています。将来的には、個別化医療や新しい治療法の登場に伴い、APIの重要性はさらに増すことでしょう。医薬品の研究開発や製造現場において、APIは常に中心的な役割を担い続けるのです。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

カテゴリ： MarketsandMarkets, 世界, 自動車

ドライブバイワイヤーの世界市場予測（～2027）：用途別、センサー別、車両別、コンポーネント別、地域別

■ 英語タイトル：Drive by Wire Market by Application (Brake, Park, Shift, Steer, Throttle), Sensor (Brake Pedal, Throttle Position, Park, Gearshift, Handwheel, Pinion), Vehicle (On & Off-Highway, BEV, PHEV, FCEV, Autonomous), Component & Region - Global Forecast to 2027
	■ 発行会社/調査会社：MarketsandMarkets ■ 商品コード：AT6667-23 ■ 発行日：2022年11月28日最新版(2025年又は2026年)はお問い合わせください。 ■ 調査対象地域：グローバル ■ 産業分野：自動車 ■ ページ数：302 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後24時間以内）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧）	USD4,950 ⇒換算￥772,200	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥1,037,400	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥1,271,400	見積依頼/購入/質問フォーム

★グローバルリサーチ資料[ドライブバイワイヤーの世界市場予測（～2027）：用途別、センサー別、車両別、コンポーネント別、地域別]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

MarketsandMarkets社は、世界のドライブバイワイヤー市場規模が2022年206億ドルから2027年279億ドルに達し、予測期間中に年平均6.2％で成長すると予測しています。本調査資料では、ドライブバイワイヤーの世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、用途別（ブレーキバイワイヤー、パークバイワイヤー、シフトバイワイヤー、ステアバイワイヤー、スロットルバイワイヤー）分析、センサー別（ブレーキペダルセンサー、ハンドホイールセンサー、ギアシフトポジションセンサー、ピニオンアングルセンサー）分析、コンポーネント別（アクチュエーター、電子制御ユニット（ECU）、エンジン制御モジュール（ECM）分析、電子スロットル制御モジュール（ETCM）、フィードバックモーター）、オンハイウェイ車両（乗用車、軽商用車、トラック、バス）分析、地域別（アジア太平洋、ヨーロッパ、北米、その他地域）分析、競争状況、企業情報、マーケットアンドマーケッツからの提言などの内容を掲載しています。また、本レポートに掲載されている企業情報には、Bosch (Germany)、Continental (Germany)、ZF (Germany)、Infineon Technologies (Germany)、Nexteer Automotive (US)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のドライブバイワイヤー市場規模：用途別
- ブレーキバイワイヤーの市場規模
- パークバイワイヤーの市場規模
- シフトバイワイヤーの市場規模
- ステアバイワイヤーの市場規模
- スロットルバイワイヤーの市場規模
・世界のドライブバイワイヤー市場規模：センサー別
- ブレーキペダルセンサーの市場規模
- ハンドホイールセンサーの市場規模
- ギアシフトの市場規模
- ポジションセンサーの市場規模
- ピニオンアングルセンサーの市場規模
・世界のドライブバイワイヤー市場規模：コンポーネント別
- アクチュエーターの市場規模
- 電子制御ユニット（ECU）の市場規模
- エンジン制御モジュール（ECM）の市場規模
- 電子スロットル制御モジュール（ETCM）の市場規模
- フィードバックモーターの市場規模
・世界のドライブバイワイヤー市場規模：オンハイウェイ車両
- 乗用車の市場規模
- 軽商用車の市場規模
- トラックの市場規模
- バスの市場規模
・世界のドライブバイワイヤー市場規模：地域別
- アジア太平洋のドライブバイワイヤー市場規模
- ヨーロッパのドライブバイワイヤー市場規模
- 北米のドライブバイワイヤー市場規模
- その他地域のドライブバイワイヤー市場規模
・競争状況
・企業情報
・マーケットアンドマーケッツからの提言

“自動車用ドライブバイワイヤー市場は、2022年の206億米ドルから、予測期間中に年平均成長率6.2%で拡大し、2027年には279億米ドルに達すると予測”
EV販売の増加、自律走行車の開発、高級車の販売拡大がドライブバイワイヤーシステムの需要を押し上げています。厳しい安全基準の導入も、自動車用ドライブバイワイヤーシステムの採用を促進しています。

“建設・鉱業用ドライブバイワイヤー分野が最も急成長する見込み”
予測期間中、建設・鉱業用が最も急成長するドライブバイワイヤーとなる見込みです。インフラプロジェクトの開発、鉱業活動、物流・貨物業界の配送センターの成長により、オフハイウェイ車の需要が高まると予想されます。さらに、OEMは、より良い操作精度と燃費を実現するために、オフハイウェイ機器にドライブバイワイヤー技術を導入することに重点を移しています。中国、インド、その他のアフリカ諸国のような多くの発展途上国では、政府が10億ドル規模の大規模なインフラ・プロジェクトを発表し、建設・採掘用車両分野全体を後押ししています。これにより、自動車メーカーはより多くのドライブバイワイヤー対応システムを構築できるようになる見込みです。

“予測期間中、ドライブバイワイヤー対応アクチュエータが最大市場を占めると予想”
予測期間中、アクチュエータが最大の市場シェアを占めると予想されます。アクチュエータはドライブバイワイヤーシステムの重要なコンポーネントであり、本調査で検討したすべてのドライブバイワイヤーアプリケーションで使用されます。すべてのドライブバイワイヤーアプリケーションは、1つまたは複数のアクチュエータを使用します。1台の車両に複数のアクチュエータが採用されるため、アクチュエータの数量は、プレミアム車両の人気の高まりとICE車両への電子回路の採用によって増加する見込みです。軽量化とスペース拡大のための技術革新が進むにつれて、より多くの電気機械システムを採用する動きが最終的に出てくると予想されます。

“アジア太平洋地域は自動車用ドライブバイワイヤー市場の最大市場”
中国、インド、韓国、日本などのアジア太平洋諸国は、先進システムを搭載したプレミアム車への需要により、ドライブバイワイヤー市場の主要シェアを占めています。多くのプレミアムカーがドライブバイワイヤーシステムを搭載しています。Volvo XC-40、TATA Altroz DCA、BMWs driveなどは、ドライブバイワイヤーを搭載した車両の一例です。また、アジア太平洋地域では排ガス規制が厳しく、ドライブバイワイヤー市場の拡大が見込まれています。これは、X-by-wireシステムを使用することで、車両全体の重量が軽減されるため、車両が軽量化され、エンジンがより効率的に機能するようになるためです。中国市場は、中型車やエコノミークラスの自動車に自動マニュアルトランスミッションなどの先進技術を採用する方向にシフトしています。その結果、メーカー各社は、スロットル・バイ・ワイヤーやシフト・バイ・ワイヤーなどのドライブバイワイヤーシステムのような先進技術の自動車への導入に投資しています。また、ドライブバイワイヤー技術、特にセンサーやアクチュエーターなどのコンポーネントにおける様々な開発が、様々な自動車メーカーにドライブバイワイヤーを普及させています。このように、前述の要因を考慮すると、ドライブバイワイヤーの採用は今後数年間で大きく成長すると予想されます。

主な内訳
この調査には、部品サプライヤーからティア1企業、OEMに至るまで、さまざまな業界専門家の見識が含まれています。主な内訳は以下の通りです：
 企業タイプ別：供給側70％、需要側30％
 職位別： Cレベル – 20%, ディレクターレベル – 20%, その他 – 60％
 地域別アジア太平洋 – 80%、ヨーロッパ – 10%、北米 – 10％

注：その他には、デザイン・エンジニア、エクステリア・ドライブ・バイ・ワイヤ・デザイナーなどが含まれます。
自動車用ドライブバイワイヤー市場の主要企業は、Bosch (Germany), Continental (Germany), ZF (Germany), Infineon Technologies (Germany), Nexteer Automotive (US)です。主要企業が市場での地位を維持するために採用している主な戦略は、事業拡大、契約・協定、パートナーシップです。

調査範囲
自動車用ドライブバイワイヤー市場：アプリケーション別（スロットルバイワイヤ、ステアバイワイヤ、シフトバイワイヤ、ブレーキバイワイヤ、パークバイワイヤ）、センサタイプ別（スロットルペダルセンサ、スロットルポジションセンサ、ピニオン角センサ、ハンドホイール角センサ、ギアシフトポジションセンサ、パークセンサ、ブレーキペダルセンサ、パークセンサー、ブレーキペダルセンサー）、コンポーネント別（ECU-Electronic Control Unit、ECM-Engine Control Module、アクチュエーター、フィードバックモーター、パーキングポール、ETCM-Electronic Throttle Control Module、ETCU-Electronic Transmission Control Unit）、オンハイウェイ車タイプ別（乗用車、オンハイウェイ車タイプ別（乗用車、小型商用車、バス、トラック）、オフハイウェイ車タイプ別（建設・鉱山機械、農業用トラクター、フォークリフト）、電気自動車タイプ別（BEV、HEV/PHEV、FCEV）、アプリケーション別自律走行車（スロットルバイワイヤ、ステアバイワイヤ、シフトバイワイヤ、ブレーキバイワイヤ、パークバイワイヤ）、電気自動車ドライブバイワイヤ市場：センサータイプ別（スロットルペダル、センサー、スロットルポジションセンサー、ピニオンアングルセンサー、ハンドホイールアングルセンサー、ギアポジションセンサー、パークセンサー、ブレーキペダルセンサー）、地域別（アジア太平洋地域、ヨーロッパ、北米、およびRoW）

レポート購入の主なメリット
本レポートは、ドライブバイワイヤー市場全体およびサブセグメント別の売上高に最も近い概算値に関する情報を提供し、同市場における市場リーダー/新規参入者に役立ちます。本レポートは、ステークホルダーが競争環境を理解し、より深い洞察を得ることで、自社のビジネスをより良く位置づけ、適切な市場参入戦略を計画するのに役立ちます。本レポートはまた、関係者が市場の動向を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供するのに役立ちます。

*** レポート目次（コンテンツ）***

1 INTRODUCTION 39
1.1 STUDY OBJECTIVES 39
1.2 MARKET DEFINITION 40
TABLE 1 MARKET DEFINITIONS 40
1.3 INCLUSIONS AND EXCLUSIONS 41
1.4 MARKET SCOPE 42
1.4.1 MARKETS COVERED 42
FIGURE 1 DRIVE BY WIRE MARKET SEGMENTATION 42
FIGURE 2 DRIVE BY WIRE MARKET: BY REGION 43
1.5 SUMMARY OF CHANGES 43
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH DATA 44
FIGURE 3 RESEARCH DESIGN 45
FIGURE 4 RESEARCH METHODOLOGY MODEL 46
2.1.1 SECONDARY DATA 46
2.1.1.1 Secondary sources for building base numbers 47
2.1.1.2 Key data from secondary sources 48
2.1.2 PRIMARY DATA 49
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 49
2.1.2.1 List of primary participants 49
2.2 MARKET ESTIMATION METHODOLOGY 50
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 50
2.2.1 SAMPLING TECHNIQUES AND DATA COLLECTION METHODS 51
2.3 MARKET SIZE ESTIMATION 51
2.3.1 BOTTOM-UP APPROACH 51
FIGURE 7 DRIVE BY WIRE MARKET SIZE: BOTTOM-UP APPROACH (ICE VEHICLE, APPLICATION, AND REGION) 51
2.3.2 TOP-DOWN APPROACH 52
FIGURE 8 DRIVE BY WIRE MARKET SIZE: TOP-DOWN APPROACH (ELECTRIC VEHICLE, AUTONOMOUS VEHICLE, AND OFF-HIGHWAY VEHICLE) 52
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 53
FIGURE 9 DATA TRIANGULATION 53
2.5 FACTOR ANALYSIS 54
FIGURE 10 DRIVE BY WIRE MARKET: FACTORS IMPACTING MARKET 54
2.6 ASSUMPTIONS 55
2.6.1 ASSUMPTIONS 55
2.6.2 MARKET ASSUMPTIONS 56
2.7 LIMITATIONS/RISK FACTORS 57
3 EXECUTIVE SUMMARY 58
FIGURE 11 DRIVE BY WIRE MARKET OUTLOOK 58
FIGURE 12 DRIVE BY WIRE MARKET, BY REGION, 2022 VS. 2027 (USD MILLION) 59
4 PREMIUM INSIGHTS 61
4.1 ATTRACTIVE OPPORTUNITIES IN DRIVE BY WIRE MARKET 61
FIGURE 13 INCREASING FOCUS ON ELECTRIFICATION AND AUTONOMOUS DRIVING TO BOOST MARKET 61
4.2 DRIVE BY WIRE MARKET, BY REGION 61
FIGURE 14 ASIA PACIFIC TO GROW AT FASTEST RATE DURING FORECAST PERIOD 61
4.3 DRIVE BY WIRE MARKET, BY APPLICATION 62
FIGURE 15 STEER-BY-WIRE TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD 62
4.4 DRIVE BY WIRE MARKET, BY SENSOR TYPE 62
FIGURE 16 GEAR SHIFT POSITION SENSORS SEGMENT TO LEAD DRIVE BY WIRE MARKET 62
4.5 PASSENGER CAR DRIVE BY WIRE MARKET, BY COMPONENT 63
FIGURE 17 ACTUATORS TO LEAD COMPONENT-WISE DRIVE BY WIRE MARKET 63
4.6 ON-HIGHWAY VEHICLES DRIVE BY WIRE MARKET 63
FIGURE 18 PASSENGER VEHICLES TO LEAD DRIVE BY WIRE MARKET FOR ON-HIGHWAY VEHICLES 63
4.7 OFF-HIGHWAY VEHICLES DRIVE BY WIRE MARKET 64
FIGURE 19 TRACTORS TO DOMINATE OFF-HIGHWAY DRIVE BY WIRE MARKET 64
4.8 ELECTRIC VEHICLE DRIVE BY WIRE MARKET, BY VEHICLE TYPE 64
FIGURE 20 BEV TO BE LARGEST SEGMENT OF DRIVE BY WIRE MARKET FOR EVS 64
4.9 AUTONOMOUS VEHICLE DRIVE BY WIRE MARKET, BY APPLICATION 65
FIGURE 21 STEER-BY-WIRE TO BE FASTEST-GROWING MARKET FOR AUTONOMOUS VEHICLE DRIVE BY WIRE APPLICATION 65
5 MARKET OVERVIEW 66
5.1 INTRODUCTION 66
5.2 MARKET DYNAMICS 67
FIGURE 22 DRIVE BY WIRE MARKET DYNAMICS 67
5.2.1 DRIVERS 67
5.2.1.1 Higher investments and adoption of systems 67
TABLE 2 FOLLOWING POPULAR VEHICLE MODELS USE BRAKE-BY-WIRE TECHNOLOGY 68
5.2.1.2 Decreased tail-pipe emissions 68
5.2.1.2.1 On-road vehicles 68
TABLE 3 EURO 5 VS. EURO 6 VEHICLE EMISSION STANDARDS ON NEW EUROPEAN DRIVING CYCLE 69
TABLE 4 ON-ROAD VEHICLE EMISSION REGULATION OUTLOOK FOR PASSENGER CARS, 2016–2021 69
FIGURE 23 ON-ROAD VEHICLE EMISSION REGULATION OUTLOOK FOR HEAVY-DUTY VEHICLES, 2014–2025 70
5.2.1.2.2 Off-road vehicles 70
FIGURE 24 OFF-ROAD VEHICLE EMISSION REGULATION OUTLOOK, 2019–2025 71
5.2.1.3 Easy integration and independence of design 71
FIGURE 25 NISSAN MURANO CONCEPT CAR: DRIVE BY WIRE 72
5.2.1.4 High operational accuracy and reduced mechanical loss 73
5.2.2 RESTRAINTS 73
5.2.2.1 High cost and limited public acceptance 73
5.2.2.2 Threat of cyberattacks 74
FIGURE 26 TOP SMART MOBILITY ATTACK VENDORS 75
5.2.3 OPPORTUNITIES 76
5.2.3.1 Advancements in autonomous vehicles 76
FIGURE 27 AUTONOMOUS VEHICLE MARKET, BY PRODUCTION, 2019–2030 (MILLION UNITS) 76
5.2.3.2 Developments in autonomous off-highway equipment 77
FIGURE 28 AUTONOMOUS TRACTOR MARKET, 2019–2025 (THOUSAND UNITS) 78
5.2.3.3 Increased demand for autonomous vehicles 78
5.2.3.4 Latent demand for semi-autonomous and autonomous trucks 78
5.2.4 CHALLENGES 79
5.2.4.1 Electronic failures 79
5.2.4.2 Rapid developments in automotive electronics 79
5.3 DRIVE BY WIRE MARKET, SCENARIOS (2018–2027) 79
FIGURE 29 DRIVE BY WIRE MARKET SCENARIOS, 2018–2027 (USD MILLION) 80
5.3.1 MOST LIKELY SCENARIO 80
TABLE 5 DRIVE BY WIRE MARKET (REALISTIC SCENARIO), BY REGION, 2021–2027 (USD MILLION) 80
5.3.2 LOW IMPACT SCENARIO 80
TABLE 6 DRIVE BY WIRE MARKET (LOW IMPACT SCENARIO), BY REGION, 2021–2027 (USD MILLION) 81
5.3.3 HIGH IMPACT SCENARIO 81
TABLE 7 DRIVE BY WIRE MARKET (HIGH IMPACT SCENARIO), BY REGION, 2021–2027 (USD MILLION) 81
5.4 MARKET ECOSYSTEM 82
FIGURE 30 MARKET ECOSYSTEM: DRIVE BY WIRE MARKET 82
TABLE 8 DRIVE BY WIRE MARKET: ECOSYSTEM 82
5.5 TECHNOLOGY ANALYSIS 83
5.6 CASE STUDY ANALYSIS 84
5.7 PATENT ANALYSIS 84
5.8 PRICING ANALYSIS 85
5.8.1 BY APPLICATION AND REGION 85
TABLE 9 DRIVE BY WIRE-AVERAGE SELLING PRICE, BY APPLICATION, 2022 (USD) 85
5.9 SUPPLY CHAIN ANALYSIS 86
FIGURE 31 SUPPLY CHAIN ANALYSIS: DRIVE BY WIRE MARKET 86
5.10 PORTER'S FIVE FORCES ANALYSIS 87
FIGURE 32 PORTER'S FIVE FORCES ANALYSIS: DRIVE BY WIRE MARKET 87
5.10.1 THREAT OF NEW ENTRANTS 87
5.10.2 THREAT OF SUBSTITUTES 88
5.10.3 BARGAINING POWER OF SUPPLIERS 88
5.10.4 BARGAINING POWER OF BUYERS 88
5.10.5 INTENSITY OF COMPETITIVE RIVALRY 88
5.11 REGULATORY LANDSCAPE 89
5.11.1 DRIVE BY WIRE STANDARDS, BY COUNTRY 89
TABLE 10 DRIVE BY WIRE STANDARDS, MAJOR COUNTRIES, AND REGIONS 89
5.12 KEY STAKEHOLDERS IN BUYING PROCESS AND BUYING CRITERIA 90
FIGURE 33 KEY BUYING CRITERIA FOR VEHICLES WITH DRIVE BY WIRE SYSTEMS 90
TABLE 11 KEY BUYING CRITERIA, BY PROPULSION TYPE 90
5.13 KEY CONFERENCES 91
5.13.1 DRIVE BY WIRE MARKET: UPCOMING CONFERENCES AND EVENTS, 2022–2023 91
6 DRIVE BY WIRE MARKET, BY APPLICATION 92
6.1 INTRODUCTION 93
6.1.1 RESEARCH METHODOLOGY 93
6.1.2 ASSUMPTIONS 93
6.1.3 INDUSTRY INSIGHTS 94
FIGURE 34 DRIVE BY WIRE MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 94
TABLE 12 DRIVE BY WIRE MARKET, BY APPLICATION, 2018–2021 (‘000 UNITS) 94
TABLE 13 DRIVE BY WIRE MARKET, BY APPLICATION, 2022–2027 (‘000 UNITS) 95
TABLE 14 DRIVE BY WIRE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 95
TABLE 15 DRIVE BY WIRE MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 95
6.2 BRAKE-BY-WIRE 96
6.2.1 CONTINUOUS DEVELOPMENTS AND BETTER OPERATIONAL ACCURACY 96
TABLE 16 BRAKE-BY-WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 96
TABLE 17 BRAKE-BY-WIRE MARKET, BY REGION, 2022–2027 (‘000 UNITS) 96
TABLE 18 BRAKE-BY-WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 97
TABLE 19 BRAKE-BY-WIRE MARKET, BY REGION, 2022–2027 (USD MILLION) 97
6.3 PARK-BY-WIRE 98
6.3.1 REDUCES WEAR AND TEAR OF VEHICLES 98
TABLE 20 PARK-BY-WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 98
TABLE 21 PARK-BY-WIRE MARKET, BY REGION, 2022–2027 (‘000 UNITS) 98
TABLE 22 PARK-BY-WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 98
TABLE 23 PARK-BY-WIRE MARKET, BY REGION, 2022–2027 (USD MILLION) 99
6.4 SHIFT-BY-WIRE 99
6.4.1 SMOOTH GEAR SHIFTING AND REDUCED VEHICLE WEIGHT 99
TABLE 24 SHIFT-BY-WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 99
TABLE 25 SHIFT-BY-WIRE MARKET, BY REGION, 2022–2027 (‘000 UNITS) 100
TABLE 26 SHIFT-BY-WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 100
TABLE 27 SHIFT-BY-WIRE MARKET, BY REGION, 2022–2027 (USD MILLION) 100
6.5 STEER-BY-WIRE 101
6.5.1 INCREASING R&D BY AUTOMAKERS AND BETTER VEHICLE HANDLING TO BOOST DEMAND 101
TABLE 28 STEER-BY-WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 101
TABLE 29 STEER-BY-WIRE MARKET, BY REGION, 2022–2027 (‘000 UNITS) 101
TABLE 30 STEER-BY-WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 102
TABLE 31 STEER-BY-WIRE MARKET, BY REGION, 2022–2027 (USD MILLION) 102
6.6 THROTTLE-BY-WIRE 103
6.6.1 STRENGTHENING OF EMISSION NORMS TO DRIVE MARKET GROWTH 103
TABLE 32 THROTTLE-BY-WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 103
TABLE 33 THROTTLE-BY-WIRE MARKET, BY REGION, 2022–2027 (‘000 UNITS) 103
TABLE 34 THROTTLE-BY-WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 104
TABLE 35 THROTTLE-BY-WIRE MARKET, BY REGION, 2022–2027 (USD MILLION) 104
7 DRIVE BY WIRE MARKET, BY SENSOR TYPE 105
7.1 INTRODUCTION 106
7.1.1 RESEARCH METHODOLOGY 106
7.1.2 ASSUMPTIONS 106
7.1.3 INDUSTRY INSIGHTS 106
TABLE 36 NUMBER OF SENSORS USED PER DRIVE BY WIRE APPLICATION 107
FIGURE 35 DRIVE BY WIRE MARKET, BY SENSOR TYPE, 2022 VS. 2027 (USD MILLION) 107
TABLE 37 DRIVE BY WIRE MARKET, BY SENSOR TYPE, 2018–2021 (‘000 UNITS) 107
TABLE 38 DRIVE BY WIRE MARKET, BY SENSOR TYPE, 2022–2027 (‘000 UNITS) 108
TABLE 39 DRIVE BY WIRE MARKET, BY SENSOR TYPE, 2018–2021 (USD MILLION) 108
TABLE 40 DRIVE BY WIRE MARKET, BY SENSOR TYPE, 2022–2027 (USD MILLION) 108
7.2 BRAKE PEDAL SENSORS 109
7.2.1 INCREASED DEMAND FOR SAFETY TO DRIVE SEGMENT 109
TABLE 41 BRAKE PEDAL SENSORS MARKET, BY REGION, 2018–2021 (‘000 UNITS) 109
TABLE 42 BRAKE PEDAL SENSORS MARKET, BY REGION, 2022–2027 (‘000 UNITS) 109
TABLE 43 BRAKE PEDAL SENSORS MARKET, BY REGION, 2018–2021 (USD MILLION) 110
TABLE 44 BRAKE PEDAL SENSORS MARKET, BY REGION, 2022–2027 (USD MILLION) 110
7.3 HANDWHEEL ANGLE SENSORS 110
7.3.1 ENHANCED SAFETY AND OPERATIONAL ACCURACY 110
TABLE 45 HANDWHEEL ANGLE SENSORS MARKET, BY REGION, 2018–2021 (‘000 UNITS) 111
TABLE 46 HANDWHEEL ANGLE SENSORS MARKET, BY REGION, 2022–2027 (‘000 UNITS) 111
TABLE 47 HANDWHEEL ANGLE SENSORS MARKET, BY REGION, 2018–2021 (USD MILLION) 111
TABLE 48 HANDWHEEL ANGLE SENSORS MARKET, BY REGION, 2022–2027 (USD MILLION) 112
7.4 GEAR SHIFT POSITION SENSORS 112
7.4.1 REDUCES WEAR AND TEAR AND INCREASES VEHICLE LIFESPAN 112
TABLE 49 GEAR SHIFT POSITION SENSORS MARKET, BY REGION, 2018–2021 (‘000 UNITS) 112
TABLE 50 GEAR SHIFT POSITION SENSORS MARKET, BY REGION, 2022–2027 (‘000 UNITS) 113
TABLE 51 GEAR SHIFT POSITION SENSORS MARKET, BY REGION, 2018–2021 (USD MILLION) 113
TABLE 52 GEAR SHIFT POSITION SENSORS MARKET, BY REGION, 2022–2027 (USD MILLION) 113
7.5 PINION ANGLE SENSORS 114
7.5.1 INCREASING ADOPTION OF STEER-BY-WIRE TO DRIVE SEGMENT 114
TABLE 53 PINION ANGLE SENSORS MARKET, BY REGION, 2018–2021 (‘000 UNITS) 114
TABLE 54 PINION ANGLE SENSORS MARKET, BY REGION, 2022–2027 (‘000 UNITS) 114
TABLE 55 PINION ANGLE SENSORS MARKET, BY REGION, 2018–2021 (USD MILLION) 114
TABLE 56 PINION ANGLE SENSORS MARKET, BY REGION, 2022–2027 (USD MILLION) 115
7.6 PARK SENSORS 115
7.6.1 EASY AND EFFORTLESS PARKING BENEFIT 115
TABLE 57 PARK SENSORS MARKET, BY REGION, 2018–2021 (‘000 UNITS) 115
TABLE 58 PARK SENSORS MARKET, BY REGION, 2022–2027 (‘000 UNITS) 116
TABLE 59 PARK SENSORS MARKET, BY REGION, 2018–2021 (USD MILLION) 116
TABLE 60 PARK SENSORS MARKET, BY REGION, 2022–2027 (USD MILLION) 116
7.7 THROTTLE PEDAL SENSORS 117
7.7.1 PROVIDES OPERATIONAL ACCURACY 117
TABLE 61 THROTTLE PEDAL SENSORS MARKET, BY REGION, 2018–2021 (‘000 UNITS) 117
TABLE 62 THROTTLE PEDAL SENSORS MARKET, BY REGION, 2022–2027 (‘000 UNITS) 117
TABLE 63 THROTTLE PEDAL SENSORS MARKET, BY REGION, 2018–2021 (USD MILLION) 117
TABLE 64 THROTTLE PEDAL SENSORS MARKET, BY REGION, 2022–2027 (USD MILLION) 118
7.8 THROTTLE POSITION SENSORS 118
7.8.1 INCREASING POPULARITY TO BOOST ADOPTION 118
TABLE 65 THROTTLE POSITION SENSORS MARKET, BY REGION, 2018–2021 (‘000 UNITS) 118
TABLE 66 THROTTLE POSITION SENSORS MARKET, BY REGION, 2022–2027 (‘000 UNITS) 119
TABLE 67 THROTTLE POSITION SENSORS MARKET, BY REGION, 2018–2021 (USD MILLION) 119
TABLE 68 THROTTLE POSITION SENSORS MARKET, BY REGION, 2022–2027 (USD MILLION) 119
8 DRIVE BY WIRE MARKET, BY COMPONENT 120
8.1 INTRODUCTION 121
8.1.1 RESEARCH METHODOLOGY 121
8.1.2 ASSUMPTIONS 121
8.1.3 INDUSTRY INSIGHTS 122
TABLE 69 DRIVE BY WIRE APPLICATION VS. AVERAGE NUMBER OF COMPONENTS USED PER APPLICATION 122
FIGURE 36 DRIVE BY WIRE MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION) 122
TABLE 70 DRIVE BY WIRE MARKET, BY COMPONENT, 2018–2021 (‘000 UNITS) 123
TABLE 71 DRIVE BY WIRE MARKET, BY COMPONENT, 2022–2027 (‘000 UNITS) 123
TABLE 72 DRIVE BY WIRE MARKET, BY COMPONENT, 2018–2021 (USD MILLION) 123
TABLE 73 DRIVE BY WIRE MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 124
8.2 ACTUATORS 124
8.2.1 INCREASING POPULARITY OF PREMIUM VEHICLES TO DRIVE SEGMENT 124
TABLE 74 ACTUATORS: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 125
TABLE 75 ACTUATORS: DRIVE BY WIRE MARKET, BY COMPONENT, 2022–2027 (‘000 UNITS) 125
TABLE 76 ACTUATORS: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 125
TABLE 77 ACTUATORS: DRIVE BY WIRE MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 126
8.3 ELECTRONIC CONTROL UNITS (ECU) 126
8.3.1 IMPROVED FUEL ECONOMY AND ACCURACY 126
TABLE 78 ECU: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 126
TABLE 79 ECU: DRIVE BY WIRE MARKET, BY COMPONENT, 2022–2027 (‘000 UNITS) 127
TABLE 80 ECU: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 127
TABLE 81 ECU: DRIVE BY WIRE MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 127
8.4 ENGINE CONTROL MODULES (ECM) 128
8.4.1 OFFERS BETTER VALVE CONTROL 128
TABLE 82 ECM: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 128
TABLE 83 ECM: DRIVE BY WIRE MARKET, BY COMPONENT, 2022–2027 (‘000 UNITS) 128
TABLE 84 ECM: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 128
TABLE 85 ECM: DRIVE BY WIRE MARKET, BY COMPONENT, 2022–2027 (USD MILLION ) 129
8.5 ELECTRONIC THROTTLE CONTROL MODULES (ETCM) 129
8.5.1 HIGHER ACCURACY AND PRECISION 129
TABLE 86 ETCM: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 129
TABLE 87 ETCM: DRIVE BY WIRE MARKET, BY COMPONENT, 2022–2027 (‘000 UNITS) 130
TABLE 88 ETCM: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION ) 130
TABLE 89 ETCM: DRIVE BY WIRE MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 130
8.6 ELECTRONIC TRANSMISSION CONTROL UNITS (ETCU) 131
8.6.1 GROWING ADOPTION OF AUTOMATIC TRANSMISSION TO BOOST SEGMENT 131
TABLE 90 ETCU: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 131
TABLE 91 ETCU: DRIVE BY WIRE MARKET, BY COMPONENT, 2022–2027 (‘000 UNITS) 131
TABLE 92 ETCU: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 131
TABLE 93 ETCU: DRIVE BY WIRE MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 132
8.7 FEEDBACK MOTORS 132
8.7.1 LOW MAINTENANCE AND HIGH EFFICIENCY 132
TABLE 94 FEEDBACK MOTORS: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 132
TABLE 95 FEEDBACK MOTORS: DRIVE BY WIRE MARKET, BY COMPONENT, 2022–2027 (‘000 UNITS) 133
TABLE 96 FEEDBACK MOTORS: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 133
TABLE 97 FEEDBACK MOTORS: DRIVE BY WIRE MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 133
8.8 PARKING PAWL 134
8.8.1 BETTER TRACTION CONTROL 134
TABLE 98 PARKING PAWL: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 134
TABLE 99 PARKING PAWL: DRIVE BY WIRE MARKET, BY COMPONENT, 2022–2027 (‘000 UNITS) 134
TABLE 100 PARKING PAWL: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 134
TABLE 101 PARKING PAWL: DRIVE BY WIRE MARKET, BY COMPONENT, 2022–2027 (USD MILLION) 135
9 DRIVE BY WIRE MARKET, BY ON-HIGHWAY VEHICLE 136
9.1 INTRODUCTION 137
9.1.1 RESEARCH METHODOLOGY 137
9.1.2 ASSUMPTIONS 137
9.1.3 INDUSTRY INSIGHTS 138
FIGURE 37 DRIVE BY WIRE MARKET, BY ON-HIGHWAY VEHICLE, 2022 VS. 2027 (USD MILLION) 138
TABLE 102 DRIVE BY WIRE MARKET, BY ON-HIGHWAY VEHICLE, 2018–2021 (‘000 UNITS) 138
TABLE 103 DRIVE BY WIRE MARKET, BY ON-HIGHWAY VEHICLE, 2022–2027 (‘000 UNITS) 139
TABLE 104 DRIVE BY WIRE MARKET, BY ON-HIGHWAY VEHICLE, 2018–2021 (USD MILLION) 139
TABLE 105 DRIVE BY WIRE MARKET, BY ON-HIGHWAY VEHICLE, 2022–2027 (USD MILLION) 139
9.2 PASSENGER CARS 140
9.2.1 GROWING DEMAND AND SALES OF PREMIUM CARS TO DRIVE MARKET 140
TABLE 106 PASSENGER CARS: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 140
TABLE 107 PASSENGER CARS: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (‘000 UNITS) 140
TABLE 108 PASSENGER CARS: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 141
TABLE 109 PASSENGER CARS: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (USD MILLION) 141
9.3 LIGHT COMMERCIAL VEHICLES (LCV) 141
9.3.1 PROVIDES AUTOMATIC TRANSMISSION 141
TABLE 110 LIGHT COMMERCIAL VEHICLES: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 142
TABLE 111 LIGHT COMMERCIAL VEHICLES: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (‘000 UNITS) 142
TABLE 112 LIGHT COMMERCIAL VEHICLES: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 142
TABLE 113 LIGHT COMMERCIAL VEHICLES: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (USD MILLION) 143
9.4 TRUCKS 143
9.4.1 BETTER MANEUVERABILITY AND REDUCED EMISSIONS 143
TABLE 114 TRUCKS: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 143
TABLE 115 TRUCKS: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (‘000 UNITS) 144
TABLE 116 TRUCKS: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 144
TABLE 117 TRUCKS: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (USD MILLION) 144
9.5 BUSES 145
9.5.1 INCREASED ADOPTION OF SHIFT-BY-WIRE EXPECTED TO DRIVE MARKET 145
TABLE 118 BUSES: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 145
TABLE 119 BUSES: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (‘000 UNITS) 145
TABLE 120 BUSES: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 146
TABLE 121 BUSES: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (USD MILLION) 146
10 DRIVE BY WIRE MARKET, BY ELECTRIC VEHICLE TYPE 147
10.1 INTRODUCTION 148
10.1.1 RESEARCH METHODOLOGY 148
10.1.2 ASSUMPTIONS 148
10.1.3 INDUSTRY INSIGHTS 149
FIGURE 38 DRIVE BY WIRE MARKET, BY ELECTRIC VEHICLE TYPE, 2022 VS. 2027 (USD MILLION) 149
TABLE 122 ELECTRIC VEHICLE DRIVE BY WIRE MARKET, BY TYPE, 2018–2021 (‘000 UNITS) 149
TABLE 123 ELECTRIC VEHICLE TYPE DRIVE BY WIRE MARKET, BY TYPE, 2022–2027 (‘000 UNITS) 150
TABLE 124 ELECTRIC VEHICLE TYPE DRIVE BY WIRE MARKET, BY TYPE, 2018–2021 (USD MILLION) 150
TABLE 125 ELECTRIC VEHICLE TYPE DRIVE BY WIRE MARKET, BY TYPE, 2022–2027 (USD MILLION) 150
10.2 BATTERY ELECTRIC VEHICLES (BEV) 151
10.2.1 INCREASED INVESTMENTS BY AUTOMAKERS TO ELECTRIFY PRODUCTS TO DRIVE MARKET 151
TABLE 126 BEV: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 151
TABLE 127 BEV: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (‘000 UNITS) 151
TABLE 128 BEV: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 152
TABLE 129 BEV: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (USD MILLION) 152
10.3 PLUG-IN HYBRID ELECTRIC VEHICLES (PHEV) 152
10.3.1 BENEFITS LIKE VEHICLE WEIGHT REDUCTION 152
TABLE 130 PHEV: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 153
TABLE 131 PHEV: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (‘000 UNITS) 153
TABLE 132 PHEV: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 153
TABLE 133 PHEV: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (USD MILLION) 153
10.4 FUEL CELL ELECTRIC VEHICLES (FCEV) 154
10.4.1 DEVELOPMENTS IN FCEV DRIVE BY WIRE COMPONENTS 154
TABLE 134 FCEV: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (‘000 UNITS) 154
TABLE 135 FCEV: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (‘000 UNITS) 154
TABLE 136 FCEV: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 155
TABLE 137 FCEV: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (USD MILLION) 155
11 EV DRIVE BY WIRE MARKET, BY SENSOR TYPE 156
11.1 INTRODUCTION 157
11.1.1 RESEARCH METHODOLOGY 157
11.1.2 ASSUMPTIONS 157
11.1.3 INDUSTRY INSIGHTS 157
TABLE 138 NUMBER OF SENSORS USED PER EV DRIVE BY WIRE APPLICATION 158
FIGURE 39 EV DRIVE BY WIRE MARKET, BY SENSOR TYPE, 2022 VS. 2027 (USD MILLION) 158
TABLE 139 EV DRIVE BY WIRE MARKET, BY SENSOR TYPE, 2018–2021 (‘000 UNITS) 158
TABLE 140 EV DRIVE BY WIRE MARKET, BY SENSOR TYPE, 2022–2027 (‘000 UNITS) 159
TABLE 141 EV DRIVE BY WIRE MARKET, BY SENSOR TYPE, 2018–2021 (USD MILLION) 159
TABLE 142 EV DRIVE BY WIRE MARKET, BY SENSOR TYPE, 2022–2027 (USD MILLION) 159
11.2 BRAKE PEDAL SENSORS 160
11.2.1 OPTIMIZATION OF REGENERATIVE BRAKING MECHANISM TO DRIVE MARKET 160
TABLE 143 EV BRAKE PEDAL SENSORS MARKET, BY REGION, 2018–2021 (‘000 UNITS) 160
TABLE 144 EV BRAKE PEDAL SENSORS MARKET, BY REGION, 2022–2027 (‘000 UNITS) 160
TABLE 145 EV BRAKE PEDAL SENSORS MARKET, BY REGION, 2018–2021 (USD MILLION) 161
TABLE 146 EV BRAKE PEDAL SENSORS MARKET, BY REGION, 2022–2027 (USD MILLION) 161
11.3 HANDWHEEL ANGLE SENSORS 161
11.3.1 MANDATE FOR ELECTRONIC STABILITY CONTROL TO INCREASE DEMAND 161
TABLE 147 EV HANDWHEEL ANGLE SENSORS MARKET, BY REGION, 2018–2021 (‘000 UNITS) 162
TABLE 148 EV HANDWHEEL ANGLE SENSORS MARKET, BY REGION, 2022–2027 (‘000 UNITS) 162
TABLE 149 EV HANDWHEEL ANGLE SENSORS MARKET, BY REGION, 2018–2021 (USD MILLION) 162
TABLE 150 EV HANDWHEEL ANGLE SENSORS MARKET, BY REGION, 2022–2027 (USD MILLION) 163
11.4 GEAR SHIFT POSITION SENSORS 163
11.4.1 EASY INTEGRATION WITH ICE AND EV VEHICLES 163
TABLE 151 EV GEAR SHIFT POSITION SENSORS MARKET, BY REGION, 2018–2021 (‘000 UNITS) 163
TABLE 152 EV GEAR SHIFT POSITION SENSORS MARKET, BY REGION, 2022–2027 (‘000 UNITS) 164
TABLE 153 EV GEAR SHIFT POSITION SENSORS MARKET, BY REGION, 2018–2021 (USD MILLION) 164
TABLE 154 EV GEAR SHIFT POSITION SENSORS MARKET, BY REGION, 2022–2027 (USD MILLION) 164
11.5 PINION ANGLE SENSORS 165
11.5.1 INCREASING ADOPTION OF STEER-BY-WIRE TO BOOST SEGMENT 165
TABLE 155 EV PINION ANGLE SENSORS MARKET, BY REGION, 2018–2021 (‘000 UNITS) 165
TABLE 156 EV PINION ANGLE SENSORS MARKET, BY REGION, 2022–2027 (‘000 UNITS) 165
TABLE 157 EV PINION ANGLE SENSORS MARKET, BY REGION, 2018–2021 (USD MILLION) 165
TABLE 158 EV PINION ANGLE SENSORS MARKET, BY REGION, 2022–2027 (USD MILLION) 166
11.6 PARK SENSORS 166
11.6.1 ADVANCED DRIVING FEATURES 166
TABLE 159 EV PARK SENSORS MARKET, BY REGION, 2018–2021 (‘000 UNITS) 166
TABLE 160 EV PARK SENSORS MARKET, BY REGION, 2022–2027 (‘000 UNITS) 167
TABLE 161 EV PARK SENSORS MARKET, BY REGION, 2018–2021 (USD MILLION) 167
TABLE 162 EV PARK SENSORS MARKET, BY REGION, 2022–2027 (USD MILLION) 167
11.7 THROTTLE PEDAL SENSORS 168
11.7.1 ENHANCED DRIVING COMFORT AND INCREASED BATTERY EFFICIENCY 168
TABLE 163 EV THROTTLE PEDAL SENSORS MARKET, BY REGION, 2018–2021 (‘000 UNITS) 168
TABLE 164 EV THROTTLE PEDAL SENSORS MARKET, BY REGION, 2022–2027 (‘000 UNITS) 168
TABLE 165 EV THROTTLE PEDAL SENSORS MARKET, BY REGION, 2018–2021 (USD MILLION) 168
TABLE 166 EV THROTTLE PEDAL SENSORS MARKET, BY REGION, 2022–2027 (USD MILLION) 169
11.8 THROTTLE POSITION SENSORS 169
11.8.1 DECREASING POPULARITY OF PHEV TO REDUCE MARKET SHARE 169
TABLE 167 EV THROTTLE POSITION SENSORS MARKET, BY REGION, 2018–2021 (‘000 UNITS) 169
TABLE 168 EV THROTTLE POSITION SENSORS MARKET, BY REGION, 2022–2027 (‘000 UNITS) 169
TABLE 169 EV THROTTLE POSITION SENSORS MARKET, BY REGION, 2018–2021 (USD MILLION) 170
TABLE 170 EV THROTTLE POSITION SENSORS MARKET, BY REGION, 2022–2027 (USD MILLION) 170
12 DRIVE BY WIRE MARKET, BY OFF-HIGHWAY VEHICLE 171
12.1 INTRODUCTION 172
12.1.1 RESEARCH METHODOLOGY 172
12.1.2 ASSUMPTIONS 172
12.1.3 INDUSTRY INSIGHTS 173
FIGURE 40 OFF-HIGHWAY VEHICLE DRIVE BY WIRE MARKET, 2022 VS. 2027 (USD MILLION) 173
TABLE 171 OFF-HIGHWAY VEHICLE DRIVE BY WIRE MARKET, BY VEHICLE TYPE, 2018–2021 ('000 UNITS) 173
TABLE 172 OFF-HIGHWAY VEHICLE DRIVE BY WIRE MARKET, BY VEHICLE TYPE, 2022–2027 ('000 UNITS) 174
TABLE 173 OFF-HIGHWAY VEHICLE DRIVE BY WIRE MARKET, BY VEHICLE TYPE, 2018–2021 (USD MILLION) 174
TABLE 174 OFF-HIGHWAY VEHICLE DRIVE BY WIRE MARKET, BY VEHICLE TYPE, 2022–2027 (USD MILLION) 174
12.2 AGRICULTURE TRACTORS 175
12.2.1 DEVELOPMENT OF INTELLIGENT TECHNOLOGIES EXPECTED TO DRIVE SEGMENT 175
TABLE 175 AGRICULTURE TRACTORS: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 ('000 UNITS) 175
TABLE 176 AGRICULTURE TRACTORS: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 ('000 UNITS) 175
TABLE 177 AGRICULTURE TRACTORS: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 176
TABLE 178 AGRICULTURE TRACTORS: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (USD MILLION) 176
12.3 CONSTRUCTION AND MINING EQUIPMENT 177
12.3.1 INCREASED FUEL ECONOMY OF AUTONOMOUS EQUIPMENT EXPECTED TO DRIVE DEMAND 177
TABLE 179 CONSTRUCTION AND MINING EQUIPMENT: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 ('000 UNITS) 177
TABLE 180 CONSTRUCTION AND MINING EQUIPMENT: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 ('000 UNITS) 178
TABLE 181 CONSTRUCTION AND MINING EQUIPMENT: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 178
TABLE 182 CONSTRUCTION AND MINING EQUIPMENT: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (USD MILLION) 178
12.4 FORKLIFTS 179
12.4.1 INCREASING INDUSTRIAL OPERATIONS AND GROWTH OF E-COMMERCE TO DRIVE MARKET 179
TABLE 183 FORKLIFTS: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 ('000 UNITS) 179
TABLE 184 FORKLIFTS: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 ('000 UNITS) 179
TABLE 185 FORKLIFTS: DRIVE BY WIRE MARKET, BY REGION, 2018–2021 (USD MILLION) 180
TABLE 186 FORKLIFTS: DRIVE BY WIRE MARKET, BY REGION, 2022–2027 (USD MILLION) 180
13 AUTONOMOUS VEHICLE DRIVE BY WIRE MARKET, BY APPLICATION 181
13.1 INTRODUCTION 182
13.1.1 RESEARCH METHODOLOGY 182
13.1.2 ASSUMPTIONS 182
13.1.3 INDUSTRY INSIGHTS 183
FIGURE 41 AUTONOMOUS VEHICLE DRIVE BY WIRE MARKET, BY REGION, 2025 VS. 2030 (USD MILLION) 183
TABLE 187 AUTONOMOUS VEHICLE: DRIVE BY WIRE MARKET, BY REGION, 2025–2030 ('000 UNITS) 183
TABLE 188 AUTONOMOUS VEHICLE: DRIVE BY WIRE MARKET, BY REGION, 2025–2030 (USD MILLION) 184
TABLE 189 AUTONOMOUS VEHICLE: DRIVE BY WIRE MARKET, BY APPLICATION, 2025–2030 (‘000 UNITS) 184
TABLE 190 AUTONOMOUS VEHICLE: DRIVE BY WIRE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 185
13.2 BRAKE-BY-WIRE 185
TABLE 191 AUTONOMOUS VEHICLE: BRAKE-BY-WIRE MARKET, BY REGION, 2025–2030 ('000 UNITS) 185
TABLE 192 AUTONOMOUS VEHICLE: BRAKE-BY-WIRE MARKET, BY REGION, 2025–2030 (USD MILLION) 186
13.3 PARK-BY-WIRE 186
TABLE 193 AUTONOMOUS VEHICLE: PARK-BY-WIRE MARKET, BY REGION, 2025–2030 ('000 UNITS) 186
TABLE 194 AUTONOMOUS VEHICLE: PARK-BY-WIRE MARKET, BY REGION, 2025–2030 (USD MILLION) 186
13.4 SHIFT-BY-WIRE 187
TABLE 195 AUTONOMOUS VEHICLE: SHIFT-BY-WIRE MARKET, BY REGION, 2025–2030 ('000 UNITS) 187
TABLE 196 AUTONOMOUS VEHICLE: SHIFT-BY-WIRE MARKET, BY REGION, 2025–2030 (USD MILLION) 187
13.5 STEER-BY-WIRE 187
TABLE 197 AUTONOMOUS VEHICLE: STEER-BY-WIRE MARKET, BY REGION, 2025–2030 ('000 UNITS) 188
TABLE 198 AUTONOMOUS VEHICLE: STEE-BY-WIRE MARKET, BY REGION, 2025–2030 (USD MILLION) 188
13.6 THROTTLE-BY-WIRE 188
TABLE 199 AUTONOMOUS VEHICLE: THROTTLE-BY-WIRE MARKET, BY REGION, 2025–2030 ('000 UNITS) 189
TABLE 200 AUTONOMOUS VEHICLE: THROTTLE-BY-WIRE MARKET, BY REGION, 2025–2030 (USD MILLION) 189

※参考情報

ドライブバイワイヤーとは、車両の操作系を電子的な信号によって制御する技術のことを指します。従来の機械的なリンクやワイヤーを使用するのではなく、センサー、アクチュエーター、ECU（エンジンコントロールユニット）などの電子機器を使用して、運転者の意図を車両に伝えます。この技術は、自動車の操縦性や安全性、快適性を向上させるために導入されています。
ドライブバイワイヤーにはいくつかの種類があります。まず、スロットルバイワイヤーが挙げられます。これは、アクセルペダルの操作を電子信号に変換し、エンジンのスロットルを制御します。運転者がアクセルを踏むと、その情報がセンサーによってECUに送られ、ECUがエンジンのスロットルバルブを調整する仕組みです。スロットルバイワイヤーは、エンジンの応答性を向上させるだけでなく、燃費の向上や排出ガスの低減にも寄与しています。

次に、ブレーキバイワイヤーについてです。これは、ブレーキペダルの操作を電気信号に変換し、ブレーキシステムをアクチュエートします。ブレーキバイワイヤーは、センサーとアクチュエーターを使用して、ブレーキの作動を迅速かつ正確に行うことができます。これにより、ブレーキの応答性を高め、運転者の意図に即した制動が可能となります。

さらに、ステアリングバイワイヤーも重要な技術です。これにより、ステアリングホイールの回転が電子信号に変換され、タイヤを操るためのアクチュエーターが制御されます。ステアリングバイワイヤーは、パワーステアリングと組み合わせることで、運転しやすさやハンドリング性能を大幅に向上させます。また、運転シナリオに応じた操舵特性の調整も容易になります。

ドライブバイワイヤーの用途は多岐にわたります。主に自動車産業で利用されていますが、航空機や工業機械、無人機（ドローン）など、さまざまな分野にも応用が進んでいます。例えば、航空機でのフライバイワイヤー技術は、操縦性や安定性を向上させるために用いられています。無人機では、精密な操作が求められるため、ドライブバイワイヤー技術が不可欠です。これにより、複雑な制御が可能になり、様々な環境での運用を支えています。

ドライブバイワイヤーの関連技術には、センサー技術、通信技術、データ処理技術が含まれます。センサーは、運転者の操作を正確に把握し、リアルタイムでデータをECUに送信します。通信技術は、各種デバイス間の情報伝達を行うため、非常に重要です。CAN（Controller Area Network）バスなどのプロトコルが用いられ、効率的なデータ通信が実現されています。また、データ処理技術は、センサーからの情報を分析し、適切なアクションを実行するために必要な処理を行います。

ドライブバイワイヤーの導入は、車両の安全性や効率性を高めるだけでなく、自動運転技術の発展にも寄与しています。電子制御システムを基盤とすることで、より複雑な制御が可能になり、運転者が求めるスタイルや環境に応じた運転支援機能を実現することができます。自動運転車では、ドライブバイワイヤーが欠かせない要素となり、運転行動の自動化を進める上での基盤となっています。

このように、ドライブバイワイヤー技術は、自動車をはじめとする様々な輸送手段や自動制御システムにおいて、今後ますます重要な役割を果たすことが期待されています。技術の進化に伴い、さらに便利で安全な運転環境が実現されるでしょう。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

globalresearch のすべての投稿

微小残存病変検査の世界市場予測（～2027）：技術別、用途別、エンドユーザー別、地域別

電池製造機の世界市場予測（～2027）：製品種類別、電池種類別、用途別、地域別

5G NTNの世界市場予測（～2027）：コンポーネント別、産業別、用途別、地域別

医薬品原薬（API）の世界市場予測（～2027）：種類別、メーカー別、合成別、製品別、薬物別、用途別

ドライブバイワイヤーの世界市場予測（～2027）：用途別、センサー別、車両別、コンポーネント別、地域別

グローバル市場調査会社